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In this thesis the development of novel synthetic methodologies and their application 
towards the syntheses of cell cycle regulators using palladium-catalysed 
cross-coupling reactions and microwave assisted organic synthesis is presented. This 
synthetic methodology was developed in order to generate small libraries of nitrogen 
containing heterocycles with inherent structural diversity. To achieve this aim, 
a palladium catalysed cross-coupling approach was chosen, in which, particularly, 
carbon-carbon and carbon-nitrogen bond forming reactions were implemented. For 
palladium catalysed C-C and C-N bond forming reactions, microwave-assisted 
procedures can improve the combinatorial productivity significantly and, 
consequently, in this work, microwave conditions were systematically implemented 
to minimise the reaction times, optimise chemical yields, and reduce solvent waste, 
which is in concurrence with the growing societal need for sustainable developments. 
A general and versatile method for the synthesis of 13-aryl/alkylarylidene malonates 
has been developed. It has been shown that the key step involves the coupling of an 
arylboronic acid II with a 3-ch1oroa1ky1Iarylidene malonate, I, in the presence of 
K2CO3 and 1 mol % of the air-stable palladium catalyst (POPd) under microwave 
irradiation, to afford 3-aryl/alkylarylidene malonates III in good yields. The 
combination of mild reaction conditions, an air-stable catalyst, and microwave 
assisted chemistry, and high levels of functional group compatibility render this an 
attractive synthetic approach to this class of compounds. 
'—OEt 	
POPd (1 mol%) 	 0 
R 	 Ri + 	 ,OH 	OEt K2CO3K2 3 (3.0 equiv) 
/I CI 	OEt 	 OH 	THF, 100°C 	 OEt 
0 MW, 3Omin 0 
R_i  
I 	 II 	 III 
Furthermore, herein is reported a novel method for the synthesis of N-substituted 
oxindoles, VI, involving a two-step process which commences with an initial 
lv 
Abstract 
microwave-assisted amide bond formation between 2-haloarylacetic acids IV and 
various alkylamines and anilines, V, followed by a palladium catalysed 
intramolecular amidation under aqueous conditions. In the case of alkylamines, the 
procedure can be carried out as a one-pot process without isolation of the 
intermediate amide. 
OH 
R 1_(T + H2N—R 
Iv 	 V 
R = alkyl, aryl 
X = Br, CI 
MW, 300W, 150 °C, 30 mm 
Pd(OAc)2/X-Phos 
base, H20/toluene or toluene 
MW, 75W, 100 0C, 30 mm 
R 1_ffl=O 
VI 
Lastly, a novel and general method has been developed for the synthesis of 
bis-aryllalkyl thioureas, IX, involving a two-step process commencing with a 
microwave-assisted amide bond formation between carboxylic acids VII and 
ethylenediamine, followed by formation of a thiourea, which was achieved by 
treating with aryl/alkyl isothiocyanates. 
F1 	 alkyl/aryl 	 Ii 	S 
OH ethylenediamine isothiocyanate 
0 	MW, 1500C 	
R' 	
0 	
CH2Cl2, MW 	'>c 	0 	H H RC/ 	
25 mm 	 75 0C, 30 mm 
VII 	 VIII 	 LX 
R = substituent 
R 1 = alkyVaryl 
Apart from the above key reactions, other synthetic routes have been investigated 
towards the synthesis of inhibitors of cell cycle regulators based on the structure of 
pyrimidine-2,4,6-triones (X & XI) which have led to the development of novel 
reactions using alloxan coupling to various C-H acidic components to produce 
derivatives based on the pyrimidinetrione skeleton. 
R1 	
R2 
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This thesis describes the development and application of new methods for the 
synthesis of inhibitors of cell cycle regulators, in particular p53-HDM2 and cyclin 
dependent kinases (CDK's). By way of introduction, a general review of the cell 
cycle and its regulatory components is given, followed by a review of the literature 
on microwave assisted organic synthesis and its application of transition metal 
catalysed cross coupling reactions. Finally, detailed aspects of the synthetic routes 
employed towards the generation of novel methods (compounds) have been 
described. 
1.1 	The cell cycle 
The cell cycle, the general sequence of events that occur during the lifetime of a 
eukaryotic cell, is divided into four distinct phases: Mitosis and cell division occur 
during the relatively brief M phase (around 1 hour); the G 1 phase (for gap, around 
10 hours), which accounts for the longest part of the cell cycle; the S phase 
(for synthesis, 6-8 hours), which, in contrast to events in prokaryotes, is the only 
period in the cell cycle when DNA is synthesised; and the G2 phase (2-6 hours), 





Figure 1.1: The Cell Cycle. 
The cell then enters M phase once again and thereby commences a new round of the 
cell cycle.' Late in the G 1 phase a cell encounters a restriction point, which marks the 
1 
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point at which the cell is able to proceed to S phase or to withdraw into a resting state 
(G0 phase). One of the tasks of the restriction point is to ensure that DNA is not 
damaged. Too many mutations, deletions etc. could increase the risk of cancer or 
other cell dysfunctions. 
The cell cycle is controlled by at least two mechanisms. The first mechanism of 
control involves a highly regulated kinase family called the cyclins. 2 Activation of a 
transiently expressed cyclin through association with a second protein subunit, a 
cyclin-dependant kinase (CDK), generates a complex with unique substrate 
specificity. Regulatory phosphorylation and dephosphorylation fine-tune the activity 
of the CDK-cyclin complex, allowing the progression of the cell through 
well-delineated transitions between cell cycle stages. 3 
A second regulatory mechanism in the cell cycle involves cell cycle checkpoints that 
monitor completion of critical events such as DNA replication and chromosome 
segregation .4  The primary cell cycle checkpoint is the restriction point at the G 1 -S 
phase transition after which, the cell is generally committed to a further round of 
DNA replication and division. There is also a checkpoint at the G 2-M phase 
transition, which prevents cells with incompletely replicated or damaged DNA from 
entering mitosis. 5 The activation of these checkpoints causes a delay in cell cycle 
progression, thus averting the danger of mutation. Two additional proteins that play 
important roles in cell cycle checkpoints are p53 and the retinoblastoma gene product 
RB, both tumour suppressors. 
1.2 The cell cycle and cancer 
In cancer, there are fundamental alterations in the genetic control of cell division, 
resulting in an unrestrained cell proliferation. Mutations mainly occur in two classes 
of genes: proto-oncogenes and tumour suppressor genes. In normal cells, the 
products of proto-oncogenes act at different levels along the pathways that stimulate 
cell proliferation. Mutated versions of proto-oncogenes or oncogenes can promote 
tumour growth. Inactivation of tumour suppressor gene p53 results in dysfunction of 
2 
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proteins that normally inhibit cell cycle progression. Cell cycle deregulation 
associated with cancer occurs through mutation of proteins important at different 
levels of the cell cycle. In cancer, mutations have been observed in genes encoding 
CDK, cyclins, CDK activating enzymes, CDK substrates and checkpoint proteins. 6 ' 7 
Eukaryotic cells have many defence mechanisms against cancerogenetic 
transformation, for example tumour suppressor proteins, such as p53 act as inhibitors 
of tumour development. Deregulation of p53, either by mutations, or by inhibition by 
other proteins was found in a majority of human cancers. HDM2 (Human Double 
Minute, the human homologue of Mouse Double Minute, MDM2) is responsible for 
keeping the level of p53 under control. Interaction of these two proteins leads to p53 
inhibition and consequent degradation. Excessive expression of HDM2 is very often 
observed in many types of cancer. Hence, disruption of p53-HDM2 complex might 
be effective in cancer therapy. Characterising the binding mode of small organic 
compounds acting as antagonists of these interactions, might offer the basis for 
structure-based drug design. 
1.3 The inhibition of p53-HDM2 interaction 
The aim of this project was to investigate the potential of small molecules to act as 
drugs to release wt-p53 from the p53-HDM2 complex. This should be beneficial for 
treating certain cancers in which an HDM2-related pathway of p53 inactivation is in 
operation. The gene for the p53 tumour suppressor protein plays a vital role in 
regulating cell growth. Since it is a tumour suppressor, it halts abnormal growth in 
normal cells and therefore prevents cancer. Mutations in this gene can cause it to 
function incorrectly, resulting in ineffective regulation of the cell cycle, and the 
possibility of cancer. 
1.3.1 The role of p53 
Known as the "guardian of the genome," and named 1993 "Molecule of the Year" by 
Science, p53 protects human DNA. The p53 gene encodes for a tumour-suppressor 
protein that provides surveillance and direction of many cellular activities. Normal 
3 
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p53 is active in control of the cell cycle, determining when and if cells are replicated, 
through interactions with various genes and proteins. When a piece of DNA is 
damaged, p53 detects the problems and stops DNA replication, allowing repair of the 
site. The p53 protein is also thought to play a role in apoptosis, a process of orderly 
cell suicide that occurs when a cell receives a signal to self-destruct. Also called 
programmed cell death, apoptosis is a normal process during growth and 
development, helping the body to rid itself of injured or obsolete cells. When p53 is 
mutated, it is unable to perform these vital functions, thereby allowing cancerous 
cells to survive and proliferate. In fact, altered p53 proteins are found in more than 
50% of all cancers. 
1.3.2 The role of HDM2 
A number of viral oncogenes target the tumour suppressor protein p53 and inactivate 
its function. This is an important step in tumourogenesis. The cellular oncogene 
HDM2 acts through a similar mechanism. It binds the N terminus of p53, thereby 
interfering with the ability of p53 transcriptionally to activate genes responsible for 
growth arrest or apoptosis. 
1.3.3 Inhibition of p53-HDM2 interaction 
In normal cells, the wt- p53 protein is present at a very low concentration. However, 
in response to various stimuli, it accumulates and thus induces cell-cycle arrest 
and/or apoptosis. 8 Many studies show that p53 and HDM2 form an auto-regulatory 
feed back loop. 9, 10 In this loop, p53 stimulates the synthesis of HDM2 and the newly 
synthesised HDM2 protein inhibits the transcriptional activity of p53 by binding to 
its transactivation domain. An additional mechanism by which HDM2 regulates p53 
protein is p53 degradation mediated by HDM2." The disruption of the interaction 
between the two proteins is therefore an attractive therapeutic target for treatment of 
the subset of human cancers expressing wt-p53 protein, assuming that they have a 
functional p53 pathway. 12  Three independent groups have demonstrated the 
feasibility of this strategy: Lane et al. have shown that p53 accumulation and 
12 
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activation are induced by the expression of a modified thioredoxin protein which is 
actually a peptidic inhibitor of p53-HDM2 interaction;' 3 Blaydes et al. revealed that 
the anti-HDM2 antibody, 3G5, increased p53 activity by preventing the binding of 
HDM2 to p53; 14 Wasylyk et al. suggested that a peptidic inhibitor, which was fused 
to the glutathione S-transeferase (GST) protein, induced p53 activity in some tumour 
cells. 15  However, after insertion into the thioredoxin protein or fusion to the GST, 
these peptides not only have inhibitory properties, but can also create steric clashes 
that affect the peptide function. 
The crystal structure of p53-HDM2 complex was determined in 1996 (Figure 1.2). 16 
The 109-residue amino-terminal domain of HDM2 bound to an 11-residue 
transactivation domain peptide of p53 revealed that HDM2 has a deep hydrophobic 
cleft on which the p53 peptide binds as an amphipathic cc-helix. The interface relies 
on the steric complementarity between the HDM2 cleft and the hydrophobic face of 
the p53 a helix and, in particular, on a triad of p53 amino acids, Phe' 9, Trp23 , and 
Leu26, which insert deep into the HDM2 cleft. These same p53 residues are also 
involved in transactivation, supporting the hypothesis that HDM2 inactivates p53 by 
concealing its transactivation domain (Figure 1.2). 16  The inactivation of p53 through 
the binding of HDM2 protein is of particular interest from a therapeutic point of view 
as this situation is one in which the p53 function could potentially be restored by 
disrupting the interaction of p53 with HDM2. 
Figure 1.2: X-ray crystal structure of the p53/HDM2 complex. 
The key side chains of Phel9, Trp23, and Leu26 are shown in stick representation. 
5 
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1.3.4 The design of inhibitors of the p53-HDM2 interaction 
The short sequence of contiguous amino acids on p53, shown to be essential for 
HDM2 binding, allows the design of small peptidic inhibitors which would mimic 
the interaction of p53. However, the significant Van der Waals character of the 
p53-HDM2 interaction differentiates it from most other known protein-peptide 
interactions in which there are extensive hydrogen bonding contacts. In these 
complexes, a significant proportion of the buried surface is polar, whereas in the 
p53-HDM2 complex the majority of the buried surface, amounting to some 1498 A2 
of surface area, is hydrophobic. Indeed, as approximately 70 % of the interfacial 
atoms are non-polar, a key feature of inhibitors of the p53-HDM2 interaction would 
be the presence of lipophilic groups, which, although having a negative effect on the 
oral bioavailability of the inhibitors, may provide a favourable entropic contribution 
to the binding energy upon interaction with HDM2. 17 However, it is important to 
conserve the key hydrogen bond in the p53-HDM2 complex, that exists between 
Trp23 on p53 and Leu54 on HDM2, in order to ensure sufficient affinity of the 
inhibitors. 
Several groups have reported small-molecule agents that disrupt p53-HDM2 
interaction. 182 ' Some of the few known p53—HDM2 inhibitors include the natural 
product chlorofusin, 22 ' 23 various linear peptides, 24-29  and some chalcone derivatives. 18 
More recently, Vassilev et al. identified cisimidazoline analogues as low-molecular-
weight antagonists of HDM2 in a high-throughput screening. 30  Most recently, 
peptidomimetics of the helical region of p53 based on a 0 hairpin 31  and 14-helix 
scaffolds 32  that disrupt the p53-HDM2 complexation were developed by the groups 
of Robinson and Schepartz, respectively. These studies serve as the 
proof-of-principle that the protein—protein interface of the p53-HDM2 complex 
provides a sound target for small molecule agents. 
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1.4 Inhibition of cyclin-dependent kinases (CDKs) 
The transition from one cell cycle phase to another occurs in an orderly fashion and 
is regulated by different cellular proteins. Key regulatory proteins are the 
cyclin-dependent kinases (CDKs), a family of serine/threonine protein kinases that 
are activated at specific points of the cell cycle. Until now, nine CDKs have been 
identified and, of these, five are active during the cell cycle, i.e. during G 1 
(CDK4, CDK6 and CDK2), S (CDK2), G2 and M (CDK1). Key cell-cycle 
components that currently serve as targets in drug discovery and development, 
including CDKs, are shown in Figure 1.3 .33  Details of CDK structure, functions and 
roles in regulatory mechanisms are beyond the scope of this section and are reviewed 














Figure 1.3: The mammalian Cell Cycle. 
Key cell-cycle components that currently serve as targets in drug discovery and 
development are shown in red. 33 
1.4.1 CDK inhibitors in anti-cancer drug development 
The evidence that CDKs, and their regulators and substrates are targets of genetic 
alteration in different types of human cancer has stimulated the search for chemical 
CDK inhibitors. There are two main strategies for therapeutic intervention to 
modulate CDK activity: targeting the major regulators of CDK activity 
7 
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(indirect strategy) or inhibiting the catalytic activity of the CDKs (direct strategy). 
Approaches for the former include overexpression of cyclin-dependent kinase 
inhibitor (CKI), synthesis of peptides mimicking the effects of CKI, decrease of 
cyclin levels, and modulation of the phosphorylated state of CDK and enzymes 
regulating it. 35  Until now, direct inhibition of CDK kinase activity has been the most 
successful strategy for the development of potent cell cycle inhibitors. All inhibitors 
identified so far act by competitive inhibition of ATP binding to CDK. The potential 
for disruption of ATP binding in the small, defined ATP pocket of CDK is much 
higher than disrupting a large protein-protein interface, such as a CDK-cyclin 
binding surface. 
1.4.2 The CDK2/ATP complex 
The X-ray crystal structure of a CDK2/ATP complex has been reported and reveals a 
number of key interactions between the kinase and the ligand, providing a solid 
foundation for further structure-based design of low molecular weight, 
ATP-competitive inhibitors. Hydrogen bonds have been identified between Leu83 
and N-i of ATP, between G1u81 and N(6)H 2 and between Asp86 and 0(2')H, and 
the phosphate chain of ATP interacts with the pocket at Lys33, Asn132, Asp145, 
Lys 129, Thr14 and Wat558. 36 A schematic of these key interaction is illustrated in 
Figure 1.4. 
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Figure 1.4: The CDK2/ATP complex. 
Schematic showing interactions between A TP and CDK2 at the A TP-binding site. 36 
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1.4.3 CDK2/ATP antagonist binding modes 
There have been a number of reports in the literature of X-ray crystal structures of 
small molecule inhibitors complexed with monomeric CDK2. The majority of these 
show inhibitors bound at the site occupied by the adenine ring in the CDK2/ATP 
complex. This site resembles a narrow cleft, formed between the N- and C- terminal 
domains of CDK2, the width of which is determined by the hydrophobic side chains 
of IlelO, Va118, Ala3l and Leu134. A t3-strand, containing the residues Phe8O, 
Glu8l, Leu83 and His84, forms the boundary wall of the cleft and links the N- and 
C- terminal domains. In all cases, the backbone amide groups of G1u8 1 and Leu83 
make key hydrogen bond interactions with the inhibitors, although two distinct 
hydrogen bonding patterns have been observed; one where the NH of Leu83 and the 
carbonyl of G1u81 act as a donor-acceptor pair for a complementary hydrogen bond 
donor and acceptor on the inhibitor, with an additional interaction between the 
carbonyl of Leu83 and a CH on the inhibitor; and one where the NH and carbonyl of 
Leu83 acts as a donor and acceptor to a complementary acceptor and donor pair on 
the inhibitor, with an additional interaction between an aromatic proton on the ligand 
and the carbonyl of G1u8 1. The former binding mode has been observed in CDK2 
complexes with ATP,"flavopiridol, 38 CYC2,39 whereas the latter binding mode has 
been observed for purvalanol B, 4° roscovitine. 41 
1.4.4 Small-molecule inhibitors of cyclin-dependent kinases 
CDKs are small serine/threonine kinases that display 11 common sub-domains 
shared by all protein kinases. The ATP-binding site, located in a deep cleft between 
the two lobes of the protein, contains the catalytic residues, which are conserved 
across eukaryotic protein kinases. 42 Small molecules that interact specifically with 
the ATP-binding site of CDKs represent the most immediate opportunity for 
pharmacological design. A group of compounds that occupy the ATP-binding pocket 
of the enzyme and are competitive with ATP have been characterised.43 
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Given the pivotal role of CDKs in cell-cycle regulation, much effort has focused on 
the development of small molecule cyclin-dependent kinase inhibitors (MI5). All 
CDK inhibitors identified so far share a common mechanism of action, acting at the 
ATP-binding pocket of the kinase and, in doing so, competing with ATP for binding. 
CDK inhibitors display antiproliferative properties, terminating the cell cycle in G 1 
and G2/M phases depending on the conditions and cell type. The ATP-competitive 
CDK inhibitors can be divided into two different classes according to their 
selectivity. The first class describes the unspecific kinase inhibitors, which can block 
CDKs and other unrelated serine/threonine and tyrosine kinases in similar 
concentrations. Among these inhibitors one can find active compounds such as 
staurosporine 1 and its analogue UCN-01 2 (Figure 1.5). The second class covers 
selective CDK inhibitors which block all subgroups of this family in an equipotent 
manner (for example, flavopiridol 3, Figure 1.5) and those that show a strong 
preference for one of these groups. The purine analogues olomoucin, roscovitine 4, 
flavopiridol 3 and purvalanol have proven useful both as probes for basic cell 











1 	 2 	 3 
Figure 1.5: Specific and non-specific kinase inhibitors. 
High-throughput screening of compound libraries has also identified a number of 
CDK inhibitors. Aminothiazole-based compounds are relatively selective CDK2 
inhibitors compared with CDK1 and CDK4 and the determination of structures for 
selected members of this series, in complex with CDK2, provided a rationalisation of 
10 
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their potency and selectivity. 44  Roscovitine 4 (Figure 1.6) was developed through a 
series of structure-Ieadlstructure-activity relationship studies from 
6-dimethylaminopurine, a compound that had been widely used in early cell cycle 
studies as an inhibitor of Hi kinase activity in starfish oocyte extracts .45 
R-roscovitine 5 (CYC202) (Figure 1.6) is currently undergoing phase II clinical trials 
in combination with standard chemotherapy regimes for advanced breast cancer and 















Figure 1.6: Roscovitine 4 and R-roscovitine 5 (CYC-202). 
Because these inhibitors have been the subject of reviews in recent years ,46 ' 8 the 
following section will highlight only the oxindole class of inhibitors for CDK 
inhibition. 
1.4.5 Oxindole based kinase inhibitors 
Indirubin 6 (oxindole based pharmacophore) showed a high selectivity for CDKs 
compared to other protein kinases in different in vitro tests. Several derivatives with 
enhanced pharmacological properties were synthesised because of the poor water 
solubility and low bioavailability of 6. Analogues, such as indirubin sulfate 7 and 
indirubin monoxime 8, were more active and showed a preference for CDK1, 2, and 
5 versus CDK4. The crystal structure of 7 in complex with CDK2 supported the view 
that the indirubins were ATP-competitive inhibitors (Figure 1.7). 
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The oxindole 7 forms three hydrogen bonds to the peptide backbone (G1u81 and 
Leu83, Figure 1.7) and reaches deep into the ATP binding pocket .49  Oxime 8 inhibits 
the proliferation of several cell lines in the late Gi and G2/M phases by blocking 





Figure 1.7: Schematic representation of the ATP binding pocket of CDK2 in the 
complex with ATP (A) and 7 (B). 
The hydrogen bonds to the peptide backbone are indicated in blue and red. The 
hydrophobic area of the binding region is depicted in green. The delimitation of the 
A TP binding pocket is shown in yellow. 50 
Oxindole 9 was identified, together with diarylketone 10 and the urea derivates 11 
and 12, in a high throughput screen as a moderate inhibitor of CDK4/D1 
(Figure 1.8).51  The 3,5 -di substituted oxindole derivative SU9516 13 shows a similar 
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Figure 1.8: small molecule inhibitors for cyclin-dependent kinases. 
1.4.6 Summary 
Advances in combinatorial and synthetic methods, the continued search for 
biologically relevant small molecules and the development of chemical genetics 
approaches to small molecule target identification assures that potent and specific 
inhibitors of the cell cycle will continue to be developed. In less than a decade, the 
field of chemical inhibitors of CDKs has seen spectacular developments. It has been 
accompanied by a large variety of studies ranging from kinase/inhibitor interaction at 
the atomic level (crystallography), in silico screening, molecular modeling, thorough 
investigation of the inhibitor's selectivities and cellular effects, and pre-clinical 
studies. 
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1.5 Palladium-catalysed cross-coupling reactions 
Transition-metal catalysed carbon—carbon and carbon-heteroatom bonds between or 
within functionalised and sensitive substrates provided new opportunities, 
particularly in medicinal chemistry but also in total synthesis, process chemistry and 
chemical biology. Prominent among these processes are the palladium-catalysed 
carbon—carbon and carbon-nitrogen bond forming reactions. Because the historical, 
mechanistic, theoretical, and practical aspects of these processes have been reported 
in detail, 53 ' this section will focus solely on selected applications of some important 
palladium-catalysed reactions, namely, the Suzuki, and the Buchwald-Hartwig 
amination reactions, with particular emphasis on the some of the most recent 
examples. 
Carbon-carbon and carbon-hetero atom bonds are found in many compounds that 
exhibit important biological, pharmaceutical and materials properties. 5457 Due to the 
importance of these bonds, there has been a need to develop mild and general 
methods for their synthesis. 58-60  Classically, the synthesis of such bonds involved 
nucleophilic aromatic substitution reactions, which required the use of electron 
deficient aryl halides or N2 as a leaving group. The discovery of transition-metal 
mediated reactions for the synthesis of carbon-carbon and carbon-heteroatom bonds 
was an important discovery for synthetic chemists. Most prevalent among these 
methods are the palladium(0)-catalysed cross-coupling reactions which include the 
Heck, Stille, Negishi, Sonogashira and Suzuki reactions and the Hartwig-Buchwald 
coupling (Scheme 1.1)61  These palladium(0)-based methods gained increasing 
popularity amongst pharmaceutical chemists as they are mild and generally tolerant 
of a wide-range of functional groups, hence, they can be used for the synthesis of 
complex molecules. 
14 
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Heck Reaction: 
R4 R 1 	H 
	
cat. Pd(0) 	R 1 	 R4 = aryl, benzyl, vinyl 
	
+ R4 -X 	 ON 
R2 	R3 R2 	R3 	
X = Cl, Br, I, OTf 
Stille Reaction: 
R 1 = alkyl, alkynyl, aryl, vinyl 
cat. Pd(0) 	 R2 = acyl, aryl, benzyl. vinyl 
R1 — SnR3 + R2 —x 	 ' R 1—R2 
X = Br, I, OTf, OTs 
Negishi Reaction: 
R 1 = alkyl, alkynyl, aryl, vinyl 
cat. Pd(0) 	 R2 = acyl, alkynyl, allyl, aryl, benzyl, vinyl 
R1 —ZnR2 + R3 —x 	 - 	R—R3 
X = Cl, Br, I, OAc, OP 
Sonogashira Reaction: 	
R 1 = alkyl, aryl, vinyl 
________________ 	________ 	 R2 = aryl, benzyl, vinyl cat. Pd(0) 	
R 1 = R2 = H + 	R2 —x 	
x = Cl, Br, I, OTf 
Suzuki Reaction: 
R 1 = alkyl, alkynyl, aryl, vinyl 
R 1 — BY2 	+ 	R2 —x 	
cat. Pd(0) 	
R1 	R2
R2 = alkyl, alkynyl, aryl, benzyl, vinyl 
X = Cl, Br, I, OTf, OTs 
Buchwald-Hartwig Coupling: 
cat. Pd(0) 
R 1 NH2 + R2  —x 
R1 = alkyl, aryl 
R 1 	R2 	 R2 = aryl, heteroaryl 
X = Cl, Br, I, OTf 
Scheme 1.1: The commonly utilised palladium-catalysed-cross-coupling reactions. 
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1.5.1 General mechanism for Cross-coupling reactions 
Palladium-catalysed cross-coupling reactions of organohalides (organotriflates, etc.) 
with organometallic reagents follow a general mechanistic cycle (Figure 1.9). The 
L2Pd(0) 17, a 14- electron structure [the active catalyst PdL is 12 electron when 
P(o-to03 is used as the ligand] is sometimes reduced from a Pd(II) species 14 by an 
organometallic reagent R 1 M 15. The transmetalation product 16 from the reaction of 
14 with 15 undergoes a reductive elimination step, giving rise to the Pd(0) species 
17, along with the homocoupling product R'-R'. This is one of the reasons why the 
organometallic coupling partners are often used in a slight excess relative to the 
electrophilic partners. When the Pd(0) catalyst 17 is generated, the catalytic cycle 
goes through a three-step sequence; (a) The electrophile, R 2-X 18, undergoes an 
oxidative addition step to Pd(0) to afford a 16-electron Pd(II) intermediate 19. 
(b) Subsequently, 19 undergoes a transmetalation and isomerisation step with the 
organometallic reagent, R'M 15, to produce the intermediate 21. When there is more 
than one group attached to the metal, M, such as with tin, the order of 
transmetalation for different substituents is: 
alkynyl > vinyl> aryl> allyl benzyl > alkyl 
The transmetalation step, often rate-limiting, is the step to which attention should be 
directed if the reaction goes awry. (c) Finally, with appropriate syn geometry, 
intermediate 21 undergoes a reductive elimination step to produce the coupling 
product, R2-R' 22, regenerating the palladium(0) catalyst 17 to close the catalytic 
cycle (Figure 1.9). 
trarismetalation 
L2Pd(lI) + 	R I M 	 10 
14 	15 





R 1—R 1 + L2Pd(0) 
17 
16 





















M—X 	 M—R 1 
20 	transmetalation 	15 
Figure 1.9: General mechanism for palladium-catalysed cross-coupling reactions. 
1.5.2 Suzuki reaction 
The Suzuki reaction is an extraordinarily useful palladium-catalysed carbon-carbon 
bond-forming reaction that involves the palladium-mediated coupling of organic 
electrophiles, such as aryl or vinyl halides and triflates, with organoboron 
compounds in the presence of a base (Scheme 1.1).62  The first examples of this 
protocol were reported by the Suzuki group in 197963a1  although, the inspiration for 
this development can be found in earlier work by others. 64,65  The ensuing quarter of a 
century saw remarkable developments in the field. Amongst its manifold 
applications, the Suzuki reaction is particularly useful as a method for the 
construction of conjugated dienes, as well as for biaryl and related systems. 
Furthermore, tremendous progress has been made in the development of Suzuki 
coupling reactions of unactivated alkyl halides, enabling C(sp2)-C(sp3) and even 
C(sp3)-C(sp3) bond-forming processes. 6667a) The ease of preparation of 
organoboron compounds (e.g. aryl, vinyl, alkyl) and their relative stability to air and 
water, combined with the relatively mild reaction conditions and formation of non-
toxic by-products, makes the Suzuki reaction an extremely attractive method for C-C 
bond formation. Indeed, it has become one of the most reliable and widely applied 
17 
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palladium-catalysed cross-coupling reactions in medicinal chemistry, where it has 
found a prominent role. For example, it has been applied industrially to the 
production of Losartan 23,68  which is a Merck antihypertensive drug, and has been 
used for the large scale synthesis of compound 24, which is a key intermediate for 
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Figure 1.10: Industrial applications of Suzuki reaction. 
The scope of the Suzuki reaction for synthetic applications has been surveyed in 
several excellent reviews which cover the work before 199870-75and the 
developments from 1999 to 2001 have been surveyed by Kotha, Lahin and 
Kashinath, 76 and by Miyaura. 77  On the other hand, the review published in 2002 by 
Littke and Fu 78 summarises several results from 1986 to late 2001 in the area of the 
palladium-catalysed Suzuki cross-coupling reactions of aryl chlorides. A recent 
review highlighted the complete picture of the studies carried out so far on Suzuki 
palladium-catalysed cross-coupling reactions and, in particular, on recent 
developments in the area of new efficient catalyst systems for this reaction and their 
activity towards challenging substrates. 79 
1.5.3 Suzuki reactions of aryl chlorides 
Until recently, nearly all reports of palladium-catalysed couplings described the use 
of organic bromides, iodides, and triflates as substrates. Organic chlorides, on the 
other had, were less commonly used, despite the fact that, among the halides, 
chlorides are arguably the single most useful class of substrates, as a result of their 
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lower cost, greater diversity and commercial availability. 80 Unfortunately, chlorides 
were generally unreactive under the conditions employed to couple bromides, 
iodides, and triflates. 81 ' The low reactivity of chlorides is usually attributed to the 
strength of the C-Cl bond (bond dissociation energies for Ph-X: Cl: 96 kcalmoF 1 ; 
Br: 81 kcalmor 1 ; I: 65 kcalmor 1 ),80  which leads to a reluctance of aryl chlorides to 
oxidatively add to Pd(0) centres, a critical initial step in palladium-catalysed 
coupling reactions. 82,83  A great degree of progress has been achieved since 1998 in 
the development of palladium-based catalysts that can in fact accomplish Suzuki 
cross-couplings and Heck reactions on a wide array of organic chlorides. 84 
1.5.4 Suzuki reactions of activated aryl chlorides 
Aryl chlorides, specifically, electron-poor aryl chlorides, which are activated toward 
oxidative addition, have long been known to serve as suitable substrates for Suzuki 
reactions. Thus, Suzuki couplings of heteroaryl chlorides such as chioropyridines can 
often be achieved with traditional triaryiphosphane-based palladium catalysts. 85 This 
reactivity is especially significant because of the abundance of chlorine containing 
nitrogen heterocycles that are commercially available. The use of a Suzuki reaction 
of a heteroaryl chloride to produce 2-phenyl-3-aminopyridine 26, a key intermediate 
in the synthesis of 2-phenyl-3-aminopiperidine has recently been reported 
(Scheme 1.2) .86   Direct coupling of 2-chloro-3-aminopyridine 27 with phenylboronic 
acid was unsuccessful; however, a one-pot protection/Suzuki coupling/deprotection 
sequence furnished the target compound in excellent yield on a greater than 
100-gram scale. Other interesting examples and recent developments of Suzuki 
couplings of activated aryl chlorides have been discussed in recent review by Fu. 78 
Ph 1 
NH2 PhCHO, PhB(OH)2 	 N" 	I 	 NH2 
[PdCl2(PPh3)2] 	 H30 
	
N 	aq Na2CO3, toluene, 85 °C [ 	N 	j 	 N 
ç —Ph  
27 26 
Scheme 1.2: Suzuki reaction of heteroaryl chloride. 
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1.5.5 Suzuki reactions of unactivated aryl chlorides 
Before the development of catalyst systems that could couple aryl chlorides in 1998, 
there were no reports of effective palladium catalysed Suzuki reactions of electron-
poor or electron-rich aryl chlorides. Clearly, this represented a serious limitation in 
the scope of this important process. Buchwald and co-workers reported that biphenyl 
ligands 28 and 29 are more effective ligands for palladium-catalysed Suzuki 
reactions of aryl chlorides.  87  Remarkably, this catalyst system couples a broad 
spectrum of aryl chlorides, such as electron-poor and electron-rich substrates, at 
room temperature (Scheme 1.3). 
+ (HO)2B—.(j? 	
Pd(OAc)2, 29 
xo-(~'-'—/~N—Cl 	 Y KF,THF,rt 
X = 4-NO2, CN, CO2Me, OMe 	 R 1 
Y=3-COMe, H,2-OMe 	 R=Cy, R 1 H 28 
R = f-Bu R 1 =H 29 
PR 
Scheme 1.3: Suzuki reactions of unactivated aryl chlorides. 
In the same year as the original report by Buchwald et al. Littke and Fu also 
described a versatile method for palladium catalysed Suzuki cross-couplings of aryl 
chlorides in which they used a sterically demanding and electron-rich 
trialkyiphosphane, P(t-Bu) 3 (Scheme 1. 4) . 88  Alkyl boronic acids, which are often less 
reactive in Suzuki reactions than aryl boronic acids, are suitable substrates for 
Pd/P(t-Bu) 3 . Since the original report, a number of research groups have applied 
PdfP(t-Bu) 3 to Suzuki couplings of a wide range of activated and unactivated aryl 
and heteroaryl chlorides.  89 
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IIJ 	+ (HO)2B— 	
Pd2(dba)3, P(t-Bu)3 
x  
Cs2CO 3, dioxane, 90 °C 
30 	 31 	 32 
X = 4-CO2Me, OMe, NH2 
Y = 4-CF3, H, OMe, 2-Me 
Scheme 1.4: Suzuki reactions of unactivated aryl chlorides. 
Phosphinous acids are a promising new class of phosphorus ligands for Suzuki cross 
couplings of unactivated vinyl and aryl chlorides. Hydrolysis of diorganophosphorus 
halides 33 generates phosphane oxides 35 and their less-stable phosphinous acid 
tautomers 34. Binding of a phosphinous acid to palladium can provide a P-bound 
adduct, which may be deprotonated to yield an electron-rich, anionic palladium-
phosphane complex 36 suitable as a catalyst for coupling processes (Scheme 1.5). 
Li has recently demonstrated the use of air-stable palladium(TI)complexes 
(POPd, POPd1, and POPd2) possessing phosphinous acid ligands in the cross 
coupling reactions of vinyl and aryl chlorides. The use of phosphine oxide 
[R2P(H)O] as a ligand precursor instead of phosphine ligand (R 3P) is the key to 
generate these air-stable complexes. The attraction of generating catalytically active 
electron-rich anionic species in the presence of bases, is that these complexes can 
facilitate the rate-limiting oxidative addition of unactivated aryl chlorides with 
palladium complexes, and also help stabilise transition-metal complexes in the 
catalytic cyc le. 9oab 
R 	 H20 
P—x 
R 1 	 -HX, X = Cl, Br 
33 
But ,B u t 
HO 	Ci cl 







R 1—P0 35 
H 
isolated air-stable solid 
Scheme 1.5: Synthesis of air-stable phosphinous acid ligand complexes. 
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1.5.6 The Buchwald-Hartwig amination or amidation reaction 
As a result of the pioneering efforts of Buchwald and co-workers 91  and 
Hartwig et al. 92  metal-catalysed C(aryl)-N bond formation has recently emerged as 
an extremely powerful tool for the synthesis of aniline derivatives, which are 
important in a diverse array of fields, such as pharmaceuticals, agrochemicals, and 
photography. 93a-' A simplified overview of the mechanism of the Buchwald-Hartwig 
reaction is provided in Figure 1.11. The pathway is analogous to that of the 
C-C bond-forming reactions described above (Figure 1.9), except that the 


















Figure 1.11: Simplified mechanism for palladium-catalysed C-N bond formation. 
Buchwald—Hartwig aminations usually require a catalytic system containing four 
components to efficiently generate the desired C-N bond. A palladium precursor is 
typically stabilised in solution by an adequate ligand that also raises the electron 
density at the metal to facilitate oxidative addition and provides sufficient bulkiness 
to accelerate reductive elimination. A base is required to deprotonate the amine 
substrate prior to or after coordination to the palladium centre. Owing to the often 
heterogeneous nature of the reaction due to poor solubilities of the base or substrates, 
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the solvent plays a more prominent role than in other transition metal-mediated 
processes. These four parameters, shown in Figure 1.12, greatly influence the 
performance of any given C-N coupling reaction and are all of similar importance in 
designing a screening or reaction set-up. 
paHadu urn 	
-; 
Figure 1.12: Components for Buchwald-Hartwig amination reactions. 
1.5.7 Palladium precursors for amination reactions 
The choice of a suitable palladium precursor for conducting an amination reaction is 
far more limited than the choice of the ligand. Typically, Pd(0) or Pd(II) precursors, 
are used, which can be reduced, in situ to the corresponding zero oxidation state, 
most often by the amine in the presence of phosphine and base. The most prominent 
Pd(0) precursors are Pd 2(dba)3 and Pd(dba)2 . The most versatile Pd(II) precursor is 
Pd(OAc) 2 . Concerning the catalyst loading, the range is much broader than in other 
types of cross coupling reactions. While special substrates can be coupled with 
palladium loadings down to 0.01 mol %, it is much more typical to start a screening 
set-up with 1-2 mol % of palladium. An important point concerning the reliability of 
the reaction in general is the purity of the components of the catalyst system. Organic 
or inorganic impurities in the ligand or palladium precursor can have a large impact 
on the performance of the reaction. 
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1.5.8 Ligands for the amination reaction 
Although catalyst systems containing no ligand have been reported over the last few 
years for some organometallic transformations, 94  C-N coupling reactions are usually 
carried out with an added ligand. The ratio of ligand to palladium depends mostly on 
the ligand employed and can have a distinct influence on the catalytic performance. 
The quest for suitable ligands showing higher reactivity and selectivity has been a 
field of enormous activity over the last few years. 95-97  The first ligands to be used 
were P(o-Tol) 3 98 and P(t-Bu 3). 99 The chelating bisphosphines B1NAP 37, DPPF 38 
and DtBPF 39 used by Buchwald and Hartwig then became standard until Buchwald 
reported the synthesis of monodentate phosphine ligands with a biphenyl backbone 
in 1998 (Figure 1.13).100  These ligands greatly enhanced the scope of aminations to 
aryl chlorides and unactivated aryl halides, even under very mild conditions. 101 
The design of the new bulky 2,4,6 tri-isopropyl-substituted ligand X-Phos 42 
(Figure 1.13) led to the most active and stable biphenyl based ligand to date, 102  even 




R = Ph 38 
L PPh2 	 F, e 	 R = tBu 39 
37 
gPCy2 L-P(tBU)2 	L,'PCy2 	




40 (Dave-Phos) 	41 	 42 (X-Phos) 	43 (Xant-Phos) 	44 (DPEPhos) 
Figure 1.13: Most common ligands used in C-N bond formation reactions. 
With the advent of carbenes showing outstanding performance in other 
organometallic transformations as sterically bulky and good electron-donating 
ligands, these non-phosphorus-based ligand systems increased the variety of ligand 
architectures. ' °3°6 In parallel, van Leeuwen' °7 developed Xant-Phos 43 and 
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DPEPhos 44 (Figure 1.13) that show especially high activity for coupling of aryl 
halides with amides, 108 ' 1° hydrazines, 11 ' oxazolidinones, 112 and ureas. 113 
1.5.9 Bases for the amination reaction 
The third component of the reactive system is the base which deprotonates the amine 
before or after coordination to palladium. Two types can be distinguished: bases that 
are only sparingly soluble in the typically used apolar solvent (e.g., toluene) and 
bases that give nearly homogeneous reaction mixtures. The most common bases for 
C-N couplings are: t-BuONa, t-BuOK, Cs 2 CO3 , K2CO3, NaOH, and KOH. The 
relative base strength determines the functional group tolerance. Unfortunately, 
direct comparisons of base strengths are difficult owing to heterogeneous mixtures in 
which solubilities play a significant role, as well as to the broad variety of solvents 
employed. Nevertheless, a general trend can be outlined. As already mentioned, 
solubility plays a crucial role. This is effected by the counter ion of the base 
(Cs2 CO3>K2CO3>Na2CO3) as well as more subtle parameters such as the particle 
size of the base. Apart from the base-sensitivity of the substrate, the combinations of 
base and ligand as well as base/temperature are also important parameters. Recently, 
Hartwig and Buchwald even reported the use of the most inexpensive bases 
(KOH, NaOH) in aqueous solutions which are active in combination with biphenyl-
based systems as well as Hartwig's palladium-dimer complex. 114,115 
1.5.10 Solvents for the amination reaction 
Buchwald—Hartwig aminations are usually run within an organic solvent system. 
Apart from dissolving the coupling partners as well as parts of the base and allowing 
for a respective temperature window for the reaction, the solvent also plays a crucial 
role in stabilising intermediates in the catalytic cycle. The majority of the reactions 
reported are run in toluene. 95-97  Frequently, ethers such as DME, THF or dioxane are 
used. For solubility reasons, the polar solvents DMF, NMP or DMSO can also be 
used for C-N coupling. The solvents usually have to be dry and deoxygenated but 
this is strongly dependent on the air-sensitivity of the catalyst system used. In special 
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cases, using only slightly air-sensitive phosphines, reactions can be run entirely in air 
without significant changes in yield. 106  Also, the addition of water can even be 
beneficial as can be seen from the use of aqueous bases in the amination 
reaction."""' Nevertheless, this only holds true for substrates that are not 
hydrolysed under basic conditions. Some aminations can even be run in water as the 
only solvent. 102 
1.5.11 C-N bond coupling reactions with non-amine nucleophiles 
The Buchwald—Hartwig amination methodology has also been expanded to nitrogen 
nucleophiles carrying electron-withdrawing or electron-donating groups directly 
attached to the amine such as carbonyl, sulfonyl or amino groups. These can also be 
arylated using catalysts that are similar to the classical amination systems, although 
bis-chelating ligands seem to be more versatile for this kind of transformation. 
Nevertheless, the new biaryl based phosphines also show a high activity in this 
reaction. 
1.5.12 C-N bond coupling of amides, sulfonamides, carbamates and ureas 
A large body of literature regarding the coupling of carbonic acid amides has been 
reported in the last years. Intramolecular cyclisation of bromo-substituted, amide 
functionalised arenes was reported in 1999 by Buchwald (Scheme 1.6a). 110 An 
intermolecular coupling of carbamates with aryl bromides using P(t-Bu) 3 was 
reported by Hartwig in 1999 (Scheme 1.6b). 116 In 2000, Buchwald outlined the 
intermolecular coupling of amides with aryl halides using XantPhos as the ligand. 
Using this procedure, it was shown that carbamates and sulfonamides were also 
viable substrates for the coupling reaction. Moreover, the scope was extended from 
aryl halides to aryl triflates as coupling partners (Scheme 1.6c).' 09 
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NHBn 
n 
Pd catalyst, ligand 





+ 	J1 ,-t-Bu Pd(dba)2, P-(t-Bu)3 
	
H2N 0 	 100 00 	 R 
0 	 0 
RIiI 	+ Ri_NA  R 	Pd(OAc)2 , XantPhos 	RII_R 2 H 	Cs2CO3, 1,4-dioxane, 100 00 	 R 1 
X = Br, 011, I 
0 
Ri 	
02h + 	 Pd(OAc)2, X-Phos 	 -N R  R 1—N R2 H 	 PhB(OH)2, K2CO3, 
t-BuOH, 110 00,  18-24 h 




HNYO K2CO3, toluene 
0 	
0 
Scheme 1.6: C-N bond coupling reactions with non-amine nucleophiles. 
Recently, Buchwald reported the first amidation of arenesulfonates using X-Phos 
with K2CO3 as the base and t-BuOH as the solvent (Scheme 1.6d).' °2 Further 
examples for the coupling of cyclic carbamates and ureas were provided by Ghosh 117 
and Madar.' 18 Madar used Pd2(dba) 3 in conjunction with BINAP and cesium 
carbonate as the base to couple cyclic ureas and carbamates with aryl bromides. 
Ghosh developed an efficient method for the first intermolecular cross-coupling of 
oxazolidinones with aryl chlorides using Pd 2 (dba) 3 , Cs2 CO3 or K3PO4 as the base and 
Buchwald's biaryl ligands (Scheme 1.6e). 
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1.5.13 Palladium-catalysed cross-coupling reactions of heterocycles 
The applications in which the palladium chemistry is used for the synthesis of 
heterocycles have increased exponentially over recent years. Several review articles 
summarise the development of palladium chemistry in the synthesis of heterocyclic 
products.' 19-123  A myriad of heterocycles are biologically active and therefore of 
paramount importance to medicinal and agricultural chemists. Many heterocycle-
containing natural products have elicited great interest from both academic and 
industrial research groups. Today the palladium-catalysed cross-coupling reactions 
are the common method for the synthesis of a wide range of fine chemicals, 
pharmaceutical intermediates and active pharmaceutical ingredients. 
1.5.14 Summary 
Nowadays, cross-coupling reactions appear as reliable transformations in medicinal 
chemistry, natural product syntheses and chemical biology. This has been made 
possible by the important advancements in cross-coupling chemistry, which took 
place during the last decade. 
Suzuki cross-coupling reaction is more robust and user-friendly than other coupling 
reactions and is widely employed in the synthesis of various natural and non-natural 
products. This methodology has found extensive use in the preparation of several 
drug-like molecules. Various advances to overcome the problems associated with 
less reactive electrophiles such as aryl chlorides are discussed. 
The Buchwald-Hartwig animation approach of C-N coupling is modular, owing to 
the variability of both the aryl halide and the amine nucleophile, a broad range of 
amine products is accessible, for which no other comparably versatile methodology 
is available. The reaction conditions are very robust and the reaction shows a high 
degree of reproducibility if the standard ligands are used and the conditions are 
optimised. This reliability is one of the central issues for its implementation in 
academic and pharmaceutical research laboratories. 
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1.6 Microwave-assisted chemistry-Applications in drug discovery 
The impact of genomics and proteomics is creating an explosion in the number of 
drug targets. In order to identify more potential drug candidates for all of these 
targets, pharmaceutical companies have made major investments in high-throughput 
technologies for genomic and proteomic research, combinatorial chemistry, and 
biological screening. However, lead compound optimisation remains the bottleneck 
in the drug discovery process. Developing chemical compounds with the desired 
biological properties is time-consuming and expensive. Consequently, increasing 
interest is being directed toward technologies that allow more rapid synthesis and 
screening of chemical substances to identify compounds with functional qualities. 
The conventional synthesis approach typically involves optimisation of the reaction 
conditions to afford the desired products in acceptable yields and purities. Since 
many reaction sequences require at least one or more thermally driven steps for 
extended time periods, these optimisations are invariably time-consuming. 
Microwave-assisted heating under controlled conditions has been shown to be an 
invaluable technology for medicinal chemistry and drug discovery applications, since 
it often dramatically reduces reaction times, typically from days or hours to minutes 
or even seconds. Therefore, the adoption of microwave assisted organic synthesis 
techniques enables the evaluation of many reaction parameters in a shorter time 
window compared to conventional synthesis methods, thereby enhancing the 
optimisation process. Furthermore, microwave assisted organic synthesis allows the 
rapid synthesis of libraries of compounds in either a parallel or (automated) 
sequential format using this new, enabling technology. In addition, microwave 
synthesis allows for the discovery of novel reaction pathways, which serve to expand 
"chemical space" in general, and "biologically relevant, medicinal chemistry space" 
in particular. 
Specifically, microwave synthesis has the potential to impact upon medicinal 
chemistry efforts in at least three major phases of the drug discovery process: lead 
generation, hit-to-lead efforts, and lead optimisation. To the pharmaceutical industry 
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and the medicinal chemist, time truly does equal money, and microwave chemistry 
has become a central tool in this fast-paced, time-sensitive field. 
1.6.1 Microwave-assisted organic synthesis (MAOS) 
The first reports on the use of microwave heating to accelerate organic chemical 
transformations were published by the groups of Richard Gedy& 24 and 
Raymond J. Giguere/George Majetich 125 in 1986. In the 1990s, several groups started 
to experiment with solvent-free microwave chemistry (dry-media reactions), which 
eliminated the danger of explosions. ' 26 Particularly in the early days of microwave-
assisted organic synthesis (MAOS), the solvent-free approach was very popular since 
it allowed the safe use of domestic microwave ovens and standard open-vessel 
technology and was also environmentally friendly. 
Alternatively, microwave-assisted synthesis has been carried out using standard 
organic solvents under open-vessel conditions. If solvents are heated by microwave 
irradiation at atmospheric pressure in an open vessel, the boiling point of the solvent 
typically limits the reaction temperature that can be achieved. In order to achieve 
high reaction rates, high-boiling, microwave-absorbing solvents have been frequently 
used in open-vessel microwave synthesis.' 27  It is obvious that compounds with large 
dielectric constants (DMSO, DMF, NMP) tend to absorb energy readily under 
microwave irradiation, while less polar substances or compounds with no net dipole 
moment (hexane, dioxane) are microwave inactive. However, the use of these 
solvents presented serious challenges in relation to product isolation and recycling of 
the solvent, a fact that is clearly evident surveying the recently published literature in 
the area of controlled microwave-assisted organic synthesis. It appears that the 
combination of rapid heating by microwaves with sealed-vessel (autoclave) 
technology will most likely be the method of choice for performing MAOS on a 
laboratory scale in future. Importantly, recent innovations in microwave reactor 
technology now allow controlled parallel and automated sequential processing under 
sealed-vessel conditions, and the use of continuous- or stop-flow reactors addresses 
the issue of scale-up. 
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Today, a large body of work on microwave-assisted synthesis exists in the published 
literature. Many review articles, 126-138  and several books 139-141  already provide 
extensive coverage of the subject. Since 2001, the number of publications related to 
MAOS has increased dramatically, to such a level that it might be assumed that, in a 
few years, most chemists will probably use microwave energy to heat chemical 
reactions on a laboratory scale. 142,14'  Not only is direct microwave heating able to 
reduce chemical reaction times significantly, but it is also known to reduce side 
reactions, increase yields, and improve reproducibility. Therefore, many academic 
and industrial research groups are already using MAOS as a technology for rapid 
reaction optimisation, for the efficient synthesis of new chemical entities, or for 
discovering and probing new chemical reactivity. 
1.6.2 Theories behind microwave heating 
Microwave irradiation is electromagnetic irradiation in the frequency range from 0.3 
to 300 GHz. However, most domestic microwave ovens and chemical reactors 
operate at a frequency of 2.45 GHz (corresponding to a wavelength of 12.24 cm) in 
order to avoid interference with telecommunication frequencies. The energy of the 
microwave photon in this frequency region (0.0016 eV) is too low to break chemical 
bonds and is also lower than the energy of Brownian motion. It is therefore clear that 
microwaves cannot induce chemical reactions. Microwave-enhanced chemistry is 
based on the efficient heating of materials by "microwave dielectric heating" effects. 
This phenomenon is dependent on the ability of a specific material 
(solvent or reagent) to absorb microwave energy and convert it into heat. 
The electric field component of a microwave is responsible for dielectric heating. 
There are two mechanisms associated with microwave heating: dipole polarisation 
and ionic conduction. 144  When a molecule is irradiated with microwaves it will 
attempt to align itself with the electric field by rotation (Figure 1.14).145  If the 
frequency of molecular rotation is similar to the frequency of microwave radiation 
(2.45GHz), the molecule will continually align and realign itself with the oscillating 





Figure 1.14: Dipole polarisation. 
Dipolar molecules which try to align themselves with an oscillating electric field. 
The second mechanism, ionic conduction, also contributes to the microwave heating 
effect, if ions are involved in the sample. When the ions move through the solution 
under the applied field, heat is generated by frictional losses, which depend on the 
size, charge and conductivity of the ions, converting the kinetic energy to heat 
(Figure 1.15). 1 15  This mechanism is a much more efficient method of heat generation 
than dipolar polarisation. The allocated frequency of 2.45 GHz used in all 
commercial systems lies between these two extremes and gives the molecular dipole 
time to align in the field, but not to follow the alternating field precisely. 146, "s 
Figure 1.15: Ionic conduction. 
Charged particles in a solution will follow the applied electric field. 
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1.6.3 Thermal effects 
A substance's ability to convert electromagnetic radiation into heat depends on its 
dielectric properties, 147 and is calculated by the loss angle, tan £5, which is expressed 
as tan £5 = c '7 s'. The loss factor c" quantifies the efficiency with which the 
absorbed energy is converted into heat, while e', the dielectric constant, describes the 
ability of molecules to be polarised by an electric field. A reaction medium with a 
high tan £5 value efficiently absorbs electromagnetic radiation and converts it into 
heat, whereas substances with low tan £5 values are considered transparent to 
microwaves. 130  Thermal effects are accelerations in rate that can not be achieved or 
duplicated by conventional heating but are essentially the result of dielectric heating. 
These include the superheating of solvents up to 26 °C above their boiling points 
under MW irradiation at normal atmospheric pressure, as well as the selective 
heating of strongly MW absorbing catalysts or reagents in a heterogeneous reaction 
mixture. ' 3 " The loss factors for some common organic solvents are summarised in 
Table 1.1. 
Solvent tan ö Solvent tan ö 
toluene 0.040 H20 0.123 
DCM 0.042 DMF 0.161 
THF 0.047 NMP 0.275 
acetone 0.054 MeOH 0.659 
EtOAc 0.059 DMSO 0.825 
acetonitrile 0.062 EtOH 0.941 
CHC13 0.091 ethylene glycol 1.350 
a 
Values determined at 2.45 GHz and 20 C 
Table 1.1: Loss factors (tan ) of different solvents. a 
Other common solvents without a permanent dipole moment such as carbon 
tetrachloride, benzene, and dioxane are more or less microwave transparent. It has to 
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be emphasised that a low tan 6 value does not preclude a particular solvent from 
being used in a microwave-heated reaction. Since either the substrates or some of the 
reagents/catalysts are likely to be polar, the overall dielectric properties of the 
reaction medium will in most cases allow sufficient heating by microwaves. 
Thermal effects arise from the different characteristics of microwave dielectric 
heating and conventional heating (Table 1.2). The magnitude of heating depends on 
the dielectric properties of the molecules, in contrast to conventional heating. These 
characteristics mean that absorption of the radiation and heating may be performed 
selectively. 
Microwave heating 	 Conventional heating 
Energetic coupling 









Dependent on the properties of the material Less dependent 
Table 1.2: Characteristics of microwave and conventional heating. 
Microwave irradiation is rapid and volumetric, with the whole material heated 
simultaneously and uniformly. In contrast, conventional heating is slow and is 
introduced into the sample from the surface (Figure 1.16). The thermal effects 
observed under microwave irradiation conditions are a consequence of the inverted 
heat transfer, the inhomogeneities of the microwave field within the sample and the 
selective absorption of the radiation by polar compounds. These effects can be used 
efficiently to improve processes, modify selectivities or even to perform reactions 
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Figure 1.16: Inverted temperature gradients in microwave versus oil-bath heating. 
Difference  in the temperature profiles after 1 min of microwave irradiation (left) and 
treatment in an oil bath (right). Microwave irradiation raises the temperature of the 
whole volume simultaneously (bulk heating) whereas in the oil-heated tube, the 
reaction mixture in contact with the vessel wall is heated first. 38 
1.6.4 Microwave effects 
The main advantage of using microwaves in organic synthesis is to dramatically 
shorten reaction times. However, since the introduction of microwave assisted 
organic synthesis in 1986, there have been debates about what actually alters the rate 
outcome of the synthesis? Is it merely an effect of the thermal heat generated by the 
microwave or is it a kind of "specific microwave effect?" 
By the Arrhenius Equation (Eq. 1. 1), there are basically two ways to increase the rate 
of a chemical reaction. The factor A, which describes the molecular mobility and 
depends on the frequency of vibrations of the molecules at the reaction interface, has 
been proposed to be affected. 149,150  Other investigations, however, have suggested 
that microwave irradiation produced an alteration in the exponential by changing the 
free energy AG. 151 




Chapter 1 	 Introduction 
Mingos has claimed that the rate acceleration can be contributed to the microwave 
irradiation superheating the solvent. Since c" and c' are temperature dependent, tan 
will increases with temperature. Therefore, the heating rate for these solvents will 
increase during microwave heating, probably by limiting the formation of "boiling 
nuclei". 152  This phenomenon is described as superheating and may result in the 
boiling points of solvents being raised up to 26 °C above their conventional values. 
Mingos has also estimated that superheating can lead to 10-15-fold reduction in 
reaction times for solution phase MAOS at atmospheric pressure, compared with 
traditional reflux conditions. 153  Strauss studied the kinetics of the Diels-Alder 
reaction between anthracene and diethyl maleate and found that the reaction rate is 
independent of the mode of heating by drawing the Arrhenius plot for both oil bath 
and microwave conditions. Therefore, he concluded that there is no non-thermal 
"specific microwave effect" in microwave assisted organic synthesis. Even if there is 
this effect, it should appear to be less important than stated in earlier publications. 
1.6.5 Microwave applications in organic synthesis 
The recent introduction of single-mode technology assures safe and reproducible 
experimental procedures and microwave synthesis has gained acceptance and 
popularity among the synthetic chemist community. Single-mode cavities offer more 
consistent and predictable energy distribution. Single-mode instruments produce one 
homogeneous, intense pocket of energy that is highly reproducible. Due to their 
uniform energy distribution and higher power density, these systems typically couple 
more efficiently with small samples. 
Pelle Lidstrom gave a detailed survey of MAOS from the literature published from 
l994-2000.' A recent review by Oliver Kappe highlights applications of microwave 
heating technology in organic synthesis from 2000-2004.' ° Several other reviews 
have been published on the application of microwaves to solvent-free reactions, 154,155 
cycloaddition reactions, 156  the synthesis of radioisotopes, 157  fullerene chemistry,' 58 
polymers, 159 heterocyclic chemistry, 160,161  carbohydrates,  162,163  homogeneous  164  and 
heterogeneous catalysis, 165  medicinal and combinatorial chemistry 166-171  and green 
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chemistry. 172,173  Since it is undesirable to list all of the microwave-assisted reactions, 
this section will document some of the recent synthetic applications, in particular 
transition metal catalysed C-C (Suzuki) and C-N (amination or amidation) bond 
formation reactions. 
The majority of the microwave-promoted reactions reported to date that rely on 
transition metal catalysis are catalysed by palladium. Palladium-catalysed 
carbon—carbon and carbon—heteroatom bond-forming reactions typically need hours 
or days to reach completion with traditional heating under reflux conditions and 
often require an inert atmosphere. Larhed et al. and others have demonstrated over 
the past few years that the rate of many of those transformations can be enhanced 
significantly by employing microwave heating under sealed vessel conditions, in 
most cases without an inert atmosphere. 136  The use of metal catalysts in conjunction 
with microwaves may have significant advantages over traditional heating methods, 
since the inverted temperature gradients under microwave conditions (Figure 1.16) 
may lead to an increased lifetime of the catalyst through elimination of wall 
effects. 174, 175 
1.6.6 Microwave-assisted Suzuki cross coupling reactions 
The Suzuki reaction is probably the most versatile among the cross-coupling 
reactions and the reaction has attracted the interest of researchers involved in modern 
organic synthesis and high-throughput chemistry. Carrying out high-speed Suzuki 
reactions under microwave conditions can be considered almost a routine synthetic 
procedure today. Examples include the use of the Suzuki protocol for the high-speed 
modification of various heterocyclic scaffolds of biological interest. 176-179  In 1996, 
Larhed first applied microwave techniques to Suzuki coupling. The reaction of 
polymer bound arylhalides with arylboronic acids and a palladium catalyst could be 
achieved after microwave irradiation of only 4 minutes at 45 W (Scheme 1.7). 180  The 
polymer used was PEG grafted polystyrene (Tentagel). Solid phase reactions allow 
for easy separation but typically suffer from slow rates of reaction due to 
heterogeneity. Larhed showed that microwave techniques perfectly bridge this gap. 
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ArB(OH)2, Pd(PPh3) 4 , 2M Na2CO3 
HO, EtOH, DME, MW, 4 mm 	 Ar 
45 	 46 
Scheme 1.7: The first application of Suzuki reaction using microwave chemistry. 
The formation of a 15-membered meta, meta-cyclophane, biphenomycin B, 48, 
featuring a key microwave-induced intramolecular Suzuki-Miyaura reaction step, has 
been demonstrated by Lepine and co-worker (Scheme 1.8). 181 Controlled microwave 
heating was utilised to increase the cyclisation efficiency in the key C-C coupling 
reaction of the tri-peptide precursor 47. The study of solvent effect, taking into 
account the advantage of best ligand-base combination, found the toluene-water 
solvent system in the presence of TBAB as an additive, to give the best yields (50 %) 
as compared to MeCN and DMSO under identical conditions. 
0 	 K2003, TBAB 
Pd(dba)2, ligand 
N CO2Me 	
MW, 110 °C, 30 mm 	







47 48 Cbz 
Scheme 1.8: Microwave-induced intramolecular Suzuki-Miyaura reaction. 
Coats and co-workers utilised successive reductive aminations and Suzuki cross 
coupling reactions to prepare a 192-member library of tropanylidene benzamides 51 
(Scheme 1.9). 182  For the solution phase preparation of functionalised tropanylidenes, 
the authors simply dispensed 1 ,2-dichloroethane (DCE) solutions of the bromo N-H 
precursor 49 to a set of microwave vials, added the aldehydes (3 equiv.) and a 
solution of sodium triacetoxyborohydride in DMF (2 equiv.), and subjected the 
mixture to MW irradiation for 6 min at 120 °C. Quenching the reductive amination 
with water and subsequent concentration allowed a microwave-assisted Suzuki 
reaction on the crude products. 
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Scheme 1.9: Reductive aminations and Suzuki cross coupling reactions. 
Wang et al. have reported very efficient Suzuki coupling reactions involving 
immobilised polyethylene-supported FibreCat Pd catalysts (Scheme 1.10). 183  The 
reported method can be used to couple a range of aryl halides and triflates with 
boronic acids in solvents such as water or ethanol. 
FibreCat Pd (3 mol %) 
O_X 
+ ,B—(3S 
K2CO3,  EtOH 
 Do- 0 
— 0 
R 
HO 	 MW, 120 °C, 10-25 min  
52 	 53 	 54 
Scheme 1.10: Polymer-supported Pd catalysts for MW-assisted Suzuki reaction. 
A series of air- and moisture-stable (N-heterocyclic carbene)Pd(allyl)Cl complexes 
has been shown by Nolan and co-workers to catalyse Suzuki-Miyaura cross coupling 
reactions of aryl chlorides 55 with boronic acids 56 (Scheme 1.1 1).184  This catalytic 
system is compatible to microwave conditions and rapid couplings were observed 
within 1.5 min at 120 °C. The conventionally heated reactions (60 °C.) required 
several hours to reach completion. 









Scheme 1.11: N-heterocyclic carbene complexes for MW-assisted Suzuki coupling. 
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A recent report by Zhang and co-workers describes a new strategy to improve the 
efficiency of Suzuki coupling reactions by combining rapid microwave synthesis 
with fluorous separation techniques (F-SPE).' 85  Aryl perfluorooctylsulfonates 59 as 
precursors for Suzuki-type couplings were readily prepared from phenols 58 and 
commercially available perfluorooctylsulfonylfluoride. Subsequent Suzuki reaction 
with aryl boronic acids in the presence of a suitable Pd catalyst provided the desired 
biaryls 60 in high yield. Work-up simply involved filtration of the reaction mixture 
through a fluorous solid-phase extraction cartridge (F-SPE) (Scheme 1.12). 
ArB(OH)2 , Pd(dppf)C12 
OH C8F17S02F, K2CO3 , DMF (_ I O. s_C8F17 K2CO3toIuene/acetone, H20 	 Ar R-- R -_j 	







Scheme 1.12: MW-assisted Suzuki coupling using fluorous separation techniques. 
Recently, a significant advance in Suzuki chemistry has been reported in the 
literature that includes water as the solvent in conjuction with microwave heating 116 
and the absence of ligand' 87 or Pd catalyst. 188 
1.6.7 Microwave-assisted amination or amidation reactions 
In recent years, the Pd-catalysed amination of aryl halides, which was independently 
developed by the groups of Buchwald and Hartwig, has become a powerful method 
for the synthesis of substituted anilines. Conventionally, this reaction requires high 
temperatures and long reaction times. Many fast and highly efficient applications 
have been developed in conjunction with microwave irradiation. 189,190  In 2002 
Alterman and co-workers described the first high-speed Buchwald—Hartwig 
aminations by controlled microwave heating (Scheme 1.13). 191  The best results were 
obtained in DMF as the solvent without an inert atmosphere by employing 5 mol% 
of Pd(OAc) 2 as pre-catalyst and BINAP as the ligand. The procedure proved to be 
quite general and provided moderate to high yields for both electron-rich and 
electron-poor aryl bromides. 
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R 1 , R3 = H, alkyl, aryl 
Scheme 1.13: Buchwald-Hartwig amination using microwave chemistry. 
Caddick and co-workers were also able to extend this rapid amination protocol to 
electron-rich aryl chlorides by utilising more reactive discrete Pd—NHC complexes or 
in situ generated palladiumlimidazolium salt complexes. 192  Microwave-assisted 
palladium-catalysed aminations have been reported on a number of different 
substrates, including bromoquinolines,' 93 aryl triflates,' 94 intramolecular aminations 
for the synthesis of benzimidazoles,' 95  and the coupling of aryl chlorides with 
sulfonamides. 196 
Skjaerbaek and co-workers have disclosed an efficient protocol for the synthesis of 
aryl aminobenzophenone 67, p 38  MAP kinase inhibitors using microwave-assisted 
Pd-catalysed animations (method A, Scheme 1.14).' '' Several different strategies 
involving halide, triflate and tosylate leaving groups were investigated, in addition to 
an alternative amination mode (method B, Scheme 1.14). Amination of an 
electronically diverse array of aryl halides 65 with a variety of anilines 66 was 
realised in good to excellent yields for most cases, without the necessity to work 
+ 	 —R 
H 2 N 
66 
under an inert atmosphere. 




' Me 	Br 
65  
Pd(OAc)2, ligand (X-Phos) 	0 	CI 
NaOtB u , t-BuOH, toluene 






Scheme 1.14: Microwave-assisted aminations for the synthesis of kinase inhibitors. 
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A recent report by Maes et al. describes general Pd-catalysed amination conditions 
for the high-speed coupling of electron rich and neutral aryl chlorides 68 with all 
types of aliphatic amines 69 under temperature controlled microwave heating at 
150 °C with DCPB or DTPB as ligand using a low loading of catalyst in only 
10 minutes (Scheme 1 . 15) . 198 






Cl 	 MW, 150 °C, 300W, 10 mm 
68 	 69 	 70 
Scheme 1.15: Microwave-assisted aminations of aliphatic amines. 
1.6.8 Summary 
Microwave heating is a very efficient energy source and can be used to significantly 
reduce reaction times of numerous organic reactions. The presented examples 
indicate that the microwave/catalysis strategy provides broad scope in the future 
development of clean and sustainable organic chemistry. Specific advantages include 
the following: the successful combination of metal catalysis under air and with water 
as solvent; the use of milder and less toxic reagents at high temperature; the 
possibilities to integrate efficient synthesis with non chromatographic purifications 
(solid or fluorous separations). It is already clear that modem automatic microwave 
synthesisers have much to offer the medicinal and high-throughput chemists engaged 
in library generation. 199 It is also likely that the widespread acceptance of this 
technique, as an important tool for the development of laboratory-scale 
environmentally conscious chemistry, will result in the microwave synthesiser 
becoming an integral part of every modem organic laboratory. 
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1.7 Aims of the present study 
This study is a part of research project aimed at the development of novel cell cycle 
regulators for Cyclacel. 
The overall aim of this study was: 
To develop and apply novel synthetic routes for cell cycle regulators. 
The specific objectives of this study were: 
• To develop practical, palladium-catalysed carbon-carbon bond formation 
methods suitable for inhibitors of p53-HDM2 and cyclin-dependent kinases. 
These methods could be used for the synthesis of libraries. 
To develop practical, palladium-catalysed carbon-nitrogen bond formation 
methods suitable for inhibitors of CDK2. 
• To develop and demonstrate the applications of microwave assisted organic 
methods for the synthesis of cell cycle regulators. 
• To demonstrate the scope and limitations of the developed methods by 
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2 	Results and Discussion- Synthesis of pyrimidinetriones 
2.1 Aim 
The aim of this part of the project was to develop methodology for the synthesis of 
derivatives of barbitunc acid 71 (pyrimidine-2,4,6-triones) (where X = 0, S, and 















Figure 2.1: Pyrimidinetrione pharmacophore. 
2.2 The history of barbituric acid derivatives 
The history of the discovery of the class of drugs known as barbiturates is a classic 
tale, and typical of many classes of drugs. A German chemist, Adolph von Baeyer, 
founder of what was to become the Bayer Chemical Co., synthesized "malonylurea" 
71 from the reaction of urea 75 with malonic acid 74 (Scheme 2.1). Malonylurea 
became known as "Barbituric acid". 200 
0 
:: 
+ H2Ny NH 2 
74 	 75 
-2H20 	HNy NH 
71 
Scheme 2.1: Synthesis of pyrimidine-2,4,6-trione (trivial name barbituric acid). 
Barbituric acid or malonylurea 71 is based on a pyrimidine heterocyclic skeleton. 
Barbiturates are derivatives of barbituric acid. They can be used as hypnotics, 
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sedatives, anticonvulsants and anaesthetics, although they are probably most familiar 
as 'sleeping pills'. The different properties of the various barbiturates depend upon 
the side groups attached to the ring. Barbituric acid 71, itself, is not 
pharmacologically active, but chemists immediately began making a great variety of 
derivatives for potential use as drugs. The medical value of these substances was not 
realised, however, until 1903 when two other German chemists, Emil Fischer and 
Joseph von Mering, discovered that one of these compounds, diethylbarbituric acid, 
Barbital (Verona!) 76, was very effective at sedating dogs (Figure 2.2). 
Figure 2.2: Barbituric acid derivatives as drugs. 
When this discovery was announced, chemists rapidly produced many new medically 
active barbiturates, including the sleeping pill, Phenobarbital (Luminal) 77, which is 
often used to induce sleepiness before full pre-operative anaesthesia (Figure 2.2). 
Barbituric acid derivatives exert important action on the central nervous system and 
recently have found totally new biomedicinal applications in fields such as cancer, 
AIDS therapy, and protease inhibitors. 201 
2.3 Project background-ligand design 
2.3.1 Identification of a new p53-HDM2 inhibitor pharmacophore 
With the aim of developing methodology that would aid the rapid design and 
synthesis of inhibitors of HDM2, research carried out in collaboration with Professor 
Walkinshaw of the Institute of Cell and Molecular Biology at Edinburgh, has led to 
the discovery of a novel class of ligand for HDM2. For the current work, no crystal 
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known about the structure of p53 and HDM2 16 Using the available structural 
information about the p53-HDM2 complex, the LIDAEUS programme screened the 
drug-like compound database for small molecules able to bind to the hydrophobic 
cleft of HDM2. A number of substructures were identified. Of these, the thiophene 
sulfonamide series were selected for further investigation by our industrial 
collaborators, Cyclacel Ltd. who purchased a number of commercially available 
examples and subjected them to in vitro screening (Figure 2.3). 
[LIDAEUS screening of drug-like compound databas e) 
ID 
(75 hits (4 confirmed in vitro assay)) 
IG 
[Hit expansion library (based on hit SS)] 
437 
[191 hits (7 confirmed in vitro assay)) 
437 
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(Lead optimisation ) 
Figure 2.3: Identification of p53 -HDM2 pharmacophore. 
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Thiophene sulfonamides formed the basis of extensive research undertaken at 
Cyclacel. However, as data was collected, it became apparent that the most 
promising of these compounds in terms of activity, suffered from poor bioavailability 
and had undesirable pharmacokinetic properties. These findings led to the further 
investigation into the alternative pharmacophores which had been identified in the 
initial LIDAEUS screen, the most promising of which, in terms of hit rate, was based 
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Figure 2.4: The pyrimidinetrione pharmacophore. 
2.3.2 Identification of a new CDK2 inhibitor pharmacophore 
Interestingly, these pyrimidinetriones had also been identified as potential lead 
compounds for inhibition of CDK2 (Figure 2.4). Using the X-ray crystal structure of 
CDK2,39  we have employed a structure-based design approach to identify novel 
ligands that have the potential to form strong interactions with CDK2. To achieve 
this, LIDAEUS was used to select lead compounds. This process led to the 
identification of pyrimidine-2,4,6-trione 78 (Figure 2.5) as a potential lead structure 
for CDK2. Confirmation of pyrimidine-2,4,6-trione 78 as a lead was achieved by 
obtaining an X-ray crystal structure of the molecule bound in the active site of CDK2 
(Figure 2.5). This revealed key interactions between the kinase and the ligand, 
which provided information for further analogue design. In this case, the backbone 
amide groups of Glu81 and Leu83 make key hydrogen bond interactions with the 
pyrimidinetrione 78, although two distinct hydrogen bonding patterns have been 
observed; one where the NH of Leu83 and the carbonyl of G1u81 act as a donor -
acceptor pair for a complementary hydrogen bond donor and acceptor on the 
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(pyrrole) on the inhibitor; and one where the NH and carbonyl of Leu83 acts as a 
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Figure 2.5: Crystal structure of pyrimidinetrione 78 in complex with CDK2. 
Based on the above findings, we have designed a series of small molecules based on 
the pyrimidinetnone pharmacophore to seek non-peptidic HDM2 inhibitors that can 
block p53-HDM2 binding and recover its tumour suppressing function. Firstly, our 
main aim was to incorporate alkyl or aryl substituents at R, which would provide 
structurally diverse lead compounds. A further aim of this project was to develop 
new synthetic routes to pyrimidinetriones and their related compounds (Figure 2.6). 









Figure 2.6: Pyrimidinetrione and isoquinolinedione. 
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2.4 Synthetic strategies towards the synthesis of pyrimidinetriones 
The 5-alkylidene/arylidene barbituric acid derivatives are important members of the 
pyrimidine family (Figure 2.6). The major importance of these compounds derives 
from their application as useful precursors in the preparation of new heterocyclic 
compounds. 20 2-204 In our search for new barbituric acid derivatives with enhanced 
biological activity it came as a surprise that there was no available method for the 
preparation of simple barbituric acid derivatives such as 5,5-aryl/alkyledene 
barbiturates. Our aim was to synthesise novel compounds based around the 
pyri midinetrione pharmacophore. Following an investigation into some 
commercially available compounds, it was noted that there were only a handful in 
which R :~ H (Figure 2.6). Development of a synthetic route to these types of 
compounds, with a view to tailoring the chemistry towards a combinatorial chemistry 
approach, was therefore attractive. 
2.4.1 Retrosynthesis of pyrimidinetriones 
Initially, the pyrimidinetrione preparation was intended to follow the retrosynthetic 
analysis shown in Scheme 2.2. The first approach involved, dividing the molecule 
into sub-components (71 and 79). Barbituric acid 71 was commercially available and 
could be converted into the pyrimidinetrione derivatives via a Knoevenagel 
condensation with various substituted aryl/alkyl ketones 79. The second general 
approach to prepare barbituric acid derivatives was through the condensation of urea 
75 with malonic acid esters 80. The malonic acid ester segment 80 was a key target 
whose synthesis had to be developed. 
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Scheme 2.2: Retrosynthesis of pyrimidinetriones. 
The original proposed route to the target molecules is shown in Scheme 2.3. The key 
idea was to incorporate alkyl or aryl substituents at R, which would provide 
structurally diverse lead compounds. Combinatorial techniques would then be 
employed to generate a library of ligands for subsequent assay. However, the first 
challenge was to develop robust, reproducible chemistry, with the aid of 
incorporating an alkyl or aryl group at the R position. 
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Aryl 	R rro 	 _ H NNH + Aryl 
	
y 	
R 	conditions 	o)Co 
0 	 HNjfNH 
71 	 79 	 0 
Aryl 	R 	 ArykR 
+ Aryl 
	
conditions 	oI10 conditions 	oJI robo-
o 
OEt OEt 




83 	 79 	 80 
75 
Scheme 2.3: Proposed routes to substituted barbituric acid derivatives. 
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2.4.2 Knoevenagel condensation of ketones 
As an important carbon-carbon bond forming reaction, Knoevenagel condensation 
has been extensively studied. This involves the condensation of a carbonyl 
compound with an active methylene compound of the type 'Z-CH 2 -Z. 'This classical 
reaction usually catalysed by organic bases (primary, secondary and tertiary 
ammines), ammonia and ammonium salts or Lewis acids such as CuC1, ZnC1 2 and 
SmI. In recent years, chemists paid more and more attention to the clean synthesis of 
alkenes by Knoevenagel condensations. The Knoevenagel condensations between 
aldehydes and active methylene compounds in dry media catalysed by ZnC1 2 , 205 
silica ge1206  and ammonium acetate (NH40Ac)-basic alumina 207 have been reported. 
Recently Bigi's group described the same reactions which could proceed efficiently 
in water without any catalyst. 208  More recently, Wang and co-worker found that 
aldehydes reacted with active methylene group efficiently in the absence of catalyst 
and solvent under microwave irradiation. 209  However, much less work on the 
Knoevenagel condensation involving ketones has been done because ketones are 
generally very unreactive towards Knoevenagel condensation. In general, the 
reactivity order of carbonyl compounds towards nucleophiles is as shown in 
Figure 2.7. 
HH > RH > RR 
Figure 2.7: Relative reactivity of carbonyl compounds. 
The substituents have two contributing factors: 
• Size of the substitutents attached to the C=O. Larger groups sterically hinder 
the approach of the nucleophile. 
• The electronic effect of the substituent. Alkyl groups are weakly electron 
donating so they make the carbonyl carbon less electrophilic. 
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Microwave irradiation has been utilised to promote the Knoevenagel condensation 
reactions of various ketones in our study. Attempts at direct condensation of a 
number of ketones with either barbituric acid 71 or diethyl malonate 83 (Scheme 2.3) 
were unsuccessful, despite employing a number of different conditions as shown in 
Table 2.1 and Table 2.2. However, it was hoped that using forcing conditions in the 
microwave would overcome the poor reactivity and steric issues associated with 
these ketones. 
Aryl 	CH, 





0 	 conditions 	 NyNH 
0 	 H 
71 79 	 0 





Br 	 cI 	 3 
79A 	 79B 	 79C 	 79D 
Entry Conditions 79A 79B 79C 79D 
1 NH40Ac, MW, 100 °C, 10 min failed failed failed failed 
2 piperidine, MW, 100 °C, 10 min failed failed failed failed 
3 piperidine, toluene, reflux, 20 h failed failed failed N/A 
4 piperidine, ethanol, reflux, 20 h failed failed failed N/A 
5 Et3N, CH2 C12, MW, 100 °C, 10 min failed failed failed N/A 
6 Et3N, DMSO, MW, 100 °C, 10 min failed failed failed N/A 
7 Et3N, DMF, MW, 100 °C, 10 min failed failed failed N/A 
8 Et3N, methanol, MW, 100 °C, 10 min failed failed failed N/A 








°r° + __ CH, 	X 	 oy o 
OEt OEt 	 conditions  
0 	 OEt OEt 
83 	 79 80 
Entry Conditions 7A 7B 7C 7D 
1 N}I40Ac, basic A1203, MW, 	100 °C, failed failed failed failed 
10 mm 
2 N}J40Ac, ethanol, MW, 100 °C, 10 mm 
failed failed failed failed 
3 piperidine, ethanol, MW, 100 °C, 20 mm 
failed failed failed failed 
4 piperidine, MW, 100 °C, 10 min failed failed failed failed 
Table 2.2: Ketone condensation reactions with diethyl malonate. 
Two Knoevenagel condensations with malonic ester 83/malonamide 84 and acetyl 











85 	 84 
Piperidine, EtOH 	0 	OEt 
MW, 100 00, 30 nn 	H3C 	OEt 
86 
Piperidine, EtOH 	0 	 NH2 
MW, 100°C,3Omin 	H30 	NH2 
87 
Scheme 2.4: Knoevenagel condensation of malonic ester/amide with acetyl furan. 
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2.4.3 Alternative strategy-I 
Owing to the failure of the ketone condensation reactions, a different strategy had to 
be employed. In the pursuit of a feasible and robust synthetic route to the 
compounds of interest, attention has turned to developing chemistry that allows for 
generating libraries. We proposed a different synthetic strategy in order to obtain 
novel pyrimidinetriones (Scheme 2.5). The enolisable acylated diethyl malonate 88 
can be prepared by treating the acyl chloride 89 with malonic ester 83. The product 
88 can be converted to its chioro derivative 90 with chlorinating agents. With earlier 
reports on the nucleophilic vinylic substitution (SNV) reactions 210 between various 
chioro esters and nucleophiles in mind, it was envisaged that the anilino and phenoxy 
esters 91 could result from SNV reactions between anilines, phenols and the 




(i) M902, 2Et3N 	 0 	R 
0 	0 	CH3CN, 25 °C, 12 h 	 P003, Bu3N 
Cl 	R 
oIXro 
OEt OEt 	(ii) H3O OEt OEt 	110 C, 12 h OEt OEt 
89 83 88 90 
R 1_ R 1_J 
Cl 	R substituted aniliries c Et3N, 90 C, 12 h 	or R 	Urea, NaOEt X 	R 
OEt OEt 
substituted phenols OO 	EtOH, 80 C, 10 h OO 
K2CO3, DMF, 140 °C, 12 h 
OEt OEt HNyNH 
90 R = alkyl or aryl 91 0 
X=0, N 
92 
Scheme 2.5: Proposed synthetic route for the synthesis of pyridiminetriones. 
We decided to investigate the utilisation of -chloro alkyllarylidene malonates 21 ' 90 
as starting materials in our synthetic work because they are accessible in large 
quantities from readily available acyl malonates 88 212,-b and especially because the 
high level of functionality that is present in these chioro esters leads to chemical 
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reactivity not otherwise attainable. These esters possess three areas for 




Figure 2.8: -chloro alkyl/arylidene malonate, 90. 
Hormi et al. demonstrated the significance and powerful nature of the three 
functionalities and these chioro esters were converted into biologically important 
compounds, 2 12a-b, 213 some of which are natural products. This group has also 
developed an improved synthesis of 13-chloro alkyllarylidene malonates using tertiary 
amines for the formation of the enolate of acyl malonate instead of starting from 
alkali salt .2 12b  Progress was made towards the desired compounds using the 
chemistry shown in Scheme 2.5. Facile acylation of diethyl malonate followed by 
reaction with POC13  afforded the p-Cl intermediate 90 in good yield. This versatile 
intermediate can be further reacted with nucleophiles to give 91 in good yield. 
2.4.3.1 Acylation of diethyl malonate 
A standard procedure for the C-acylation of active methylene compounds 93 is to 
convert to the enolate 94, followed by reaction of the enolate with an acid chloride in 
a second, separate, step (Scheme 2.6).214 
o 	 0 	 0 
base 	 x RCOCI 	R 
<I low 	 _____ 
rX 	 x 	 0 
0 	 0 	 0 
93 X=EWG 	94 	 95 
Scheme 2.6: C-acylation of active methylene compounds. 
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An inherent problem in this approach is that the acylation product 95 is always a 





R 	X 	 —X 	 ' —X 	R1X 
0 	X 	 17—X 	
)—X 	
0 	X 
o a o 0 
95 	 94 	 93 	 96 
Scheme 2.7: C-acylation of active methylene compounds. 
One solution to this problem is a single-step acylation conducted in the presence of 
2 molar equivalents of base (Scheme 2.8). A requirement for success with this latter 
procedure is that the base must not react destructively with the acid chloride. This 
seems to have restricted the application of the single-step procedure to the acylation 
of very strong carbon acids (e.g. Meldrum's acid, PKa = 5)215 whose enolates can be 
formed quantitatively by the relatively mild tertiary amine bases. 
0 
2equiv base 	R H3O 	 R  
RCOCI 	 0 	X 	 0 
o 	 0 	 0 
93 	 96 	 95 
Scheme 2.8: Single-step C-acylation. 
One way to extend the single-step acylation procedure to weaker carbon acids would 
be to use metal complexation to enhance acidity to the point where tertiary amine 
bases could be used . 216  Diethyl malonate 83 has previously been acylated by a 
variety of procedures, 217  with perhaps the most useful based on enolate formation 
with magnesium ethoxide. 218  Similarly, Ratlike and Cowan have developed a 
remarkably simple single-step acylation of diethyl malonate 83 using tertiary amine 
bases and magnesium chloride. 219 
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Addition of acid chloride 89 to an acetonitrile solution of diethyl malonate 83 
containing 2 molar equivalents of triethylamine and magnesium chloride gave 
acylated diethyl malonates 88 in excellent yields . 219 Results obtained for the 
acylation of diethyl malonate with a variety of acid chlorides in the presence of 
MgC12 are shown in Table 2.3. 
o 	1. M9Cl2, Et3N (2 equiv) 	0 
—OEt 	CH3CN, 12 h, 25 °C R 	OEt +  
R CI 	
—QEt 	2. H30 	
___0 
	OEt 
o 	 0 
89 	 83 	 88 a-d 
Entry Product Acid chloride Yield (%)C 
88a 
	e-I cI 94 
0 
88b 	 95 
3a 0 88c 	
H3CACI 	 95 
4b 
0 
88d 	 95 
 
CI 
" Reaction conducted on 100 mmol scale; 1:1:1:2 diethyl malonate: acid chloride: MgCl2: Et3N. 
bReaction conducted on 4.77 mmol. C  Yields based on weight of distilled product. 
Table 2.3: Acylation of diethyl malonate. 
2.4.3.2 Chlorination of acyl malonate 
The reaction between an enolisable carbonyl group and chlorinating agents such as 
POCI3 , SOd 2 , PC15  etc. is one of the most important ways of introducing a vinylic 
chlorine.220' 221 Syntheses of several -chloro arylidene/alkylidene malononitriles, 
cyanoacetates and cyanoketones from corresponding acyl compounds and Pd 5 or 
from alkali salts of corresponding acyl compounds and POC1 3 have previously been 
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described in the literature.221' 223 An improved synthesis of -chloro alkyl/arylidene 
malonates using tertiary amines was developed by Hormi.212b The author described 
yields which were improved by performing the decomposition of intermediate 
phosphorous-dichioridate in presence of tributylammonium chloride, which can be 
regarded as an exceptionally mild source of hydrogen chloride (Scheme 2.8). 
0 	 0 
CI  
R 	' OEt decomposition with HCI 	
R - 	 OEt 
CI-—O 	—0Et 	 CI 	OEt 




Scheme 2.8: Decomposition of intermediate enolphosphorous di-chloridate. 
The catalytic activity of tributylammonium chloride on the decomposition of 
intermediate enoiphosphorous di-chioridate 97 depends upon the hydrogen chloride 
produced in situ from tributylammonium chloride. Several j3-chloro alkylidene and 
arylidene malonates 90a-d were prepared from the corresponding acyl compounds 
88a-d using POC13 and tributylamine (Table 24)212b 
R10Et 	 POCI3 	 R 	OEt 
0 	
>- 
OEt 	Bu 3N, 110°C, lOh 	c 	OEt 
88 a-d 	 90 a-d 
Entry Compound R Yield (%)a 
1 90a CH3 43 
2 90b Isopropyl 54 
3 90c Phenyl 57 
4 90d 5-bromofuryl 47 
a  Isolated yield. 
Table 2.4: Synthesis of f3-Chloro alkylidene/arylidene malonate. 
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2.4.3.3 Nucleophilic vinylic substitution reactions 
The -chloromalonates 90a-d are of interest because they have an activated double 
bond for potential functionalisation by the SNV approach. The aim was to treat the 
chioromalonate 90 with substituted phenols and potassium carbonate in 
dimethylformamide (modified Claisen conditions). 224 Adopting this approach the 
phenoxymalonate 98b was synthesised in 71 % yield (Scheme 2.9), from the chioro 
malonate 90b and para-fluorophenol 99. 
0 	 0 
R )—OEt 	 R '—OEt 
CI',—OEt 	
+ 	HO— 	---F 	
K2CO3, DMF 
Refflux, 12 h 
0 	
F_j_o>OEt 
90b (R = isopropyl) 	99 	 98a (R = isopropyl) 
90c (R = phenyl) 98b (R = phenyl) 
Scheme 2.9: Synthesis of 13-phenoxymalonates. 
We have demonstrated the utilisation of the chioro esters in the synthesis of 
13-anilinoarylidenemalonates. With the earlier reports on the nucleophilic vinylic 
substitution (S NV) reactions 210 between various chioro esters and nucleophiles in 
mind, we hoped that the corresponding anilino esters could be synthesised from SNV 
reactions between aniline and the appropriate chioro esters (Scheme 2.10). 
+ R1 
90c 	 100 
R = phenyl 
R 1 = H, CH 3 
K2CO3, DMF 




\=! R J 
101a R = Ph, R 1 = H 
lOIbR= Ph, R 1 = CH 3 
Scheme 2.10: Synthesis of 3-anilinomalonates. 
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Conversion of the 3-chloroarlylidenemalonates 90c into the required 
-anilinoma1onates 101a-b was achieved by treating the chioro esters with aniline 
derivatives 100 in the presence of triethylamine (12 h, 90 °C). The 
3-anilinomalonates 101 a-b were produced in 60-70 % yield. 
2.4.3.4 Cyclisation 
The next task in the pyrimidinetrione synthesis was to cyclise the -phenoxy or 
3-anilinomalonates by reacting with either urea or hydrazine. Although several 
conditions were tried, unfortunately, the cyclisation of these intermediates has 
proven to be problematic (Scheme 2.11). It postulated from analysis of NMR data 
collected from these reactions that nucleophilic attack of the a,-double bond with 
the methoxide or ethoxide base is followed by elimination of the phenol to afford 
102 and 103. It was thought that the use of a non-nucleophilic base, such as KOBut, 






Hydrazine hydrate, NaOEt 	1ZL,.o 	Urea, NaOEt
X 	No 
EtOH,reflux,lOh. 	 O_!.yO 	
I 
HN 	
EtOH, reflux, 10 h HNTNH 
OEt OEt 	 0 
102 	 98b 	 103 
Scheme 2.11: Cyclisation of the di-ester intermediate. 
2.4.4 Alternative strategy-Il 
Another approach was to convert the di-ester 98b to the di-acid 104 and couple with 
urea using DCC (Scheme 2.12). It was envisaged that the acid derivative could be 
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Ph '—OEt 
	
KOH, EtOH 	 Ph ' —OH 	Urea, DCC 	 Ph 
reflux, 1.5 h F—(J-- >=< 
H
OH THF, reflux, 10 h 	 0 - 	0 H 
98b 	 104 	 106 
(COd)2, CH202 
DMF, rt, 6 h 
Ph—CI Et3N, urea, reflux, 12 h 	Ph 
F_fj_o>,_CI 	 F—fj_- cfH 
105 	 106 
Scheme 2.12: Synthesis of pyrimidinetriones. 
Hydrolysis of -phenoxymalonate 98b with potassium hydroxide in ethanol gave a 
quantitative yield of the potassium salt of di-acid. Acidification of the salt using 
aqueous hydrochloric acid afforded the di-acid 104 in 70% yield. The di-acid was 
converted to the di-chloride 105 by treatment with oxalyl chloride and a catalytic 
amount of DMF. However, both the cyclisations were not successful. 
2.4.5 Alternative strategy-Ill 
It may be possible for the chioro intermediate 90 to undergo palladium 
cross-coupling reactions to afford the arylidene intermediate 107 as shown in 
Scheme 2.13. This approach would afford novel compounds where R would be a 
poor leaving group and therefore may aid the cyclisation step. 
R> 1OEt 	Palladium Catalysed 	R 	'LOEt 	 R 	' NH Urea 
NH OEt 	Cross-Coupling 	 OEt 	Cydisation 
R4I RLI ° Cl  
90 	 R = alkyl/aryl 	 107 	 108 
Scheme 2.13: Synthesis of pyrimidinetriones using palladium chemistry. 
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The electrophilic sites in the cross coupling reactions represented in Scheme 2.13 are 
usually sp2-carbons attached to a good leaving group (e.g. aryl and vinyl halides). 
Due to their electronic properties, ethylenecarboxylates exhibit especially high 
reactivity. However, these compounds are difficult to prepare. To date, there have 
been no general methods reported for the synthesis of J3-aryl alkyl/arylidenes 107 
that employ catalytic amounts of palladium. Because of the potential of such 
compounds as important synthetic intermediates, we set out to develop a general and 
mild catalytic method that would provide easy access to a wide variety of 
-aryl alkyl/arylidene malonates 107 that could be further manipulated to generate a 
wide number of desirable products. 
2.4.5.1 Suzuki reaction 
Amongst the various reactions involving palladium-mediated coupling of sp 2-carbon 
atoms with organometallic compounds to form carbon-carbon bonds, the Suzuki 
reaction has attracted much interest due to a number of attractive features including 
high yields, mild reaction conditions and tolerance of a wide variety of functional 
groups. 70 '74 In view of the proven versatility of this reaction, we contemplated its use 
in the preparation of -aryl/alkyl-arylidene malonates 107, which could be employed 
as precursors for the synthesis of a wide range of derivatives including substituted 







Figure 2.9: Examples of heterocycles possessing biological activity. 226 
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Previous approaches to 3-aryl/alkyl-arylidene malonates 107 have relied largely upon 
the Knoevenagel condensation of diethyl malonate with the corresponding ketone. 
However, this reaction is limited in scope and generally only proceeds well for 
methyl ketones and cyclohexanone derivatives. 227  We have proposed an alternative 
strategy centred on the palladium catalysed cross-coupling reaction between 
13-chioro-alkylidine/arylidene malonates 90 and arylboronic acids 111 to yield the 
desired products 107 (Scheme 2.14). Vinyl chlorides 90 appeared attractive 
precursors since they are readily prepared in high yield and on a large scale from acyl 
malonates. It was reasoned that vinyl chlorides 90 should possess high chemical 
reactivity in the Suzuki reaction, and hence, be amenable to coupling with a wide 
range of aryl boronic acids. Finally, an additional aspect of our planned approach 
involved the use of microwave enhanced synthesis to facilitate the coupling 
reactions. 179  The requisite f3-chloro-alkyllarylidene malonates 90 were prepared 
according to the literature procedure involving initial treatment of diethyl malonate 
with an acyl chloride to yield the 2-acyl malonate (yields 9095%)219  followed by 





OEt 	M9Cl2 , Et3 N 
0 
R ' —OEt 	 R 	OEt 
O 	 I OEt C'—OEt POd




R 	OEt 	R 1 	OH + 
C1 	OEt 	0\/ — 10 H 
0 	 (1.5equiv)  
POPd (1 mol%) 	 0 
K2CO3 (3.0 equiv) R 	OEI 
THF,100 °C 	- 	OEt 
MW, 30 







Scheme 2.14: Synthesis of 3-aryl/alkyl-arylidenemalonates. 
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2.4.5.2 Optimisation of Suzuki reaction conditions 
An initial screen of some typical palladium catalysts [e.g., Pd(OAc)2 , Pd(Ph3P)4 , 
tris(dibenzylideneacetone) dipalladium (0)] for their ability to mediate the coupling 
of vinyl chloride 90a (R = Me) with 3-chiorophenyl boronic acid gave low yields of 
the coupled product 107a (10-15 %). We therefore turned our attention to the 
commercially available 228  and air-stable palladium (II) complex 
[(t-Bu) 2P(OH)] 2PdC12 (abbreviated as POPd, 36, Figure 2.10). 
But 	 ?1 ,But 
HO-P-Pd-P-OH 
But 	ci But 
Bu\ But But But 
H 	L 
P Ci 
d. 5'd 	'H 
But But But But 
But Bu t  
HO-P\ CL J 




POPd 36b 	 POPdI 36a 	 POPd2 36 
Figure 2.10: Structures of palladium(II)complexes. 
These air-stable phosphine oxides, which were derived from novel combinatorial 
technologies '229  served as efficient ligand precursors for a variety of cross-couplings 
of unactivated aryl chlorides. This catalyst contains phosphinous acid ligands on the 
palladium that are generated by tautomerisation of RR'P(0)H to less stable 
phosphinous acids in the presence of transition metals (Scheme 2.15)230 
R 	 R 	 [MJ 	 R 	 base R12P0 	 - 	'P-OH 	 . 	[M1-­P-0H 	 R--O 
R 1 	 R 1 	 R 1 
35 	 34 	 36 	 112 
Scheme 2.15: Air-stable phosphine oxides. 
Since the original introduction of these catalysts by Li, 90 they have become widely 
used for cross-coupling reactions23 la,b  and appear particularly effective for coupling 
aryl- and vinyl-chlorides. Thus Li 232  demonstrated the coupling of 1-chloro-
cyclopentene to aryl boronic acids using POPd (Scheme 2.16). Of interest to us was 
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the performance of this catalyst, not only with vinyl chlorides 90, but also under 




Cl + 	R 	
K2CO3, THE, 65 °C 
113 	 114 	 115 
Scheme 2.16: Palladium-catalysed cross-coupling of 1-chloro cyclopentene. 
Initial optimisation studies were carried out using a variety of different bases 
(Na2CO3 , K2CO3,  Cs2CO3 and K3PO4) and all were found to be effective for the 
cross coupling of 3-chloro-alky/arylidene malonates 90 with phenylboronic acid 
lila. Optimisation of the reaction conditions allowed for the clean and rapid 
coupling of the model substrate (90a, R = Me) with phenylboronic acid 111 a, using 
the air-stable palladium catalyst, POPd to give the product 107a (Table 2.5). 
+ 
R\ pH 
cf–B / OH 
POPd (1 mol%) 
K2CO3 (3.0 equiv) 
THF, 100 °C 










Entry 	Compound 	R 	Boronic acid Product yjeld(%)a 
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H3CO 	B(OH)2 	
\_( "-0Et 
















-< ' -0Et 




H2N- j 0 
B(OH) 2  
15 	107o 	Ph 	
OH '. .' 0
HO-0 	 OEt 	
58 
' Isolated Yield 
Table 2.5: Synthesis of 13-aryl/alkyl-arylidenemalonates. 
Optimised conditions were vinyl chloride 90 (1 equiv.), arylboronic acid 111 
(1.5 equiv.), K2CO3 as base (3.0 equiv.) and 1 mol% of POPd in THF. Reactions 
were irradiated with microwave heating for 30 minutes at 100 °C followed by work-
up and silica chromatography to yield the corresponding 0-aryl/alkyl-arylidene 
malonates 107a-o in good yields (Table 2.5). The Suzuki arylation reaction was 
found to work with a wide range of arylboronic acids including electron-rich 
(Entries 3, 4, 7, 14), electron-deficient (entries 2, 6, 9) and sterically demanding 
(Entries 5, 10, 12) systems. As has been observed before, the Suzuki reaction was 
found to be compatible with -NIH 2 and -OH functionality in the arylboronic acid, 
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H2N 	 - 
0 	POPd (1 mol%), K2CO3 
Cl 
	OEt POPd (1 mol%), K2CO3 HO 	/ 0 




Scheme 2.17: Chemoselective Suzuki reaction. 
In view of the known ability of POPd to mediate Suzuki couplings of aryl 
chlorides, 232  the product 107a (Entry 1, Table 2.5) was subjected to a further Suzuki 
reaction with o-nitrophenylboronic acid leading to the biphenyl derivative 116 in 








POPd (1 mol%), K2CO3 (3.0 equiv) 









Scheme 2.18: Suzuki coupling of aryl chloride using POPd. 
Finally, as an illustration of the further application of the 3-aryl/aIkyl-arylidene 
malonates shown in Scheme 2.19, treatment of 107i with polyphosphoric acid 






100 °C,1.5 h 
0 




Scheme 2.19: Cyclisation of the 3-a1ky1Jarylidene malonate. 
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2.4.5.3 Cyclisation of 9-alkyl/aryIidene malonates 
The cyclisation of the di-ester 107g was been successful using hydrazine hydrate, to 
generate compounds with the template 118 shown in Scheme 2.20. Again, 
unfortunately, there was no reaction between the di-ester and urea. As expected, no 
loss of the isopropyl substituent was detected presumably owing to it being a poor 
leaving group. It was envisaged that these bis-aryllalkyl intermediates could also be 
coupled with hydrazine hydrate if desired. 
	
,0 	 J o 
OEt 	Urea, NaOEt 	 NH
- 	 - 	>=o 
- 	OEt 	EtOH,Reflux 	- 	NH 
\/ o 	 \/ o 
107g 	 119 
Hydrazine hydrate 






Scheme 2.20: Cyclisation with hydrazine hydrate and urea. 
2.4.6 Alternative strategy-IV 
The vinylic substitution of halosubstituted electrophilic olefins (via addition-
elimination) by nucleophiles is an attractive synthetic strategy for the synthesis of 
tetra substituted alkenes (Eq. 2.1). We have demonstrated the utility of this reaction 
for the preparation of 0-aryllalkyl-arylidene malonates. Based on the encouraging 
results using palladium cross-coupling methodology, we have planned an alternative 
synthetic strategy for the synthesis of pyrimidinetrione template (Scheme 2.21). 
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Y and/or Y 1 = EWG 	
0 
X = Cl, Br 
Having established reaction conditions, it was hoped that diethyl malonate 83 or 
barbituric acid 71 could easily functionalise by Knoevenagel condensation with 
aldehydes to afford alkene derivatives. The next step would be involved the 
bromination of alkene 120 or 123 using brominating agents such as bromine in CC1 4 . 
Palladium catalysed cross-coupling reaction of the bromo derivatives 121 and 124 
would provide the molecules of interest (Scheme 2.21). 
Ar 	 Br 
0 	0 	conditions Ar—CHO  







boronic adds__O. rO 






0 r i r0 
Br-.,. 	Ar 
conditions 	or._[t.-.roboronic acids_)I.0.:T1tI-.ro 
R 	Ar 
HNyNH 	Knoevenagel HN....NH bromination 	HNyNH Pd catalysed HN..NH 
condensation 










Scheme 2.21: Proposed synthetic route for the synthesis of pyrimidinetriones. 
2-(1H-Indole-3-ylmethylene)-malonic acid di-ethyl ester 126 was prepared by 
Knoevenagel condensation of indole-3-carboxaldehyde and diethyl malonate in 
methanol using piperdine as a base. 233 Condensation reactions with both malonic 
acid ester and barbituric acid with 2,3,4-trimethoxybenzaldehydes containing a 
catalytic amount of piperidine required only several hours in refluxing methanol. The 
condensation products 127 and 128 (Figure 2.10) precipitated as yellow solids from 







126 	 127 	 128 
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Figure 2.10: Knoevenagel condensation reaction. 
It was anticipated that intermediates 126, 127 and 128 could be halogenated and 
converted into 5,5-disubstituted barbituric acid derivatives via palladium catalysed 
cross coupling reactions using our newly developed methodology. Attempts at 
forming the corresponding bromo product through the reaction with bromine in CCLI 
and various different conditions were unsuccessful. An examination of the NMR 
spectra of the major product revealed it to be the starting material (Scheme 2.22). 




Bromine/CC14, rt, 15 h 
Bromine/CCI4 , reflux, 2 h 
b) N-bromoacetamide/TI-IF 
Scheme 2.22: Bromination of aldehyde adduct. 
2.4.7 Alternative synthetic strategy-V 
A successful alternative synthetic strategy has been developed, which involved 
Knoevenagel type condensation under high dilution to afford compounds of the 
desired pharmacophore 131 and 133 (Scheme 2.23).234  We have shown that methyl 
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and ethyl ketones will undergo Knoevenagel condensation reactions with barbituric 
acid 71 in large amounts of methanol under reflux to give the products 131 and 133. 
It is thought that these forcing conditions are required due to the extremely poor 
solubility of barbituric acid. Although the duration of these reactions is long 
(ca. 5 days) and to date has been low yielding (10 %), it is felt that the chemistry 
could be optimised to provide novel candidates for screening. 
CH3 - 
O_.O 	
CH3 	OCH3 Piperidine (Cat) 
HNyNH + 	
MeOH (high dilution) 	O 
o 	 0 	 reflux, 5 days 	
HNyNH 
0 
71 	 130 	 131 
H3CO 
O 	 H3C 	 Piperidine (Cat) 	 H3CJjJ 
—O 
	
HNyNH + H ;)0 MeOH3C 	(high dilution) 	0  o 	 0 	 reflux, 5 days 	
HNyNH 
0 
71 	 132 	 133 
Scheme 2.23: High dilution chemistry to afford novel pyrimidinetriones 
2.4.8 Alternative strategy-VI 
Another successful and new approach to the pyrimidinetriones family of compounds 
(with intermediates that are amenable to parallel synthesis) involves alloxan 134 as a 
starting material. Alloxan was conveniently prepared from its hydrate by chemical 
removal of the water using acetic anhydride in boiling acetic acid . 235 The central 
C=O group of this trione is extremely electrophilic. Reaction of 134 with 
2 equivalents of active methylene C-H acidic component 135 in anhydrous 
dimethoxyethane enabled facile isolation of the water-soluble product 136 in good 
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134 	 135 	 136 
Scheme 2.24: Alloxan with an active methylene C-H acidic component. 
In this case, only the central carbonyl group of alloxan monohydrate reacted. This is 
in agreement with earlier observations of reactions between 1 ,2,3-triketones with 
species having an activated methylene group. 237  The structure of the product was 
assigned by easily interpretable 'H and ' 3 C NItvlR data. The synthesis of analogues 
was attempted using similar methodology (Table 2.6) to generate a range of target 
structures. The successful coupling of alloxan to produce various derivatives based 
on the pyrimidinetrione skeleton opens the door to the parallel synthesis of 
potentially useful analogues. 
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Table 2.6: Alloxan with active C-H components. 
2.5 Synthesis of Isoquinolinediones (Ilomophthalimides) 
Homophthalic acid derivatives are important building blocks for the synthesis of 
alkaloids and a variety of medicinally interesting structures. 238 Homophthalimides 
were first described as hypnotics by Lumiere and Perrin 239  in 1924, who prepared the 
4,4-diethyl, diallyl, ethyl propyl and dipropyl derivatives and reported that the latter 
had hypnotic action. Since the —CO-NH-CO- configuration in homophthalimide also 
appears in several classes of compounds, including pyrimidinetriones possessing 
marked kinase activity, a study of substituted homophthalimides appeared worthy of 
further investigation (Figure 2.11). 
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Figure 2.11: Pyrimidinetrione and Isoquinolinedione (homophthalimide). 
Synthetic routes to these deceptively simple compounds are, surprisingly, scarce and 
of very limited scope.238' 240a-c  Copper catalysed aromatic substitution of 
2-halobenzoic acids and the oxidative ring cleavage of indanones are the two main 
routes to homophthalic acids, and subsequently, to homophthalimides. Except in the 
simplest of cases, the substrates required in both of these approaches are not 
generally available. 
We have been able to synthesise isoquinolinedione 140 using a reported 
procedure .240a  This route involves copper-catalysed displacement of bromide from 
2-bromobenzoic acid 137 with the sodium salt of ethylacetoacetate 138 and 
concomitant loss of acetate to give the homophthalate half-ester 139. Reaction of 
half-ester 139 with urea at 150 °C for 45 minutes provided the desired 
isoquinolinedione 140 in 31% yield (Scheme 2.25).240a 
Br 	+ o o CuBr, NaOEt 	(1-0O2C2H5 	Urea 
COOH )LOC2H5 EtOH. reflux, 3h C00H 	150 °C 	
NH 
0 
137 	 138 	 139 	 140 
Scheme 2.25: Synthesis of isoquinolinedione. 
Treatment of 140 with pyrrole-2-carboxaldehyde using potassium fluoride and basic 
alumina under microwave irradiation, afforded the desired compound 141 in good 
yield (60%) (Scheme 2.26). 
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Scheme 2.26: Synthesis of isoquinolinedione derivative. 
Unfortunately, both of the above mentioned methods for the preparation of 
isoquinolinediones 140 inherently require a specifically functionalized precursor 
(e.g., the presence of an o-halogen, or a pre-existing ring system). Thus, a nontrivial 
synthetic sequence may be required to prepare the appropriate precursors. A classical 
approach to this type of systems that circumvents the need for such functionalisation 
is the Friedel-Crafis cyclisation. 24 ' While it is a modular technique in that the 
reactive functional group is transferred away from the aromatic nucleus, the strongly 
acidic conditions and high temperatures required for such reactions limit the range of 
functional groups that are tolerated. 242 In this context, it is quite important to develop 
new methods for these type of compounds. We hoped that we could develop a novel 
variant of the Friedel-Crafts procedure using palladium-catalysed C-H 





N. 1100C,30min 	 N 
0 	 0 
142 	 143 
Scheme 2.27: Proposed synth 
Pd (OAc)2 
Ligand, base, solvent 
MW, 100 °C, 10-30 min 	0  
140 
etic route for 140. 
We thought that the various combinations of palladium catalysts and sterically 
hindered phosphine ligands would covert N-(2-chloroacetyl)-N-alkyllaryl 
benzamides 143 to its cyclised product 140 via C-H functionalisation. The requisite 
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substrates 142 could be easily prepared by the condensation of the corresponding 
amines with the carboxylic acids. 244 
We have adopted similar reaction conditions which were discussed in Chapter 3 to 
prepare amides 142 using a focused microwave synthesis with the CEM Discover® 
Microwave Synthesizer. Experiments were carried out without catalyst with 
carboxylic acids 144 and amines 145. A variety of amides were prepared under 
solvent-free conditions (Scheme 2.28). In all cases, average to good yields were 
obtained within 30 mins of microwave exposure and the results are summarized in 
Table 2.7. 
Ri< 	 Ri..<- 
OH 	+ H2N—R
R R2 	 MW, 150 °C, 30 mm 
0 	 0 
144 	 145 	 142 
Scheme 2.28: Synthesis of amides using microwave irradiation. 
Entry Compound R Ri R2 Yield (%)a 
1 142a allyl H H 45 
2 142b n-butyl H H 53 
3 142c i-butyl H H 64 
4 142d i-butyl 4-F H 72 
5 142e i-butyl 3-Cl H 74 
6 142f i-butyl 3-OCH 3 3-OCH3 57 
7 142g i-butyl 3-OCH 3 5-OCH3 57 
a Isolated yield. 
Table 2.7: Synthesis of amides using microwave irradiation. 
The chloro substrates are prepared by the condensation of the corresponding amide 
with the inexpensive chioroacetyl chloride .245  N-substituted benzamides 142 were 
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refluxed in toluene in the presence of chioroacetyl chloride until complete reaction 
(TLC monitoring). The precipitated chioroacetamide 143 was filtered, dried, and 
used directly in the following step (Scheme 2.29). In case of simple benzamides, 
products were isolated quantitatively by refluxing neat chioroacetyl chloride in 
equimolar amounts. 246  The results are summarized in Table 2.8. 
CI 
Ri<- 	
chioroacetyl chloride 	Ri 
L "ORR 	110 0C,3Omin  
	
0 	 0 
142 	 143 
Scheme 2.29: Synthesis of chloro substrates. 
Entry Compound R Ri R2 Yield (%)a 
1 143a H H H 59 
2 143b H 2-NO2 H 82 
3 143c benzyl H H 66 
4 143d phenyl H H 43 
5 143e H 4-Cl H 53 
6 143f n-butyl H H 43 
7 143g i-butyl H H 42 
8 143h i-butyl 4-F H 36 
9 1431 CH3 H H 57 
a Isolated yield. 
Table 2.8: Synthesis of chloro substrates. 
A recent report in the literature suggested forming oxindole derivatives via C-H 
functionalisation using the combination of catalytic amounts of palladium acetate 
and 2-(di-tert-butylphosphino) biphenyl 41 as a ligand. 245 Among the phosphine 
ligands examined by Buchwald and Hennessy, only 41 was highly effective for the 
transformation. Even structurally similar phosphines commonly used in 
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cross-coupling reactions provided considerably lower amounts of oxindole in the 
time reactions employing 41 proceeded to nearly complete conversion. 
We hoped that similar catalytic system would rapidly give us isoquinolinediones via 
C-H functionalisation and products could be derivatised using Krioevenagel 
condensation reactions. Direct conversion of 143 to the cyclised product 140 was 
attempted using a literature procedure which involved adding triethylamine and 
toluene to the mixture containing palladium acetate (3.0 mol %), 
2-(di-tertbutylphosphino) biphenyl (Pd:ligand = 2:1), and the chioroacetamide 
substrate (1.00 mmol). However, this procedure failed to give any of the desired 
products 140. Instead, the unexpected products 146a-g were isolated. It was thought 
that the formation of the seven-membered palladacycle might not be possible in this 
case (Scheme 2.30). 
Cl 
Ri 	LQ 	Pd (OAc)2 	 Rt< 
	
-- Q 
ft,L N 	 LLR R Ligand, base, solvent 	 N R 2] 	r MW, 100 DC, 10-30 min 0 	 0 







Scheme 2.30: Palladium-catalysed C-H functionalisation. 
We have also screened a variety of phosphine ligands (Figure 2.12) with a number of 
palladium catalysts [e.g. PdC12 , Pd(Ph3P)4 , tris(dibenzylideneacetone) dipalladium 
(0)] under different reaction conditions including microwave irradiation. None of the 
conditions tested resulted in successful C-H activation and the unexpected products 
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41 	 42 (X-Phos) 	43 (Xant-Phos) 
Figure 2.12: Ligands used in palladium-catalysed C-H functionalisation. 
Entry Compound 	Substrate 	Expected 	Isolated 	Yield 
product product (%)a 
CI 	 OAc 
L N H 	
- 
146a 	
. Lr NH 	 NO2 	
c1 NH 	28 
N020 	 N020 
CI 	 0 	 OAc 
2 	146b 	 x  (*N 	 Bn () N. 	31Br, 0 	 Bri 
O 	 0 
ci 	 0 	 OAc 
L cç i  Lo 3 	146c 	
l LyN.
o




O 	 0 
CI 	 0 	 OAc Gf Lyo 
4 	146d CJ- Bu tIIlLN.. 	31 Bu 	 0 	 Bu 
0 	 0 
CI 	 OAc 
5 	146e Q ~N-., 
0 	
30 
0 	 0 
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7 	 0 	 0 
a Isolated yield. 
Table 2.9: Synthesis of isoquinolidinediones. 
2.6 Summary and Future work 
In summary, we have developed an efficient and versatile route for the synthesis of 
-aryl/alkyl-arylidene malonates 107, from readily available precursors, using the 
air-stable palladium catalyst POPd. A wide range of aryl boronic acids, bearing a 
variety of functional groups, can be tolerated in the reaction. The use of microwave 
assisted heating permits the reaction time to be reduced to 30 minutes enabling a 
number of different analogues to be prepared in a short period of time. We have also 
demonstrated the utility of alloxan chemistry for the synthesis of a highly substituted 
pyrimidinetrione skeleton which opens the door to the parallel synthesis of 
potentially useful analogues. 
Further work which potentially could be undertaken in this area includes 
optimisation of the cyclisation of 0-aryllalkylidene malonates 107 in order to afford 
pyrimidinetrione analogues with the template 72 and 73. As we have shown that it is 
possible to generate pyrimidinetrione analogues using alloxan and various 
CH acidic components to introduce variable functionality, attention may be given to 
applying this methodology towards the preparation of a library of compounds based 
on the general structure of the lead. This work may involve the employment 
combinatorial techniques to carry out the reactions in a parallel format in solution. 
A further interesting investigation would be to develop novel methods for the 
synthesis of isoquinolinediones using palladium catalysed C-H functionalisation. 
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3 	Results and Discussion - Synthesis of N-substituted 
oxindoles 
3.1 Aim 
The aim of this project was to develop a new approach for the synthesis of 
substituted oxindoles. It was thought that these small molecule inhibitors could be 
used to probe protein function and investigate protein-ligand interactions, 
particularly with cyclin-dependent kinases (CDKs). 
3.2 Alkaloids 
The first alkaloid obtained in pure form was morphine, which was isolated from 
opium by Serturner in 1806.247  The product was commercialised by Merck and was 
the first medicine sold with a purity guarantee in 1822. In 1819, Meissner introduced 
the term alkaloid for nitrogen-containing substances of vegetable origin as a 
description of their basic (alkaline) character. 248 Soon after, however, the definition 
had to be adjusted, as alkaloids were also discovered in animals, for example in 
insects and amphibians. Today, alkaloids are defined as nitrogen-containing 
substances originating from vegetable and animal origin. Some classes of compounds 
that match this definition are not considered alkaloids, namely amino acids, peptides 
and nucleotides. 249 
Plants produce alkaloids from amino acids by enzymatic decarboxylation to afford 
the corresponding biogenic amines, which subsequently undergo condensation with 
secondary metabolites such as polyketides, shikimate metabolites, terpenes and 
steroids to form alkaloids (Figure 3.1). The condensation products of secondary 
metabolites with ammonia as a nitrogen source instead of an amine are referred to as 
pseudo alkaloids. The classification of alkaloids is rather difficult because of their 
enormous structural diversity and, according to the context, a different mode of 
classification can be useful, for example biogenesis, structural relationship, and 
botanical origin or spectroscopic criteria (chromophore for LIV spectroscopy, ring 
skeleton for MS). These classification systems are generally not exclusive. 
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alkaloids I 	I pseudo alkaloids 
Figure 3.1: Biogenesis of alkaloids in plants. 
The most useful classification for the organic chemist is made on the basis of the 
nitrogen containing substructure: 250 
- heterocyclic alkaloids 
- alkaloids with exocyclic nitrogen and aliphatic amines 
- putrescine, spermidine and spermine alkaloids 
- peptide alkaloids 
- terpene and steroid alkaloids 
3.3 Oxindole alkaloids 
The indole template is generally recognised as a privileged structure in medicinal 
chemistry and, in particular, oxindoles (2-indolinones) are important constituents of 
natural indole alkaloids as well as drugs in development and also in the clinic. 25 
Oxindoles have served as essential intermediates in the total synthesis of other 
indolic alkaloids. The oxindole alkaloids are a subclass of the indole alkaloids, 
a family of heterocyclic alkaloids. Indole alkaloids comprise of alkaloids that contain 
the indole chromophore 147 itself, or a structural element derived from an indole, for 
example 148-154 (Figure 3.2). 
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:N~ 	CQ 	()~~N 	WN 
indole 147 	 dihydroindole 148 	indolenine 149 	3-oxindole 150 
 Cy \, 
N 
R 	 I 	 I 	 I 
R R R 
2-oxindole 151 	carbazole 152 	beta-carboline 153 	gamma-carboline 154 
Figure 3.2: Structural motifs of some indole alkaloids. 
3,4 Oxindole kinase inhibitors 
In recent years, a multitude of chemical scaffolds and low molecular weight agents 
have been reported as ATP-competitive CDK inhibitors.  252  For a number of these 
inhibitors the oxindole core is a common structural feature. For instance, the natural 
product indirubin 7,252 253 the potent and selective CDK2 analogue 
GW5181 155252, 254  and the CDK1 and CDK2 selective derivatives 5U9516 13252,255 
and 156 256  all share the oxindole core and belong in the broader oxindole class of 









N 	 N' 
H 	 H H H 
Indirubin7 	 GW5181 155 	 SU9516 13 	 156 
Figure 3.3: ATP-competitive inhibitors of CDKs from the oxindole class. 
Indirubin, 7, was isolated from a Chinese herbal mixture that was used to treat 
chronic myeloid leukaemia (CML). Recently, indirubin and its analogues, 5-chioro- 
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indirubin, indirubin-3'-monoxime and indirubin-5-sulphonic acid, were identified as 
potent and selective CDK inhibitors. They show inhibitory activity against CDK1, 
CDK2, CDK4 and CDK5. 257 Jndirubin-3'-monoxime has activity in several tumour 
models and blocks the cell cycle at GuS and G2IM. 258 SU9516, 13, a novel 
3-substituted indolinone inhibits the activity of CDK1, CDK2 and CDK4 and 
induces apoptosis in colon carcinoma cells. 259  Oxindole (2-indolinone)-based 
inhibitors with effects on CDK have been developed and are described by Andreani 
et al. 260 Bramson et al. 261 and Davis et al.262 
3.5 Ligand design 
We have applied a new virtual-screening computer program (LIDAEUS) for the 
automated docking of small ligands to the active site of CDK2. This newly 
developed docking program can efficiently screen very large databases in a 
reasonable time. 39 Using this screening approach, we have identified several groups 
of structurally related compounds representing putative CDK2/ATP antagonist 
pharmacophores. One of these groups consisted of substituted oxindoles, 157 which 
were predicted to form a binding feature common to most known CDK inhibitors 
(Figure 3.4). In all cases the inhibitors form two or three specific H bonds with the 
backbone amide groups of Glu 8 ' and Leu83 . The crystal structure of 7 in complex 
with CDK2 supported the view that the indirubins were ATP-competitive inhibitors 
(Figure 3.5). Development of a novel synthetic route into these types of compounds 





157 R = H, alkyl, aryl 
Figure 3.4: Indirubin, 7 and oxindole pharmacophore 157 for CDK2 inhibition. 
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The oxindole 7 forms three hydrogen bonds to the peptide backbone 
(G1u81 and Leu83) and reaches deep into the ATP binding pocket 
(Figure 1.7, Chapter 
3.6 Existing methods for the synthesis of substituted oxindoles 
Numerous methods for the synthesis of oxindoles have been reported. Friedel-Crafts 
cyclisations of a-haloacetanilides and variations on the Fischer indole synthesis are 
the classical methods of oxindole synthesis. 263  Cyclisations of 2-haloacryloylanilide 
derivatives by a variety of radical initiators have been reported more recently. 264, 265 
Metal-catalysed routes to oxindoles include palladium-catalysed cyclocarbonylations 
of 2-aminostyrenes, 266 rhodium-catalysed carbonylations of 2-alkynylanilines, 267 
rhodium catalysed cyclisations of a-diazoamides, 268 and intramolecular Heck 
couplings of 2-haloacryloylanilides. 269 Photochemical and radical-promoted 
cyclisations of saturated 2-haloanilide derivatives have also been reported. Selections 
of these methods are discussed in the following sections in more detail. 
3.6.1 Radical mediated synthesis of oxindoles 
Bowman et al. reported a facile new synthesis of oxindoles using intramolecular 
addition of o-aryl radicals onto the a-position of a,3-unsaturated N-alkylamides 158 
by exclusive exo-cyclisation. 264 The substrates were prepared by acylation of 
o-haloaniline with the respective a,3-unsaturated acid chloride, followed by 
alkylation of the resulting amide. Cyclisations were carried out under nitrogen in 
refluxing toluene with n-Bu 3 SnH and AIBN. The cyclisations were fully investigated 
in order to determine the synthetic utility and mechanistic parameters, e.g. the effect 
of nucleophile, 13-substitution (+1 and -I groups), a,13-disubstitution, intermediate 
radical stability, replacement of the amide oxygen by sulphur, replacement of the 
olefin by an acetylene group, and N-substitution. The cyclisations of various 
o-halo substrates with a representative range of substituents on the a-position 
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Scheme 3.1: Radical mediated cyclisation. 
The triple bond analogue 164 also gave exclusive exo-cyclisation of the intermediate 
aryl radical onto the a-position of the unsaturated system (scheme 3.2) yielding both 
double bond isomers 166 and 167. 
Ph 	 Ph 
Bu3SnH 	 0 
Nio AIBN 
Me 	 Me 






Me 	 Me 
166 	 167 
Scheme 3.2: Radical mediated exo-cyclisation. 
Cyclisation of the disubstituted a, $-unsaturated amide 168 gave the expected 
spiro- and exo-product 169 (scheme 3.3). 
c:_ 	
Bu3SnH 





Scheme 3.3: Synthesis of spiro-oxindole by radical cyclisation. 
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Jones and McCarthy have described the synthesis of 1,3,3 -tri substituted and 
3,3-disubstituted oxindoles, 171 and 174, via cyclisation of the aryl radicals derived 
from o-bromoacryloylanilides. 265 The synthetic utility of this approach to oxindole 
synthesis has been demonstrated by a formal total synthesis of the alkaloid 
geneserine. 27° Jones et al. have also demonstrated the feasibility of chiral induction 
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Scheme 3.4: Radical cyclisation using chiral auxiliaries. 
3.6.2 Photochemical synthesis of oxindoles 
Wolfe et al. reported an attractive photochemical cyclisation reaction for the 
synthesis of N-substituted oxindoles. Their synthetic strategy involved the formation 
of the monoanions of N-acyl-N-alkyl-o-chloroanilines 175, by treatment with LDA in 
THF, followed by irradiation with near-UV light to afford the 1,3-dialkyloxindoles 
176, in good yields. Photocyclisations of mono- and dianions prepared from 
a,f3-unsaturated o-haloanilides 177 proceed to form 3-alkylideneoxindoles 178 
(Scheme 3•5)•272  The influence of near-UV light and the effect of inhibitors implicate 
a radical-chain mechanism as the major reaction pathway in this convenient new 
method for oxindole synthesis. These carbanion photocyclisations provided several 
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important advantages over traditional synthesis of oxindoles; these include the use of 
readily available starting materials, convenient experimental procedures, and 
predictable regiochemistry during ring closure. 
R 1 
CI R1 	LDA 	
O:No 0 	hv 
I 	 R R 









N 0 hv 	
LLN 
R 	 R 
177 	 178 
Scheme 3.5: Photochemical cyclisation for the synthesis of N-substituted oxindoles. 
3.6.3 	Metal-catalysed routes for the synthesis of oxindoles 
3.6.3.1 	Rhodium-catalysed synthesis of oxindoles 
Takahashi et al. reported a new reaction that provided the first examples of the direct 
synthesis of oxindoles starting from acetylenic compounds. 2-Alkynylanilines 179 
undergo carbonylation, cyclisation and hydrogenation in sequence to give 
3-substituted- 1,3 -dihydroindol-2-ones 180 together with 3 -substituted-2-quinolones 
181, both of which have significant biological activities (Scheme 3.6).267  The initial 
acetylenic substrates, 2-alkynylanilines, can be prepared by the palladium-catalysed 
cross coupling between 2-haloanilines and acetylenes, 273  and the reaction may have a 
wide application to the synthesis of a variety of oxindoles. 
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Scheme 3.6: Sequential carbonylationlcyclisationlhydrogenation. 
Lee et al. described a novel route for the synthesis of biologically interesting 
oxindoles 183 and their derivatives by using thermal and rhodium(II)-catalysed 
Wolff rearrangements, commencing with a ring contraction of diazodicarbonyl 
compounds 182 (Scheme 3•7)274  The Wolff rearrangement of diazocarbonyl 
compounds has been widely investigated by many groups.  275a-  However, no study 
has been made of a thermal and rhodium (II) catalysed Wolff rearrangement of 
diazoquinolinediones. 
0 
R2 &N2 	Rh2(0Ac)4 	
30 
	
N 	0 	acetonitrile 	
I 
Fl Ri 
182 	 183 
Scheme 3.7: Rhodium catalysed ring contraction of diazocarbonyl compounds. 
Recently, a new effective catalytic system consisting of [Cp*RhC1 2 ] 2/K2CO3 
(Cp* = pentamethylcyclopentadienyl) for the lactamisation of amino alcohols 184 
has been developed by Fujita et al. 276  A variety of oxindoles 185 were synthesised 
by this catalytic system (Scheme 3.8). 
OH 	cat. [Cp*RhCl2 ] 2 
K2CO3/acetone 	O~N~o o 
 
184 	 185 
Scheme 3.8: Rhodium catalysed lactamisation of amino alcohols. 
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3.6.3.2 	Palladium-catalysed synthesis of oxindoles 
Intramolecular amide arylation of 2-haloanilides now represents a versatile 
methodology for preparing substituted oxindoles. Hartwig et al. reported the first 
example of a palladium-catalysed, intermolecular arylation of dialkylamides and 
pyrrolidinones, along with a series of intramolecular arylations that produce 
oxindoles. The ability to conduct intermolecular a-arylation of amides led them to 
investigate an intramolecular variant of this reaction that would generate oxindoles. 
The authors also investigated the use of 2-bromoanilides as substrates for cyclisation 
to oxindoles. N-(2-Bromophenyl)-N-alkylamides are readily prepared by coupling 
2-bromoaniline to an acid chloride followed by N-alkylation of the resulting amide. 
Treatment of N-benzyl-2-bromoacetanilide 186 with sodium tert-butoxide 
(1.5 equiv) in the presence of Pd(dba) 2 (5 mol %) and a chelating phosphine such as 
BINAP or DPPF resulted in the formation of l-benzyloxindole 187 (Scheme 3.9). 277 
Pd(dba)2, 5% 
Br 0 	Ligand, 7% 
Base, 1.5equiv 
Bn 	 Bn 
186 	 187 
Scheme 3.9: Palladium catalysed intramolecular a-arylation of amides. 
In addition to the synthesis of N-benzyloxindole 187, it was shown that cyclisation to 
form N-alkyl versions of the parent oxindole core occurred in good yields. The 
ability to produce 1-substituted oxindoles by this route avoids alkylation of oxindole 
that often occurs with poor regioselectivity. 278 
In contrast to the attempted intermolecular arylation of secondary and tertiary amide 
enolates, N-(2-bromophenyl)isobutyramide 188 underwent clean intramolecular 
arylation to form 1,3,3-trimethyloxindole 189 in good yield. Furthermore, the 
spirocyclic oxindole 191 was also produced in excellent yield, demonstrating that the 
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intramolecular amide arylation should be a useful methodology for generating this 
type of core in biologically active oxindoles (Scheme 3.10). 
Pd(dba)2, 5% 
Br 0 
	 Ligand, 7% 
1111)L1. 	Base, 1.5 equiv 
Me 	 Me 
188 	 189 
Pd(dba)2, 5% 
Br 0 	 Ligand, 7% 
UN 	 Base, 1.5 equiv 	ON 
MIIj 	 Me 
190 	 191 
Scheme 3.10: Synthesis of oxindoles using intramolecular amide arylation. 
A conceptually novel synthesis has recently been reported by Hartwig et al.279 where 
a palladium-catalysed intramolecular arylation of an o-chloroanilide enolate has been 
realised to give the oxindole in good yields (Scheme 3.11). Hartwig and others have 
shown recently that the use of catalysts containing sterically hindered 
alkylphosphines accelerate a number of cross-coupling reactions such as a-arylation. 
Furthermore, Buchwald et al. have shown that aryldialkylphosphines can be highly 
reactive catalysts for ketone substrates, as well as for substrates with pKa's lower 
than those in ketones. Buchwald et al.280 have reported on the use of sterically 
hindered alkylphosphines and related heterocyclic carbene ligands to accelerate the 
rates for cyclisation to form oxindoles and to allow the reactions to be conducted 
under mild conditions. Furthermore, Buchwald reported that the most hindered of the 
alkyiphosphines are not effective for these reactions, but that the slightly less 
sterically demanding PCy3 provides fast rates. 
The successful use of alkylphosphines has led to the evaluation of the cyclisation of 
chloroarene substrates. Traditionally, chloroarenes have required high temperatures 
for oxidative addition, but the use of sterically hindered alkylphosphines and 
heterocyclic carbene ligands have now allowed for reactions involving chloroarene 
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substrates to proceed under mild conditions. 280 ' The chioroarene substrates 192 
reacted at 70 °C to form oxindoles 193 in good yields (Scheme 3.11). These 
temperatures and the catalyst loadings are lower than those required for previous 
reactions involving bromoarene substrates using BINAP as a ligand, with reaction 
yields comparable. N-Methyl and N-benzyl substrates reacted at similar rates and 
also gave good yields of oxindoles. 
R 1 
II:I)L(R 
5 mol% Pd/Ligand 
base,  solvent 	
L.LN 
Me R1 	 Me 
192 	 193 
Scheme 3.11: Palladium catalysed intramolecular arylation of chioro anilide. 
The intermolecular a-arylation of amides 277  was combined with the intramolecular 
process to prepare 3-aryloxindoles in a simple fashion. The authors have developed a 
synthetic route that would utilise initial cyclisation followed by intermolecular 
arylation of indole. Moreover, the authors expected that the rate of oxidative addition 
of a bromoarene to Pd(0) would be faster than that of a chioroarene. Construction of 
3-aryl oxindoles 196 occurred in one step from simple materials by reacting 
bromo-substituted acetamide 194 with a chloroarene 195 (Scheme 3.12). 
Ar 
Br 0 
	 10 mol% Pd(AOc) 2/PCy3 
+ 	
Ar—Cl NaOtBu, 1,4ioxane 	
LN 
Me 	 70°C,12h 	 Me 
194 	 195 
	
196 
Scheme 3.12: Combined intra and intermolecular arylation. 
Zhang and Zhang have discovered a novel metal-ligand system and applied it to the 
synthesis of oxindoles from o-haloanilides. 28 ' Oxindoles 199 were formed in good 
yields from 2-chioro- or bromoanilide, 197 and 198, in the presence of a base and a 
93 
X R3 
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novel palladium imidazol-2-ylidene complex, through a process of metal-catalysed 
intramolecular arylation of amide enolates. A wide range of substrates, including 
electron rich aryl chlorides, were found to be active under this catalytic system 
(Scheme 3.13). 
X = ci, 197 	 199 
X = Br, 198 
Scheme 3.13: Synthesis of oxindoles from o-haloanilides 
The palladium-catalysed indole synthesis shown in Scheme 3.13 appeared to be the 
method of choice when Zhang et. al encountered the need for an efficient synthesis 
for a drug candidate containing an oxindole moiety. Indeed, the Hartwig procedure 
(Scheme 3.11) proved reproducible when BINAP was used in combination with 
Pd2(dba) 3 . However, it was found that the o-chloroanilides, unlike their bromo 
derivatives, failed to give any appreciable level of conversion when subjected to the 
Pd2(dba) 3/BINAP system, even at elevated temperature over a prolonged reaction 
time. A screen of catalysts using several bulky and electron rich phosphines was 
conducted, in light of reports that these ligands generally favour palladium mediated 
reactions of inactivated aryl halides. 282,283  However, the phosphine ligands screened 
were found ineffective for this particular transformation. Additionally, the use of 





& Br Me 
Figure 3.6: 1 -mesitylimidazonium salt, 200. 
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The authors prepared 1-mesitylimidazolium salt, 200, (Figure 3.6) from 
1 -mesitylimidazole and o-bromobenzyl bromide, with the intention of providing a 
less bulky, intramolecular coordination site so as to limit the possibility of forming a 
bis-(bis-imidazolidene) complex. Indeed, when compound 200 was mixed with an 
equimolar amount of palladium, the catalyst generated in situ proved to be effective 
in the oxindole forming reactions for a variety of substrates. The catalyst derived 
from 200 is generally more active than the Pd/BINAP combination, as indicated by 
both reaction rates and product yields. Moreover, o-chloroanilide was found to 
undergo cyclisation, albeit in moderate yield. 
Most of the synthetic methods for the synthesis of oxindoles inherently require a 
specifically functionalised precursor (e.g. the presence of an ortho-halogen, an amino 
group, or a pre-existing ring system). Thus, a nontrivial synthetic sequence may be 
required to prepare the appropriate precursors. A classical approach to the synthesis 
of the oxindole 206 system that circumvents the need for such functionalisation is the 
Friedel-Crafts cyclisation of a-halo-acetanilides 205 (Scheme 3.14).263  While it is a 
modular technique in that the reactive functional group is transferred away from the 
aromatic nucleus, the strongly acidic conditions and high temperatures required for 





NaH 	r( 	 70% H2SO4 
___________ 	 R-- I 




cH3 	 c5H 3 




CH3 	 H3 
206 	 205 
Scheme 3.14: Friedel-Crafts cyclisation. 
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More recently, Buchwald and his co-worker reported a novel variant of the 
Friedel-Crafts procedure using palladium-catalysed C-H fiinctionalisation, 243 
obviating the need for harsh reaction conditions. In doing so, a simple protocol for 
the regioselective synthesis of substituted oxindoles was developed (Scheme 3.15) .245 
Pd(OAc)2 (3 mol%) 
R_X 	 R— =Q 
EtN, toluene, 80 °C 
207 	 208 
Scheme 3.15: Palladium-catalysed C-H functionalisation. 
a-Chloroacetanilides 207 were smoothly converted to oxindoles 208 in high yields 
with high levels of regioselectivity, using the combination of catalytic amounts of 
palladium acetate, 2-(di-tert-butylphosphino)biphenyl as a ligand, and triethylamine 
as base. The requisite substrates were prepared by the condensation of the 
corresponding aniline with inexpensive chioroacetyl chloride. A variety of 
substituted oxindoles were obtained in high yields and even electron-deficient 
aromatic nuclei were shown to be reactive, allowing for the synthesis of oxindoles 
that may be difficult to obtain using classical Friedel-Crafts methodology. 
Importantly, functional groups incompatible with strong Lewis acids 
(-OMe, -TMS) were well tolerated, as is typical of reactions catalysed by late 
transition metals. It was shown that this method was also compatible with electron-
rich aryl chlorides, allowing for palladium-catalysed coupling reactions to occur after 
the oxindole cyclisation reaction. However, despite the efficiency of the cyclisation 
reaction, the substrate scope is limited to N-alkyl or N-aryl chioroacetanilides. They 
were unable to cyclise N-H or N-acyl (amide, carbamate) substrates. 
VU 
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3.6.4 Synthesis of N-substituted oxindoles by Forbes 
Forbes has developed a simple, flexible, and high yielding synthetic route to 209, as 
well as substituted analogues 210 and 211 (Figure 37)285  This methodology also 
constitutes a general synthesis of N-substituted indol-2-ones as it is capable of 
introducing a wide variety of substituents onto the indolone nitrogen atom. 
O:N~==  N 	 F 
b b b 
H 	 H 	 H 
209 	 210 	 211 
Figure 3.7: Synthesis of oxindoles. 
Forbes envisaged that the general process outlined in Scheme 3.16 would offer 
numerous advantages to existing routes.  286 The tert-butyl ester of 
o-aminophenylacetic acid, 214, is a stable compound , 287 which would readily allow 
reductive amination, prior to effecting ring closure. 
CO2t-Bu 
R1"O 	 R 	
CO2t-Bu 	 CO2t-Bu 
L.L. 	 , 	c_-L.  > R- 	 ' R 
	
N NH 	 1 
bc tD 	
OLH2 OtO2 
R 	 I R 
212 	 213 	 214 	 215 
Scheme 3.16: Retrosynthesis of N-substituted oxindoles. 
In practice, they have developed the route summarised in Scheme 3.17. Addition of 
di-tert-butyl malonate, under basic conditions, to the o-fluoronitrobenzene 
derivatives 216 afforded the adducts 217. The use of di-tert-butyl malonate serves 
Chapter 3 	 Results and Discussion II 
two functions: it allows facile anion formation prior to nucleophilic aromatic 
substitution and prevents unwanted cyclisation at the next stage. Thus, the nitro 
adducts 217 were hydrogenated in quantitative yield to the anilines 218, which 
showed no propensity to cyclise. Reductive alkylation of 218 using 
N-benzyloxycarbonyl-4-piperidone proceeded under standard literature conditions 288 
to provide the key di-esters 219. In a highly efficient manner, the di-esters 219 were 
converted into the desired indol-2-ones 220, by treatment with 4-toluenesulfonic acid 
in refluxing toluene for 1 h. Thus, in a single step, the di-tert-butyl esters 219 were 
deprotected, allowing concomitant intramolecular cyclisation to the indol-2-one to 
occur, in addition to the facile decarboxylation of the redundant carboxyl group. 
Removal of the benzyloxycarbonyl protecting group on the piperidine nitrogen was 
accomplished by standard hydrogenation, affording compounds of generic structure 
209. 
	




NaH, DMF _C'CO2tBu Pd-C, H2, EtOAc 
RC--L. NH2
CO2tBU  10 - 
60-90% 	
R 
NO2 	 quantitative 
 






_____________ 	I 	 reflux R 	
Pd-C, H2 	
ptsa, toluene, 	
rrCO2t-Bu - 0 	 R—j-- 0 	 R 
85-89% 	 77-88% 	 NH 
b b 6 
H 	 Z z 
209-211 	 220a-c 	 219a-c 
(a) R = H 209; (b) R = 5-F 210; (C) R = 6-F 211; Z = benzyloxycarbonyl 
Scheme 3.17: Synthesis of N-substituted oxindoles. 
Chapter 3 	 Results and Discussion II 
The route depicted in Scheme 3.17 is a versatile process for the synthesis of 
indol-2-ones possessing a diverse range of N-substituents, by appropriate choice of 
aldehyde or ketone in the reductive alkylation of 218. 
3.7 Novel methodology for the synthesis of N-substituted oxindoles 
The importance of oxindole heterocyclic system notwithstanding, above mentioned 
existing methods for oxindole synthesis are limited in their scope and generality. In 
this context, it is important to continue to develop efficient methods for the synthesis 
of this class of compounds, especially routes based upon readily available starting 
materials. Although a number of reactions have been reported for the synthesis of 
oxindoles, there remains a need for new methods. A conceptually different approach 
to the construction of heterocycles, including oxindoles, has arisen from the work of 
Buchwald, Hartwig and others, and is based upon the palladium-catalysed 
intramolecular aminationlamidationlHeck reaction of appropriately substituted 
arenes, via C-N/C-C bond formation. 277 '281 '245'289 A recent report describes the use 
of nickel rather than palladium. 290 
The palladium-catalysed amination developed by Buchwald and Hartwig is a 
powerful tool for producing nitrogen heterocycles, which are one of the most 
important classes of pharmacologically active compounds. 291 "292 In particular, 
Buchwald reported that aryl bromides with pendant secondary amide groups 221 
could be cyclised to form tertiary amides 222.293  P(o-tolyl) 3 or P(2-furyl) 3 were the 
ligands used in conjunction with [Pd 2(dba)3]. This methodology allows for easy 
access to a wide variety of nitrogen heterocycles 224. However, these cyclisation 
protocols typically employed high catalyst loadings and often long reaction times 
were necessary. However, with the proper choice of palladium catalyst, ligand and 
base, five-, six-, and seven-membered rings are formed efficiently from secondary 
amide or secondary carbamates precursors (Scheme 3.18) .294 
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Pd catalyst, ligand 
Base, toluene, 100 0C 
Bn 
221 	 222 
H 
Pd catalyst, ligand 	cti 
Base, toluene, 100 0C 
R 
223 	 224 
R = Ac, Cbz, Boc; n = 1-3 
Scheme 3.18: Palladium catalysed aminationlamidation. 
In parallel with these developments in the metal mediated construction of C-C and 
C-N bonds there has been a general recognition that microwave heating can 
accelerate a broad range of reactions in organic synthesis, especially in the field of 
metal-catalysed cross-coupling reactions. 295 Microwave heating can dramatically 
reduce reaction times, increase product purity and yields, and allow precise control 
of reaction parameters, all of which are crucial factors to consider when developing 
reaction protocols for both routine synthetic transformations and parallel synthesis. 
We have developed an efficient approach to substituted oxindoles using microwave-
assisted amide bond formation followed by palladium-catalysed intramolecular 
cyclisation reaction as shown in Scheme 3.19. 
Our approach was inspired by previous studies by Buchwald et al.293 ' 294 The authors 
described the synthesis of N-substituted oxindoles, from the corresponding 
2-bromo-N-substituted phenylacetamides, using palladium acetate and various 
phosphine ligands in high yields and with reaction times of 24-36 hours. We 
envisaged an alternative approach involving initial generation of the amide by direct 
microwave assisted coupling of a 2-haloarylacetic acid 225 with an amine 226, 









MW, 300W, 150 0C, 30 mm 
+ H2N—R 
Pd(OAc)2/Iigand 
base, H20/toluene or toluene 
226 	MW, 75W, 100 °C, 30 mm 
R1_OC'>=O 
227 
R = alkyl, aryl 
X = Br, Cl 
Scheme 3.19: Microwave assisted synthesis of oxindoles. 
3.7.1 Microwave-assisted synthesis of amides 
There is considerable interest in the formation of amides by the direct combination of 
carboxylic acids and amines, as the methods employed may also be utilised in 
peptide and lactam synthesis. In general, the formation of carboxamides from amines 
and carboxylic acids implies the activation of the carboxyl group. 296  The most 
common methods involve either conversion of a carboxylic acid to a more reactive 
functional group such as an acyl chloride, mixed anhydride, acyl azide or active 
ester; or via an in situ activation of the carboxyl group by a coupling reagent such as 
a carbodiimide.297' 298  More recently, new systems were recommended such as 
titanium or divalent tin reagents of type Sn(N(TMS) 2)2 ,299 treatment with equivalent 
amounts of triphenyiphosphine and N-halosuccinimides such as NBS 300  or with 
trichloroacetonitrile. 30 ' 
With the aim of simplification of the procedures, especially in order to avoid the 
preliminary and often expensive synthesis of coupling reagents, it was considered 
that the preparation of amides via the pyrolysis of the corresponding salts obtained 
by mixture of the amine and the carboxylic acid (Eq. 3.1), as the most interesting 
method for their syntheses in the absence of any catalyst and solvent. 302 
R—COOH + R 1—NH2 - 	 R—000, NH3R 1 
A 	 u 
0 H 
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However, the pyrolysis of amides usually suffers from rather harsh conditions with 
respect to temperature and reaction times. It has been reported that microwave 
activation has been used with a great deal of success in several cases of amide 
synthesis by direct irradiation of amine—carboxylic acid mixtures. Examples cite the 
use of different kinds of catalysts such as K-10 montmorillonite, 303 imidazole, 304 
zeolite-HY, 305 polyphosphoric acid , 306 p-toluenesulfonic acid , 307 TaC15-silica gel ,308 
KF—alumina and silica gel . 309 In a few cases, reactions were performed in the 
absence of catalyst for the synthesis of aromatic amides, 31° 2oxazolines311  and 
imides from dicarboxylic acids. 312 
Loupy et al. demonstrated the utility of microwave irradiation in the synthesis of 
amides via pyrolysis of the salts obtained by mixing neat primary amines and 
carboxylic acids. 313  Reactions proceeded under solvent-free conditions with short 
reaction times to give amides in appreciable yields. 
We have adopted similar reaction conditions to prepare amides 228 using a focused 
microwave synthesis (reactions at elevated pressures in sealed vials or at atmospheric 
conditions in the single-mode reaction chamber) with the CEM Discover® 
Microwave Synthesizer. Reaction conditions were monitored using a black body 
radiation sensor to measure temperature, and a pressure probe inserted through the 
septum of the reaction tube. Experiments were carried out without catalyst with 
carboxylic acids 225 and amines 226. The reaction temperature selected was 150 °C 
in order to favour shifting of the equilibrium by water removal (Eq. 3.2) 
0 
________ ii H 
R-COOH + R 1-NH 2 - 	 R-C-N-R 1 + H20 	(3.2) 
R = C6H5CH2 
R 1 = C6H5, C6H5CH2 
A variety of amides were prepared via pyrolysis of the salts obtained by mixing neat 
primary amines and carboxylic acids. Reactions proceeded under solvent-free 
102 
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conditions with short reaction times (Scheme 3.20). The results from this library 




+ I-12N—R C', YO MW, 300W, 150 °C, 30 mm 	 R . R1_  
225 	 226 	R = alkyl, aryl 	 228 X = Br, CI 
Scheme 3.20: Microwave assisted synthesis of amides. 
Entry Compound 	Product 	Isolated yield (%) 
	
L-O 92 1 	228a 	
i- 
NQ 	 95 2 	228b 
3 	228c 	 92 
HJ 














8 	228h 	 86 CIO 
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12 	2281 	 69 
Bro 
OCH3 





N,,,, 	 81 
C 'B 'r o  
H 
15 	228o 	 81 
1 Br ° 
16 	228P 	
F3C 	 N, 	 72 
L J 1 0 
Table 3.1: Microwave-assisted synthesis of amides. 
Product isolation was achieved by simple washing with the dichloromethane and 
sometimes used directly for next step without further purification. In all cases, good 
to excellent yields were obtained within the 30 min of microwave exposure. We have 
shown that amide formation by microwave irradiation is a convenient, highly 
efficient and high yielding approach towards the synthesis of amides. Although the 
microwave reactions were done in series, the reaction times were considerably 
shorter and the potential to generate larger libraries of compounds has been 
increased. 
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3.7.2 Mechanistic aspects of the pyrolysis of amides 313 
At room temperature, mixing of an amine and a carboxylic acid leads to the rapid 
formation of the corresponding ammonium salt by an acid-base equilibrium 
(Eq. 3.3). 
R-COOH + R 1-NH2 - 	 R-000, NH3R 1 	 (3.3) 
Subsequently, the pyrolysis of the salt leads to amide formation by equilibrium 
retrogradation and subsequent nucleophilic attack of the amine on the carbonyl 
group. This process needs temperatures higher than 100 °C for water elimination 
(Eq. 3.4). 
R-000, NH3R 1 	 R-COOH 
0 
ii H 
+ R1-NH2 	 R-C-N-R 1 	(3.4) 
H20 
Different factors can be considered to justify the relative reactivities of amines and 
carboxylic acids: Firstly, amide formation could be favoured by displacement to the 
right of the previous equilibrium (Eq. 3.3). Nucleophilic attack of the amine on the 
carbonyl group (Eq. 3.4) constitutes the rate-determining step and occurs by attack of 
nitrogen atom on carbonyl group of the acid (scheme 3.21).313 
+ 
R 	- + 





HR1 	 HR1 	 H20 	
H 
(Ground State) 	 (Transition State) 
Scheme 3.21: Mechanistic aspects of the pyrolysis of amides. 
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Very important specific non-thermal microwave effects are evidenced in the amide 
formation reaction. They seem to be increasingly important in the case of sluggish 
reactions. For instance, they allow for an improvement in yields from 25 % using 
conventional heating to 95 % using microwave activation in the reaction of 
2-bromophenylacetic acid and benzylamine. It is evident that the effect lies in the 
enhancement by microwave radiation of nucleophilic attack by the nitrogen atom on 
the carbonyl group, the rate-determining step, as the temperature of 150 °C allows 
for water removal regardless of the mode of activation. 
These effects can be easily understood by considering the possible microwave 
activation affects by dipole—dipole interactions according to mechanistic 
considerations and to an increase in the polarity of the system during the progress of 
the reaction (Scheme 3.21).314  It is well established that microwave—materials 
interactions are increased with the polarity of the materials.  315  As the transition state 
(TS) is consequently more polar than the ground state (GS), its stabilization is more 
affected by dipole—dipole interactions with the electromagnetic field, thus resulting 
in a decrease in activation energy. 
3.7.3 Optimisation of reaction conditions for amidation 
Since the initial amide forming reaction generates a molar equivalent of water it was 
essential to identify conditions in the second step that were tolerant of water. Heating 
a mixture of 2-bromophenylacetic acid 229 and benzylamine 230 under solvent free 
microwave conditions led to rapid (ca. 30 mm) formation of the corresponding amide 
231 in good to excellent yield (Scheme 3.22). 
OH 
+ 	
1) MW, 300W, 150 °C, 30 mi n
"~OLA•BrO 	 2) Pd/ligand, base, solvent 
MW, 75W, 100 °C, 30 min 	 B  
229 	 230 	 231 
Scheme 3.22: Optimisation of reaction conditions. 
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In order to identify optimal conditions for the palladium catalysed intramolecular 
amidation reaction to afford 231, we screened a range of different phosphine ligands 
232, 233 and 41-43 (Figure 3.8) for activity using various combinations of palladium 
source/solvent/base (Table 3.2). 
PPh3 	 P(0401y1)3 





L) Me ¼Me 
i-Pr 
41 	 42 	 43 
Figure 3.8: Ligands screened for intramolecular amidation. 
Recent improvements in Pd-catalysed C-N bond-forming processes have been due 
primarily to the development of new ligands 316 such as bulky, electron-rich 
monophosphines (Figure 3.9). The employment of monophosphine ligands allows 
the use of less reactive substrates such as aryl chlorides and tosylates in 
cross-coupling reactions. 317  Despite these advances, specific classes of substrates 
have remained recalcitrant. Some of these limitations have recently been overcome 
by employing ligand 42.318  The catalyst system based on 42 exhibits both 
dramatically increased activity and stability relative to those based on simpler biaryl 
ligands (e.g., 41 and 234-236). Despite this progress, little information is available as 
to the origin of the catalytic activity based on biaryl phosphine ligands. Recent 
studies suggest that the high activity of catalyst systems based on bulky phosphines 
may result from their ability to promote the formation of monophosphine complexes 
319-321 
Buchwald et al. reported a comparative kinetic examination between catalyst systems 
generated from ligands 41, 42 and 234-236 for the coupling of amines and aryl 
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the catalytic activity but also the rate of catalyst activation. Differences in reaction 
rates for the catalytic systems generated from biaryl ligands 41, 42 and 234236322 
were determined by monitoring the progress in sequential reactions using reaction 
calorimetry. 323a-c 















235 	 236 
Figure 3.9: Biaryl phosphine ligands for amination reactions. 
The catalyst derived from the bulkiest ligand in the series, the tri-iso-propyl ligand 
42, exhibits both accelerated rate and the increased stability required for practical 
application of amination reaction. In general the best results were obtained using 
either ligand 43 or 42 (6 mol %) in the presence sodium hydroxide or caesium 
carbonate (2.0 eq.) as shown in Table 3.2. 
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OH 
+ 	H2NJJ 
MW, 300W, 150 °C, 30 mm 
Pd/ligand, base, solvent C3:N 
MW, 75W, 10000 30 min Bn 
229 230 231 
Entry Conditions Yield (%)b 
1 Pd(PPh3)4, NaOt-Bu, toluene nd 
2 Pd(PPh3)4 , K2CO3, dioxane 10 
3 POPd C K2CO3, toluene 15 
4 Pd(OAc) 2, 232, NaOt-Bu, toluene nd 
5 Pd(OAc) 2 , 233, Cs2CO3 , toluene 58 
6 Pd(dba) 3 , 233, K2CO3,  toluene 55 
7 Pd(OAc) 2 , 41, H20/toluene 60 
8 Pd(OAc)2 , 43, CsCO, toluene 78 
9 Pd(dba)3 , 43, CsCO, toluene 65 
10 Pd(OAc) 2 , 43, NaOH, H20/toluene 82 
11 Pd(OAc) 2 , 43, NaOH, H20/DME nd 
12 Pd(OAc) 2 , 42, Cs2CO3 , toluene 92 
13 Pd2(dba) 3 , 42, Cs2CO3, toluene 89 
14 Pd(OAc)2 , 42, NaOH, 11 20/toluene 95 
' Reactions were conducted with 3 mol % catalyst, 6 mol % ligand, 1.0 equiv of 2-bromophenylacetic 
acid, and 2.0 equiv of base for 30 min at 100 °C on a 1.0 mmol scale of acid. b  Isolated yields. 
cPOPd: PdCl7[(t-Bu)7P(OH)12, purchased from Combiphos Catalysts, Inc. 
Table 3.2: Optimisation of reaction conditions for intramolecular amidation. a 
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3.7.4 The palladium-catalysed intramolecular amidation reaction 
The optimised conditions, shown in Table 3.2, entry 14, were then applied to the 
synthesis of a range of substituted oxindoles as shown in Table 3.3. In the case of the 
alkyl amines, the palladium-catalysed intramolecular amidation step was carried out 
without prior isolation of the intermediate amide. The reaction mixture was simply 
purged with nitrogen gas prior to introduction of the reagents for the second step. 
OH 	 1) MW, 300W, 150 ° C, 30 mm 
R 1-- 	 + H2N—R 	 ' 	 R 1-- 	 0 
X 	 2) Pd(OAc)2/ligand 42 
base, H20/toluene or toluene 	 R 
225 	 226 	MW, 75W,1000C,30min 227 
R = alkyl, aryl 
X = Br, CI 
Entry Compound Acid Amine Product Yield 
(%)b 





2-bromo butylamine Bu 
00 =0 
3 227c 2-bromo isobutylamine 85 
4 231 1ZjrII>=o 95 
2-bromo benzylamine 
p-methoxy 
5 227d 2-bromo benzylamine 92 
-OCH3 
p-methyl 
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p-chloro 	
O~N~ 0 
7 	227f 	2-bromo 	benzylamine 	 L 	 70 
CI 
8 	227g 	2,6- benzylamine 6:N~==O 	80 
dichioro 
9 	227h 	2-chioro- benzylamine &N"—O 	96 
6-fluoro Bn 
10 	2271 	2-bromo cyclopentylamine 50 








14 	227m 	 LN 
5- Bn 
trifluoro 
a Reagents and conditions. acid (1.0 mmol), amine (1.0 mmol), MW 300W, 150 "C, 30 min then, 
Pd(OAc), (3 mol%), ligand 90 (6 mol%), NaOH (2.0 equiv) H 20/Toluene (2 mL 1:1), MW 75W, 100 
°C, 30 mm. b  Isolated yield based on amide. 
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Pd(OAc)2/Iigand 42 
R 1_C')=O 
base, H 20/toluene or toluene 
MW, 75W, 100 °C, 30 min 	 R 
	
228 	 227 
R = aryl 
X = Br, CI 
Entry Compound 	Substrate 	Product 	Yield (%)b 
H 


















4 	227q 	cc01 I_5_CH3 	 N CH, 	80 
- ' CH, 




5 	227r 	-'CI 0 
	 45 




6 	227s 82 
° Reagents and conditions: amide (1.0 mmol), Pd(OA02 (3 mol%), ligand 90 (6 mol%), Cs7CO 3 
(1.5 equiv), toluene (2 mL), MW200W, 100 ° C, 30 min.'Iso1ated yield. 
R 1 Ofl(R 
Table 3.4: Synthesis of substituted oxindoles using arylamines.a 
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In the case of anilines, it was necessary to work up the reaction by extraction into 
chloroform, followed by an aqueous wash and evaporation of the organic layer to 
give the crude product that was used directly for the next step. Synthesis of a range 
of substituted oxindoles using arylamines are summarised in Table 3.4. 
The intramolecular amidation reactions shown in Table 3.3 and 3.4 were generally 
complete within 30 min and with only a few exceptions (Entries 10, 11, 13 from 
Table 3.3 and 5 from Table 3.4) the yields for the two steps were excellent, and 
typically greater than 80%. Scheme 3.23 shows the potential further application of 
the derived oxindoles in which the product 2271 from Entry 13, Table 3.3 was 
subjected to a microwave assisted palladium catalysed bis-amination reaction with 
3-fluoroaniline to give the N-substituted oxindole 237 in 65% yield (Scheme 3.23). 
3-fluoroaniline (2.0 equiv) 	&NH  
Pd(OAc)2 (2 mol%), ligand 42 (4 mol%)
0— 	
6:N>=o Cs2CO3 (1.5 equiv), toluene 
MW, 200°C, 10 min LI1. N !ZIII'I'L,. F 
H 
237 
Scheme 3.23: Palladium-catalysed intermolecular amination. 
3.7.5 Mechanistic aspects of palladium-catalysed intramolecular amidation 
In analogy with palladium-catalysed aminations of aryl halides, an oversimplified 
catalytic cycle is shown in Scheme 3 . 24 .324 Oxidative addition of the aryl halide 
238 to LPd(0) complex gives the intermediate Pd(II) complex 239.325 
Deprotonation gives the palladacycle 240 that can reductively eliminate to produce 
the desired heterocycle 241 and regenerate the Pd(0) catalyst. 326  In the intramolecular 
process, the coordination of the amide prior to the deprotonation of the Pd(II) 
intermediate is facilitated by the linkage of the amine moiety to the aryl group. 
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238 	 239 	 240 
R = alkyl or a ry l 	 -PdL 
X = Br, CI 
O:N~==O 
241 
Scheme 3.24: Catalytic cycle of palladium-catalysed intramolecular amidation. 
3.8 Summary and Future work 
In conclusion an efficient route to a range of N-substituted oxindoles using sequential 
microwave assisted amide synthesis and intramolecular amidation reactions has been 
developed. The approach is particularly efficient when using alkyl amines since there 
is no need to isolate the intermediate amide. It has been shown that the pyrolysis of 
salts obtained by mixing neat primary amines and carboxylic acids were realised 
under solvent-free conditions within short times and appreciable yields with 
microwave activation. Furthermore, it has been shown that the intramolecular 
amidation reaction proceeds well under partially aqueous conditions, in the case of 
alkyl amines, and is subject to substantial acceleration in rate when conducted with 
microwave heating. Good yields were obtained without the use of phase-transfer 
reagents which have been used previously for intramolecular amination reactions. 327 
The intramolecular amidation reaction can be carried out using aryl chlorides in 
addition to aryl bromides thereby greatly extending the range of substrates that can 
be used. The anilines can be used, in addition to alkyl amines, extending the range of 
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In summary we have demonstrated that it is possible to generate focused libraries of 
oxindole analogues using palladium cross coupling methodology and microwave 
assisted chemistry. We have also shown it is possible to use this route with the goal 
of increasing library diversity. This presents the opportunity to incorporate a broader 
range of functionality in the oxindole template as shown in Scheme 3.23. Attention 
may be given to applying this methodology towards the preparation of a library of 
compounds based on the oxindole pharmacophore. This work may involve the 
employment combinatorial techniques to carry out the reactions in a parallel format 
in solution. 
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4 	Results and Discussion - Synthesis of bis-aryl/alkyl 
thioureas 
4.1 Aim 
The overall aim of this part of the project was to design and synthesise a new class of 
inhibitors of cyclin-dependent kinase 2 (CDK2) using parallel chemical methodology 
and microwave chemistry. Through the adoption of a structure based design and 
structure-guided approach, the main focus of this research has been on the 
development of robust chemistry which can be adapted towards library construction. 
4.2 Identification of a new CDK2 pharmacophore 
Research carried out at Cyclacel Ltd. has provided a solid foundation for the 
development of a number of novel series of inhibitors of cyclin dependent kinases. 
The CYC-202 programme, focusing on the purine analogue (R)-roscovitine, 5, has 








Cyclacel Ltd. has also developed a second generation family of CDK2 inhibitors 
based around a 2-anilino-4-(thiazol-5-yl)-pyrimidine scaffold exemplified by the 
inhibitor, 242.328  The X-ray crystal structure of inhibitor 242 bound to CDK2 has 
been solved by Walkinshaw et al. and is shown in Figure 4.1.329 
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Figure 4.1: The X-ray crystal structure of the inhibitor, 242, bound to CDK2. 
Notably, the crystal structure of the CDK2/ligand 242 complex showed that Ni of 
the pyrimidine ring acts as a hydrogen-bond acceptor and interacts with the backbone 
NH of Leu83 and the anilino-NH of the inhibitor acts as a hydrogen-bond donor and 
interacts with the carbonyl of Leu83. The nitrogen of the thiazole ring was shown to 
be within hydrogen-bonding distance to the carboxylic acid of Asp 145. 
4.2.1 Kinase inhibitor pharmacophore: bis(aralkyl)thioureas 
High throughput screening identified a novel class of bis-aryl/alkyl thioureas as 
potent inhibitors of CDK2. A co-crystal structure of inhibitor 243 (CYC-44797) 
bound to the active site of CDK2 provided insight into the binding mode of this class 
of molecules (Figure 4.2). 
S 




Figure 4.2: Structure of screening hit CYC-44797, 243. 
The CDK2 screening hit CYC-44797, 243 was found to adopt an unusual 
conformation upon binding to the ATP pocket of CDK2 (Figure 4.3). Significantly, 
thiourea 243 is a low-AM (10 50= 12.41 tM) CDK2 inhibitor, despite its flexible 
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structure (7 rotatable bonds in the core structure), indicating that the ligand-protein 






Figure 4.3: Crystal structure of 243 in complex with CDK2 and modelling of 
compound 242 with CDK2 
Thiourea derivative 243 is therefore a good foundation for a structure-based design 
approach. The complex crystal structure (Figure 4.3) shows unexpected density 
(in red) suggesting an additional OH substituent next to the phenol function of 243 
would be favourable. Synthesis of analogues in which the phenol is replaced e.g. 
with catechol or resorcinol would be of interest. Furthermore, functionalisation of the 
benzylamine ring with hydrogen bond donor groups and/or small hydrophobic 
groups could be expected to supply additional interactions with the protein. Because 
of the simple structure of 243, it was postulated that the synthesis of a series of 
analogues, designed to probe the SARs of overall spacing and substitution patterns, 
would be worthwhile. An interesting target compound is the hydroxypyridyl 
analogue 244 (Figure 4.4). Modelling of this compound (Figure 4.4) shows that the 
intramolecular interaction of the phenol with the pyridyl functions should stabilise 
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244 
Figure 4.4: Pyridine derivative of CYC-44797. 
4.2.2 Bis(aralkyl)thioureas: Analogue design 
Examination of the crystal structure of 243 in complex with CDK2 indicates the 
















Figure 4.5: Crystal structure of 243 in complex with CDK2. 
Schematic showing interactions between 243 and CDK2 at the A TP-binding site. 
From the structure shown in Figure 4.5, we can identify potential H-bond interaction 
sites (red labels) and unoccupied active site volume. These unfulfilled contacts 
suggest that a number of analogues would useful in probing the structure activity 
relationship and optimizing inhibitor potency (Table 4.1). 
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243 	 245 
Entry Compound Ri R2 R3 m n p 
1 245a 3-OH H H 1 2 1 
2 245b 4-OH H 3-F, Cl, Br 1 2 1 
3 245c 4-OH 2-Me, F, Cl H 1 2 1 
4 245d 4-OH H 3-OH, F 1 2 1 
5 245e 4-OH 3-Me, F, Cl H 1 2 1 
6 245f 4-OH H 2-OH, F 1 2 1 
7 245g 4-OH H H 1 1-3 1 
8 245h 4-OH H H 1 2 0 
Table 4.1: Analogue design. 
To date there are few examples in the literature of CDK inhibitors based around a 
bis-aryllalkyl urea scaffold . 330  Therefore, the primary aim of the research discussed 
in this chapter was to develop novel and robust chemistry for the synthesis of new 
CDK inhibitors based around a bis-aryllalkyl thiourea template. By using microwave 
assisted organic synthesis, it was anticipated that a library of novel inhibitors could 
be quickly generated. 
4.2.3 Retrosynthesis: bis(aralkyl)thiou reas 
It was thought that analogues of 243, i.e. compounds of general structure 245, could 
be easily prepared (Scheme 4.1). Retrosynthetic analysis of the template structure 
shows that carboxamide disconnection gives carboxylic acid derivatives 246 
(X = OH, OR, Cl) and aminoalkylthioamides 247. The latter can be prepared by 
addition of diaminoalkanes 248 to isothiocyanates 249.' Preparation of 
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phenylisothiocyanates (p = 0) is well documented but many benzylisothiocyanates 
(p = 1) can also be prepared readily from benzyl halides 150.332  A number of the 
phenyl and benzyl isothiocyanates are commercially available. 
HH R 
0 	S 
R2 	 245 
II 
CI\ H2
N y ) 
0
*rDC 
R2 	 S 
246 	 247 
II 
H2NNH2 	SCN CO  up 





Scheme 4.1: Retrosynthesis of bis-aralkyl thioureas. 
4.3 Synthetic routes to bis-aryl/alkyl thioureas 
The proposed synthetic route for synthesising bis-aryl/alkyl thioureas 256 from their 
aminoethyl thioamide derivatives 254 firstly involves the addition of 
ethylenediamine to commercially available substituted isothiocyanates 252 to afford 
the thiourea derivative 254; secondly, activation of the acid 251 as its acid chloride 
253; and finally, N-alkylation of aminoethyl thioamide 254 to generate bis-








L ) 0 
251 
Sod2, CHCI3 





Et3N, CH202, it, 20 h 
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CH202, rt, 20 h 
R 1_jj j +  
255a-c 
R = OH, R 1 = H, CYC-44797 
Scheme 4.2: Synthesis of bis-aryl/alkyl thioureas. 
The preparation of amino-ethylbenzyl thiourea derivative 254 shown in scheme 4.2 
was achieved by treating a solution of ethylenediamine in dichioromethane with 
benzylisothiocyanate 252 at room temperature for 20 hours. Compound 256 could be 
prepared by either formation of the thiourea followed by amide formation with acid 
chloride or the reverse sequence. Isothiocyanates serve as a source of thiourea 
functionality in each case. However, analysis of the crude product by ESI-MS found 
a peak corresponding to the mass of the bis-substituted compound 255 (Scheme 4.2). 
TLC revealed two major spots indicating the formation of bis-substituted product in 
both cases. Following the reaction sequence, treatment of the crude product 254 with 
acid chloride 253, gave bis-substituted analogues in moderate yields. 
4.3.1 Alternative synthetic route to bis-aryllalkyl thioureas 
An alternative route for synthesising bis-aryllalkyl thioureas 256 (R = OH, 243) is 
via their mono substituted ethylenediamine derivative 259. This route involves, 
firstly, activating the acid 257 as its acid chloride 258; followed by the coupling of 
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ethylenediamine to generate 259; and finally reacting this with aryl/alkyl 
isothiocyanate (Scheme 4.3). 
257 
	
SOCl2 , CHCI 3 , Ft, 6 h 	
H 	 H 	c 
e 
 
N ethylereciamin 	 —.NH+R- 
R- 	
C 	
R  D" 0C 	 H 
it, 24 h 
258 	 259 	 260 
I benzylisothiocyanate 
CH202, rt, 15 h 
H 	S 
RR = 4-OH, 243 - 	 I 
H H 
256 
Scheme 4.3: Synthesis of bis-aryl/alkyl thioureas. 
Compound 259 was prepared by mono acylation of ethylenediamine with 
4-hydroxyphenylacetyl chloride 258 which was synthesised from 
4-hydroxyphenylacetic acid 257 by treating with SOd 2 . Again analysis of the crude 
product by ESI-MS found a peak corresponding to the mass of the bis-substituted 
compound 260 (Scheme 4.3). TLC also revealed two major spots indicating the 
formation of a by-product. It was hoped that excess use of ethylenediamine could 
prevent formation of bis-substituted product. The crude mixture containing both 
mono and di-acylated products was then treated with benzylisothiocyanate in order to 
afford the desired compound in moderate yield, which was isolated by column 
chromatography. 
4.3.2 Novel method for the synthesis of bis-aryL'alkyl thioureas 
Unfortunately, both of the above mentioned methods for the preparation of 
bis-aryllalkyl thioureas 256 inherently require a specific acid chloride precursor. 
Generally, acid chlorides are sensitive to moisture and difficult to handle which 
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limits their usefulness for combinatorial method development. Keeping these issues 
in mind, we have developed an efficient method for the preparation of bis-aryl/alkyl 
thioureas 256 compounds using microwave chemistry as shown in Scheme 4.4. 
The first step involved the formation of the amide bond between acid 251 and 




M C'T"'Y W, 150 °C, 25 min  
251 	 261 
I benzylisothiocyanate 










R = OH, 243 
Scheme 4.4: Novel synthesis of bis-aryl/alkyl thioureas using microwave chemistry. 
The synthesis of amide 261 is achieved by pyrolysis of the salts obtained from the 
mixture of excess ethylenediamine (5-10 equiv) and substituted carboxylic acids 251. 
Experiments were carried out without catalyst and the temperature selected was 
150 °C in order to favour shifting of the equilibrium by water removal (Eq. 4.1) 
(Detailed mechanistic aspects were discussed in chapter 3)•313 
11 H ___ 	 } R—COOH + R1—NH2 - 	R—C—N—R 1 + H2O 	(4.1) 
R = C6H5CH2 
R 1 = C6 H5, C6H5CH2 
Again, analysis of the crude product by ESI-MS found a peak corresponding to the 
mass of the bis-substituted compound. TLC revealed that the formation of 
bis-product is minor when compared to conventional syntheses described in 
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Scheme 4.4. Treatment of 261 with benzylisothiocyanate afforded bis-substituted 
thiourea derivative 256 in moderate yield (40%) and over 80% purity (by NIMR) 
(Scheme 4.4). The only impurity identified was the unreacted starting material 261. 
The development of a successful and robust method for the synthesis of 
bis-substituted thioureas 256 provided the basis for an investigation into further 
analogue synthesis. Initial amide preparations between ethylenediamine and various 
carboxylic acids are summarised in Table 4.2. Product isolation was achieved by 
simple washing with dichioromethane; sometimes the crude product was used 
directly in the next step without further purification. 
H 
R__Ø_OH 	ethylenediamine R(NNH2 
MW, 300W, 150 °C, 30 mir, 
251 	 261a-g 
Entry Compound 	Product 	Yield (%)a 
1 261a ((fl'NH 2 45 



















7 261g 15 
a Isolated yield. 
Table 4.2: Synthesis of amides. 
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Preparation of bis-aryllalkyl thioureas 256 was achieved with corresponding 
aryl/alkyl isothiocyanates from acylated ethylenediamines 261 according to the 
general synthetic route as shown in Scheme 4.4. Again isothiocyanates served as 
source of thiourea functionality in each case. An isothiocyanate was added dropwise 
to a solution of acylated ethylenediamine 261 in dichioromethane, and then subjected 
to microwave irradiation for 30 min at 75 °C. After evaporation, the residue was 
purified by column chromatography to afford a bis-substituted thiourea 256 in 
moderate to good yields (Table 4.3). A similar reaction was reported in the literature 
without using microwave irradiation, which was stirred at room temperature for 24 
hours. 333  The results from this library synthesis are summarised in Table 4.3. 
H 	 CH2Cl2 
R(NNH2 + R1—NCS 	 R(NNNR 
MW,.100W,75 0C,3Omin 	0 	
H 	H 
261 	 256a-h 
Entry Compound 	 Product 	 Yield (%)a 
H 
1 	256a 	 27 
H 










OH 	 S 
4 	256c  
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a Isolated yield. 
Table 4.3: synthesis of analogues of CYC-44797. 
4.4 Summary & Future work 
This chapter has served to highlight a range of novel chemistry, utilising microwave 
assisted organic synthesis, that has been developed during the search for a viable 
synthetic route to bis-aryl/alkyl thioureas and which is particularly amenable to the 
development of targeted combinatorial libraries. 
Unfortunately, time constraints did not allow further work on the bis-aryllalkyl 
thiourea series. However, given that the synthetic route to these ligands has now been 
established, it would be desirable to prepare further analogues of the bis-substituted 
thiourea series that have been shown to be moderately potent inhibitors of the 
CDK2/cyclin E complex such as 243. 
It would also be worthwhile to investigate other ring systems that could replace the 
central ethylene bridge with heterocyclic 262 scaffolds (Figure 4.6). Once basic 
SARs have been established, conformational constriction would be of interest, due to 
the flexibility of 243. Modeling suggests that introduction of an ethyl bridge between 
the amide nitrogen atom and the phenol ring to give benzazepinone 263 (Figure 4.6) 














Figure 4.6: Modelling studies of CYC-44797 analogues. 
Disconnection of the thiourea in 263 (Scheme 4.5 a) gives the N-2-aminoethyl-
1 ,3,4,5-tetrahydrobenzo[d]azepin-2-one 264 and the isothiocyanate 265; there are 
other ways of obtaining thioureas but, in all cases, the amine 264 will be a key 
intermediate. The aminoethyl group would be introduced in protected form, as the 
phthalimide 266 from commercially available N-(bromoethyl)phthalimide 268 by 
amide N-alkylation of key intermediate benzazepinone 267. 
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Benzazepinone 267 can be obtained by ring closure directly from N-(2-phenylethyl)-
1-chioroacetamide 272 or via reduction of the double bond in 1,3-dihydro-
benzo[d]azepin-2-one 269 from cyclisation of acetal For analogue 
synthesis the latter route is probably better because precursor phenylacetic acids 271 
should be more accessible than (aminoethyl)benzenes 273. However, the cyclisation 
of chloroacetamides 272 is less dependent on activating groups in the aromatic ring 
than that of acetals 270 (Scheme 4.5 b). 
	
OH 	 OH 
HI 	 H 
267 	 269 
OH 	 OH 
CI 
272 	 273 
OH 	 OH 
> MeO  
MeO 	N 	 HO 
H0 	 0 
270 	 271 
Scheme X b: Retrosynthesis of 263. 
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5 	Experimental 
5.1 General experimental information 
Unless otherwise noted, all materials were obtained from commercial suppliers and 
used without further purification. THF was dried and distilled from 
sodiumlbenzophenone. K2CO3 was purchased dry from commercial suppliers and 
dried under vacuum at 120 °C for 24 h. Analytical TLC was carried out on Merck 
aluminium-backed plates coated with silica gel 60 F 254 , 0.25 mm. Components were 
visualised using ultra-violet fluorescence (254 nm) and iodine spray or ammonium 
molybdate or permanganate dips. Flash chromatography was carried out using silica 
gel 60H (Merck 9385, 0.04-0.063 mm, 230-400 mesh). All 'H and ' 3C NMR spectra 
were recorded on BrUker AC250, DPX-360 or Varian Gemini-200 instruments. The 
following abbreviations are used: 6, chemical shift; d, doublet; dd, doublet of 
doublets; J, coupling constant; m, multiplet; q, quartet; s, singlet; t, triplet. Chemical 
shifts (6) are reported in parts per million (ppm) and coupling constants (J) in Hz. 
Residual protic solvent, CHC1 3 (6k-, 7.26, s) was used as the internal standard in 
'H NMR spectra, and 13 C NIVIR shifts were referenced using CDC1 3  (6c 77.0, t) with 
broad band decoupling. Electrospray (ES) nominal mass spectra were recorded 
using a Micromass Platform II mass spectrometer (CV=35). Electron Impact (El) 
and Fast atom bombardment (FAB) high resolution mass spectra were recorded on a 
Kratos MS50TC instrument. Infrared absorption spectroscopy was performed on a 
Jasco-FT/IR-410 spectrophotometer using standard techniques and Vmax values are 
quoted in cm-1 . Melting points were obtained on a Gallenkamp melting point 
apparatus and are uncorrected. Anhydrous solvents were purchased from Aldrich or 
Baker and used as received. Other solvents and reagents were standard laboratory 
grade and used without further purification. 
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5.2 Microwave irradiation experiments 
All microwave irradiation experiments were carried out using the Discover® and 
Explorer PLSTM  (manfactured by CEM Mircrowave Technology). The reactions 
were performed in heavy-walled Pyrex tubes (10 mL, length = 150 mm) sealed with 
a septum utilizing the standard absorbance level (300 W maximum power). The 
reaction volume filled not more than 1/4 of the total volume of the tube. All 
couplings and other reactions were conducted in the presence of stirring and external 
cooling. The reaction conditions were monitored using a pressure probe which was 
inserted through the septum of the reaction tube and black body irradiation measured 
to monitor the temperature of the sample. A special setting on the instrument called 
'continuous cooling' allowed simultaneous microwave irradiation and cooling of 
samples in a stream of air thus enabling higher levels of irradiation throughout the 
time course of the reaction. 
5.3 Experimental procedures 
5.3.1 General procedure A for the acylation of diethyl malonate 
A 1 00-mL round bottomed flask equipped with septum inlet and magnetic stirrer was 
flame-dried and flushed with argon. MgC1 2 (2.38 g, 25 mmol) was added to the flask 
under a slight flow of argon. Dry acetonitrile (25 mL) was then added and to the 
resulting heterogeneous mixture was added diethyl malonate (3.8 mL, 25 mmol). The 
reaction flask was immersed in an ice bath, and triethylamine (6.97 mL, 50 mmol) 
was added via the septum inlet. After the solution was stirred for 15 min at 0 °C, the 
acid chloride (25 mmol) was added. The resulting mixture was stirred for 1 h at 0 °C 
and 12 h at room temperature. After being cooled to 0 °C, the reaction mixture was 
quenched with 15 mL of SM HC1. The resulting solution was washed three times 
with 20 mL of diethyl ether. The combined ether extracts were dried (MgSO 4). 
The ether was removed under vacuum, and residue was subjected to simple vacuum 
distillation. 
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5.3.1.1 Diethyl benzoylmalonate 88a 
OEt 
Diethyl benzoylmalonate was prepared from diethyl malonate (16.0 g, 100 mmol) 
and benzoyl chloride (14.0 g, 100 mmol) in 95 % yield using general procedure A. 219 
R = 0.5 (Hexane/EtOAc = 8.5:1.5). 'H NMR (250 MHz, CDC13) 6 7.90-7.91 
(m, 2 H, Ar-H), 7.38-7.89 (m, 3H, Ar-H), 5.27 (s, 1H, CH), 4.33 (q, J= 7.0 Hz, 4H, 
OCH2CH3), 1.27 (t, J = 7.0 Hz, 6H, OCH2 CH3). MS ES (+ve) found m/z 264 
(MH, 100 %), 219 (50), 156 (55), 120 (65), 75 (20). 
5.3.1.2 Diethyl isobutyrylmalonate 88b 
OEt 
Diethyl isobutyrylmalonate was prepared from diethyl malonate (16.0 g, 100 mmol) 
and isobutyryl chloride (10.7 g, 100 mmol), gave 22.0 g (95 %) of the title compound 
using general procedure A. 219 R  = 0.5 (Hexane/EtOAc = 9:1). 'H NMR (250 MHz, 
CDC13) 6 4.76 (s, 1H, CH), 4.30-4.41 (m, 4H, 2 x  OCH2CH3), 2.89-2.96 
(m, 1H, CH3CHCH3), 1.36-1.45 (m, 6H, 2 x  OCH2CH3), 1.25-1.30 
(m, 6H, CH(CH 3)). MS ES (+ve) found m/z 187 (MHtCH(CH3)2, 100 %),159 (50). 
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5.3.1.3 Diethyl acetylmalonate 88c 
H3C  3- OEt 
Diethyl acetylmalonate was prepared from diethyl malonate (16.0 g, 100 mmol) and 
acetyl chloride (7.85 g, 100 mmol), gave 19.0 g (94 %) of the title compound using 
general procedure A. 219 R = 0.5 (Hexane/EtOAc = 9:1). 1 H NIMR (250 MHz, 
CDC13) ö 4.76 (s, 1H, CH), 4.30-4.41 (m, 4H, OCH 2CH3), 2.73 (s, 3H, CH3), 
1.36-1.45 (m, 6H, OCH2 CH3). MS ES (+ve) found m/z 203 (MH 100 %), 187 (30). 
5.3.1.4 2-(5-Bromo-furan-2-carbonyl)-malonic acid diethyl ester 88d 
Br"'~q_ 
2-(5-Bromo-furan-2-carbonyl)-malonic acid diethyl ester was prepared from diethyl 
malonate (0.76 g, 4.8 mmol) and 5-bromo-2-furoyl chloride (1.0 g, 4.8 mmol), gave 
1.5 g (95 %) of the title compound using general procedure A: R = 0.5 
(Hexane/EtOAc = 8.5:1.5). 1 H NMR (250 MHz, CDC13) 6 7.20 (d, J= 4.5 Hz, 1 H, 
ArH), 6.49 (d, J = 4.5 Hz, 1H, ArH), 5.05 (s, 1H, CH), 4.26 (q, J = 7.0 Hz, 4H, 
2 x  OCH2CH3), 1.19 (t, J = 7.0 Hz, 6H, 2 x  OCH2CH3). MS ES (+ve) found m/z 331 
(MH Br-79, 20 %) & 333 (MH Br-81, 20 %), 239 (15), 188 (50), 134 (30), 101 
(62), 78 (75), 66 (100). 
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5.3.2 General procedure B for the 3-chloroarylidene/alkylidene malonates 
Acylmalonate (0.5 mol) and phosphorus oxychloride (500 mL) were placed in 1000 
mL two necked RBF equipped with magnetic stirrer, reflux condenser and dropping 
funnel. Tributylamine (95 g, 0.51 mol) was then added with stirring. When the 
addition was complete the mixture was heated in an oil bath at 100 °C for 10 hours. 
Excess phosphorus oxychioride was removed in vacuo, and about 300 mL ether was 
added. Hexane was then added until two phases separated cleanly and the mixture 
was shaken vigorously. The layers were separated and extraction with ether —hexane 
was repeated until the ether and lower layer were clearly separate. The lower layer 
was finally extracted with ether (3 x  250 mL). The combined organic layers were 
washed with cold HC1 (100 mL), cold NaOH solution (100 mL), and finally with 
water (100 mL). The organic layer was dried over MgSO 4, filtered and concentrated 
on a rotary evaporator to give the crude chioromalonate, which was 
chromatographed on silica gel by eluting with hexane/EtOAc (9:1). 
5.3.2.1 2-(1-Chloro-ethylidene)-malonic acid diethyl ester 90a 
H 3COEt 
CI 	OEt 
2-(1-Chloro-ethylidene)-malonic acid diethyl ester was prepared using general 
procedure B from diethyl acetyl malonate (19.0 g, 94 mmol), phosphorus 
oxychioride (157 g, 1.02 mol) and tributylamine (17.8 g, 95.9 mmol) at 110 °C for 
10 h. The crude product was purified by column chromatography on silica gel using 
hexane/EtOAc (9.5:0.5) as the eluent to afford the title product as colourless oil 
(9.0 g, 43 % yield). R = 0.8 (Hexane/EtOAc = 9:1). 'H NIMR (250 MHz, CDC13 ) 
4.38-4.54 (m, 2 H, 2 x  OCH2CH3), 2.78 (s, 3H, CH3), 1.44-1.54 (m, 6H, 
2 x  OCH2 CH3). 13C NMR (63 MHz, CDC13) ö 164.2 (C=O), 162.1 (C=O), 150.0 
(OC-C=C-CO), 126.5 (C=C), 61.6 (2 x  OCH2CH3), 24.4 (CH3), 13.8 
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(2 x  OCH2CH3). MS ES (+ve) found m/z 245 (vfNa, CI-35, 20 %) 243 
(MNa, CI-3 7, 60 %), 166 (100), 157 (55). 
5.3.2.2 2-(1-Chloro-2-methyl propylidene) malonic acid diethyl ester 90b 
OEt 
CI 	OEt 
2-(1-Chloro-2-methyl propylidene) malonic acid diethyl ester was prepared using 
general procedure B from diethyl isobutyryl malonate (22.0 g, 95.6 mmol), 
phosphorus oxychioride (160.3 g, 1.04 mol) and tributylamine (18.1 g, 97.4 mmol) at 
110 °C for 10h .212b  The crude product was purified by column chromatography on 
silica gel using hexane/EtOAc (9.5:0.5) as the eluent to afford the title product as 
colourless oil (13.0 g, 54 % yield). R = 0.8 (Hexane/EtOAc = 9:1). 'H NMR 
(250 MHz, CDC13) 84.35-4.50 (m, 4 H, OCH2CH3), 4.07-4.17 (m, J= 7.0 Hz, 1H, 
CH), 1.41-1.51 (m, 6H, 2 x  OCH2CH3), 1.30 (d, 6H J = 7.0 Hz, 2 x  OCH2CH3 ). 
13C NIMR (63 MHz, CDC1 3) 8 164.1 (C=O), 162.1 (C=O), 160.1 (C=C), 125.0 
(C=C), 61.6 (2 x  OCH2CH3), 32.4 (CH), 20.2 (2 x  CH3), 13.8 (2 x  OCH2CH3). 
MS ES (+ve) found m/z 271 (MNa, CI-35, 100 %) & 273 (MNa, CI-37, 33 %), 
249 & 251 (25 & 8), 202 & 204 (35 & 12), 166 (37). 
5.3.2.3 2-(Chloro-phenyl methylene) malonic acid diethyl ester 90c 
9C I 0 0Et  OEt 
0 
2-(1-Chloro-phenyl methylene)-malonic acid diethyl ester was prepared using 
general procedure B from diethyl benzoylmalonate (25.0 g, 94.7 mmol), phosphorus 
oxychioride (158.7 g, 1.03 mol) and tributylamine (17.9 g, 96.6 mmol) at 110 °C for 
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10 h. 2121' The crude product was purified by column chromatography on silica gel 
using hexane/EtOAc (9.5:0.5) as the eluent to afford the title product as colourless oil 
(15.0 g, 57 % yield). Rj = 0.8 (Hexane/EtOAc = 9:1). 1 H NMR (250 MHz, CDC1 3) 
7.49-7.56 (m, 5 H, ArH), 4.48 (q, J= 7.0 Hz, 2H, OCH2CH3), 4.14 (q, J = 7.0 Hz, 
2H, OCH2CH3), 1.46 (t, J = 7.0 Hz, 3H, OCH2CH3), 1.15 (t, J = 7.0 Hz, 3H, 
OCH2CH3). 13C NMR (63 MHz, CDC13) ö 163.2 (C=O), 162.7 (C=O), 147.3 (C=C), 
136.7 (C=C), 130.2 (ArC), 128.1 (2 x  ArC), 127.9 (ArC), 126.9 (ArC), 61.8 
(2 x  OCH2CH3), 13.8 (2 x  OCH2CH3). MS ES (+ve) found m/z 305 
(MNa, CI-35, 90 %) & 307 (MNa, CI-37, 30 %), 262 (100), 237 (18), 186 (22). 




2-[(5-Bromofuran-2y1)-chloromethylene]-malonic acid diethyl ester was prepared 
using general procedure B from 2-(5-bromo-furan-2-carbonyl)-malonic acid diethyl 
ester (1.5 g, 4.5 mmol), phosphorus oxychioride (7.5 g, 49.2 mmol) and 
tnbutylamine (0.85 g, 4.6 mmol) at 110 °C for 10 h. The crude product was purified 
by column chromatography on silica gel using hexane/EtOAc (9:1) as the eluent to 
afford the title product as a pale yellow solid (0.750 g, 47 % yield). Rf = 0.4 
(Hexane/EtOAc = 8.5:1.5). 1 H NMR (250 MHz, CDC13) 6 7.11 (d, J = 5.0 Hz, 1H, 
ArH), 6.60 (d, J = 6.0 Hz, 1H, ArH), 4.31-4.52 (m, 4H, 2 x  OCH2CH3), 1.37-1.55 
(m, 6H, 2 x  OCH2CH3 ). 13 C NMR (63 MHz, CDC1 3) 6 164.0 (C=O), 162.1 (C=O), 
149.6 (C=C), 131.1 (C=C), 126.7 (ArC), 119.5 (2 x  ArC), 114.4 (ArC), 62.2 
(OCH2CH3), 13.8 (OCH2CH3). HRMS (FAB) (+ve) found m/z 349.9634 (MH) 
C 12H 12BrC1O5 requires 349.9657. 
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5.3.3 2-[(4-Fluoro phenoxy) phenylmethyleneJ malonic acid diethyl ester 98b 
\ / 0 
OEt 
F -t -- O 	OEt 
Diethyl-3-chlorobenzylidenemalonate (5.0 g, 17.7), 4-fluorophenol (3.0 g, 26.8), and 
potassium carbonate (2.9 g, 21.2 mmol) in 15 mL of dimethylformamide were heated 
at 140 °C in an oil bath overnight (12 h) with efficient stirring. Dimethylformamide 
was removed on a rotary evaporator, and the residue was dissolved in ether and 
added 5 % NaOH. The layers were separated, and the ether layer was washed with 
NaOH solution and finally with water. The ether phase was dried with anhydrous 
Na2 SO4 and solvent was evaporated on a rotary evaporator. The residue was 
chromatographed on silica gel by eluting with hexane/EtOAc (9:1) to give the 
product 4.5 g (71 %); mp 55-57 °C. R = 0.5 (Hexane/EtOAc = 9:1). 'H NIMR 
(250 MHz, CDC13) 6 7.53-7.67 (m, 5H, ArH), 7.01-7.16 (m, 4H, ArH), 4.50 
(q, J= 7.0 Hz, 2H, OCH2CH3), 4.35 (q, J= 7.0 Hz, 2H, OCH2CH3), 1.47 (t, J= 7.0 
Hz, 3H, OCH2CH3), 1.33 (t, J= 7.0 Hz, 3H, OCH2CH3). 13C NMR (63 MHz, CDC13) 
6 164.5 (C=O), 164.1 (C=O), 164.1 (ArC), 160.5 (ArC), 156.7 (ArC), 151.1 (CC), 
131.8 (C=C), 130.6 (ArC), 129.4 (ArC), 128.1 (ArC), 120.2 (ArC), 120.1 (ArC), 
116.0 (ArC), 61.2 (2 x  OCH2CH3), 13.86 (2 x  OCH2CH3). HRMS (FAB) (+ve) 
found m/z 358.1215 (MH), C20H, 91705 requires 358.1217. 
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Di ethyl- -chlorobenzylidenema1onate (0.3 g, 1.06 mmol), aniline (0.12 g, 1.3 mmol) 
and triethylamine (0.14 g, 1.4 mmol) were heated at 90 °C in an oil bath overnight 
(12 h) with efficient stirring. The solution was cooled to room temperature, CHC1 3 
(10 mL) was added, and the mixture was washed with water. The CHC1 3 phase was 
dried with anhydrous Na 2 SO4 and concentrated on a rotary evaporator. The residue 
was chromatographed on silica gel by eluting with ethyl hexane/EtOAc (9:1) to give 
0.27 g (75 %) of the product. Rf = 0.7 (Hexane/EtOAc = 8:2), mp = 75-77 o336 
1 H NMR (250 MHz, CDC13 ) 5  11.09 (bs, 1H, NH), 7.18-7.22 (m, 5H, ArH), 
6.88-6.99 (m, 3H, ArH), 6.57-6.60 (m, 2H, Aril), 4.20 (q, J = 7.0 Hz, 2H, 
OCH2CH3), 3.73 (q, J= 7.0 Hz, 2H, OCH2CH3), 1.24 (t, J= 6.0 Hz, 3H, OCH2CH3), 
0.76 (t, J= 6.0 Hz, 3H, OCH 2CH3). 
5.3.5 Synthesis of 2-[(Benzyl-methyl  amino) phenylmethylene] malonic acid 





Di ethyl- -ch1orobenzylidenema1onate (0.35 g, 1.2 mmol), N-methylaniline 
(0.19 g, 1.5 mmol) and triethylamine (0.16 g, 1.6 mmol) were heated at 90 °C in an 
oil bath overnight (12 h) with efficient stirring. The solution was cooled to room 
temperature, CHC13 (10 mL) was added, and the mixture was washed with water. 
The CHC13 phase was dried with anhydrous Na 2 SO4 and concentrated on a rotary 
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evaporator. The residue was chromatographed on silica gel by eluting with 
hexane/EtOAc (9:1) to give 0.3 g (66 %) of the product. R = 0.8 
(Hexane/EtOAc = 7:3). 1 H NMR (250 MHz, CDC13) ö 7.19-7.93 (m, 1OH, ArH), 
4.28 (s, 2H, benzyl CH2), 3.96 (q, J = 7.0 Hz, 4H, 2 x  OCH 2CH3), 2.74 
3H, N-CH3), 0.96 (t, J= 7.0 Hz, 6H, 2 x  OCH2CH3). 
5.3.6 Synthesis of 4-(Ethoxy-phenyl-methylene)-pyrazolidine-3, 5-dione 102 
HN-NH 
To a solution of NaOEt in EtOH (3 mL), was added hydrazine hydrate (34 p.L) and 
was the mixture stirred for 30 minutes at room temperature. Then a solution of 
di-ester (0.25 g, 0.7 mmol) in EtOH (3 mL) was added and resulting mixture was 
refluxed for 10 h. The reaction mixture was cooled and excess solvent removed in 
vacuo. The residue was neutralised with cold and dilute HC1 (5 %) and extracted 
with CHC13 (3 x 10 mL). The organic layers were washed with H 20, brine and dried 
over MgSO4 and solvent removed in vacuo to give the title product. 
'H NMR (250 MHz, CDC13) S 9.44 (bs, 1H, NH), 9.26 (bs, 1H, NH), 7.80-7.86 
(m, 2H, ArH), 7.61-7.69 (m, 3H, ArH), 4.50 (q, J = 7.0 Hz, 2H, Cl2), 1.48 
J= 7.0 Hz, 3H, CU3). MS ES (-ye) found m/z 231 [M-H] (100 %). 
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5.3.7 Synthesis of 2-[(4-Fluoro phenoxy) phenylmethylene] malonic acid 104 
\/ o  
OH 
F 	OH 
4-Fluoro--phenoxymalonate (1.95 g, 5.5 mmol) and KOH (0.7 g) were refluxed 
1.5 h in EtOH (10 mL) with efficient stirring, cooled to room temperature, and 
filtered with suction to give the di-salt. With very efficient stirring cold, concentrated 
HC1 (1.0 mL) was added to the di-salt, and the heterogeneous mixture was placed in 
a refrigerator. Filtration with suction gave 0.5 g (30 %) of title product. 
'H NMR (250 MHz, CDC13) S 7.45-7.49 (m, 2H, ArH), 7.32-7.40 (m, 3H, ArH), 
7.00-7.12 (m, 4H, Ar. ' 3 C NMR (63 MHz, CDC1 3) 5 165.3 (C=O), 165.0 (C=O), 
159.9 (ArC), 151.1 (C=C), 131.5 (C=C), 130.2 (ArC), 129.2 (ArC), 128.0 (ArC), 
120.1 (ArC), 120.0 (ArC), 118.2 (ArC), 116.0 (ArC), 115.6 (ArC). 
MS ES (+ve) found m/z 302 (MH 15 %), 260 (M-0O 2 , 100). 
5.3.8 General procedure C for the synthesis of 0-aryL'alkyl-arylidene 
malonates 
POPd (1 mol %), J3-Chloro-alkylidene/arylidenemalonate (1.0 mmol), arylboronic 
acid (1.5 - 2.0 mmol), and K2CO3  (3.0 mmol) were weighed in a microwave tube, 
equipped with a magnetic stirrer bar, and sealed with a silicon septum. THF 
(2 to 3 mL) was injected into the tube via a syringe and the reaction mixture was 
subjected to microwave irradiation for 30 min at 100 °C. The reaction vessel was 
allowed to cool to room temperature and the crude reaction mixture transferred to a 
separating funnel and diluted with hexane (50 mL) and H 2 0 (15 mL). The layers 
were separated, the organic layer was washed with H 20 (20 mL) and brine (20 mL), 
dried over MgSO4, and filtered, and solvents were removed from the filtrate by 
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rotary evaporation. The resulting residue was chromatographed on silica gel using 
hexane/EtOAc as eluents to afford f3-aryl/alkyl-arylidene malonates. 




CI- / 0 
2-[1-(3-Chlorophenyl) ethylidene] malonic acid diethyl ester was prepared using the 
general procedure C. POPd (12 mg, 0.02 mmol, 1 mol %), 2-(1-chloro-ethylidene)-
malonic acid diethyl ester (0.5 g, 2.3 mmol), 3-chiorophenyl boronic acid (0.53 g, 3.4 
mmol), and K2CO3 (0.94 g, 6.8 mmol) in THF (3 mL) yielded 0.47 g (70 %) of the 
title product as a colourless liquid. Rj = 0.5 (Hexane/EtOAc = 9:1); IR (Neat): 2982, 
1725, 1628, 1563, 1473, 1445, 1228 cm -1 . 'H NMIR (250 MHz, CDC13): 6 7.45-7.50 
(m, 3H, ArH), 7.31 (s, 1H, ArH), 4.49 (q, J = 7.0 Hz, 2H, OCH2CH3), 4.20 
(q, J = 7.0 Hz, 2H, OCH2CH3), 2.59 (s, 3H, CH3), 1.51 (t, J = 7.0 Hz, 3H, 
OCH2CH3), 1.21 (t, J = 7.0 Hz, 3H, OCH 2CH3). 13C NMR (63 MHz, CDCI3): 6 
167.5 (C=O), 165.5 (C=O), 164.4 (ArC), 153.5 (C=C), 143.1 (C=C), 134.1 (ArC), 
129.5 (2 x  ArC), 126.7 (ArC), 124.7 (ArC), 60.5 (2 x  OCH2 CH3), 22.5 












2-[1-(3,5-Difluorophenyl) ethylidene] malonic acid diethyl ester was prepared using 
the general procedure C. POPd, (11 mg, 0.02 mmol, 1 mol %), 2-(1-chloro-
ethylidene)-malonic acid diethyl ester (0.5 g, 2.3 mmol), 3,5-fluorophenyl boronic 
acid (0.71 g, 4.5 mmol), and K2CO3  (0.94 g, 6.8 mmol) in THF (3 mL) yielded 0.4 g 
(59 %) of the title product as a colourless liquid. R = 0.4 (Hexane/EtOAc = 8:2); 
JR (Neat): 2984, 1726, 1641, 1620, 1590, 1492, 1446, 1236 cm- '. 'H NMR 
(250 MHz, CDC13): 8 7.25-7.30 (m, 2H, ArH), 7.01-7.11 (m, 1H, Ar!!), 4.55 
(q, J = 7.0 Hz, 2H, OCH2CH3), 4.25 (q, J = 7.0 Hz, 2H, OCH2CH3), 2.57 
(s, 3H, CH3), 1.58 (t, J = 7.0 Hz, 3H, OCH 2CH3), 1.28 (t, J = 7.0 Hz, 3H, 
OCH2CH3). HRMS (Ef) found m/z 298.1020 (M), C 15H 16F204 requires 298.1017. 








2-[1-(3,5-Dimethyl phenyl) ethylidene] malonic acid diethyl ester was prepared 
using the general procedure C. POPd, (6 mg, 0.01 mmol, 1 mol %), 2-(1-Chloro-
ethylidene)-malonic acid diethyl ester (0.25 g, 1.13 mmol), 3,5-methyiphenyl 
boronic acid (0.25 g, 1.7 mmol), and K2CO3  (0.47 g, 3.4 mmol) in THF (2 mL) 
yielded 0.2 g (60 %) of the title product as a colourless liquid. R = 0.5 
(Hexane/EtOAc = 9:1); JR (Neat): 2981, 1724, 1623, 1445, 1266, 1223 cm -
'H NMR (250 MHz, CDC13): ö 7.11 (s, 1H, ArH), 7.01 (s, 2H, ArH), 4.43 (q, J = 7.0 
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Hz, 2H, OCH 2CH3), 4.15 (q, J= 7.0 Hz, 2H, OCH2CH3), 2.56 (s, 3H, CH3), 2.45 
(s, 6H, 2 x  OCH2CH3) 1.47 (t, J= 7.0 Hz, 3H, CH3), 1.15 (t, J= 7.0 Hz, 3H, CH3). 
13 C NMR (63 MHz, CDC13): 6 166.2 (C0), 164.6 (C=O), 156.1 (C=C), 141.4 
(C=C), 137.6 (2 x  ArC), 129.9 (ArC), 125.7 (ArC), 124.2 (2 x  ArC), 60.8 
(2 x  OCH2 CH3), 22.6 (CH3), 22.1 (CH3), 13.9 (2 x  OCH2CH3). 
HRMS (Ef4) found m/z 290.1520 (M), C 17H 1204 requires 290.1518. 







2-[1-(4-Methoxyphenyl)-ethylidene]-malonic acid diethyl ester was prepared using 
the general procedure C. POPd, (6 mg, 0.01 mmol, 1 mol %), 2-(1-Chloro-
ethylidene)-malonic acid diethyl ester (0.25 g, 1.13 mmol), 4-methoxyphenyl boronic 
acid (0.26 g, 1.7 mmol), and K2CO3 (0.47 g, 3.4 mmol) in THF (3 mL) yielded 
0.21 g (65 %) of the title product as a colourless liquid. Rf = 0.5 (Hexane/EtOAc = 
8:2). 1 H NMR (250 MHz, CDC1 3): 6 7.13 (d, J= 8.5 Hz, 2H, ArH), 6.78 (d, J= 8.5 
Hz, 2H, ArH), 4.50 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.94 (q, J = 7.0 Hz, 2H, 
OCH2CH3), 3.73 (s, 3H, 0CH3), 2.35 (s, 3H, CH3), 1.25 (t, J = 7.0 Hz, 3H, 
OCH2CH3), 0.97 (t, J = 7.0 Hz, 3H, OCH2CH3). ' 3C NMR (63 MHz, CDC13): 6 
166.5 (C=O), 164.7 (C=O), 159.7 (ArC), 155.4 (C=C), 133.6 (C=C), 128.1 
(2 x  ArC), 125.4 (ArC), 113.5 (2 x  ArC), 60.8 (2 x  OCH2CH3), 55.1 (OCH3), 22.6 
(CH3), 13.9 (2 x  OCH2CH3). MS (ES) found m/z 292 (MH, 15 %), 260 (15), 172 
(20), 110 (55), 97 (100), 80(15). 
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5.3.8.5 2-[1-(5-Fluoro-2-methoxyphenyl) ethylidene] malonic acid diethyl ester 
107e 
0 




2-[1-(5-Fluoro-2-methoxyphenyl) ethylidene] malonic acid diethyl ester was 
prepared using the general procedure C. POPd, (11 mg, 0.02 mmol, 1 mol %), 
2-(1-Chloro-ethylidene)-malonic acid diethyl ester (0.5 g, 2.26 mmol), 2-methoxy-5-
fluorophenyl boronic acid (0.77 g, 4.5 mmol), and K2CO3  (0.94 g, 6.8 mmol) in THF 
(3 mL) yielded 0.28 g (66 %) of the title product as a colorless liquid. R = 0.5 
(Hexane/EtOAc = 9:1); IR (Neat): 2982, 1725, 1637, 1610, 1594, 1465 cm 1 . 
'H NMR (250 MHz, CDC13): 5 7.27-7.35 (m, 3H, ArH), 4.55 (q, J = 7.0 Hz, 2H, 
OCH2CH3), 4.27 (q, J = 7.0 Hz, 2H, OCH2CH3), 4.06 (s, 3H, OCH3), 2.60 
(s, 3H, CH3), 1.57 (t, J = 7.0 Hz, 3H, OCH2CH3), 1.23 (t, J = 7.0 Hz, 3H, 
OCH2 CH3). HRMS (E111 ) found m/z 310.1216 (M), C 16H 19F05 requires 310.1217. 







2-[-(3-Nitrophenyl) ethylidene] malonic acid diethyl ester was prepared using the 
general procedure C. POPd, (11 mg, 0.02 mmol, 1 mol %), 2-(1-Chloro-ethylidene)-
malonic acid diethyl ester (0.5 g, 2.26 mmol), 3-nitrophenyl boronic acid 
(0.75 g, 4.5 mmol), and K2CO3 (0.94 g, 6.8 mmol) in THF (3 mL) yielded 0.3 g 
(72 %) of the title product as a colourless liquid. R= 0.3 (Hexane/EtOAc = 9:1); lIP. 
(Neat): 2984, 1724, 1631, 1574, 1474, 1446 cm - '. 'H NMR (250 MHz, CDC1 3): 
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8.12-8.26 (m, 1H, ArH), 8.05 (s, 1H, AM), 7.48-7.55 (m, 2H, AM), 4.25 (q, J= 7.0 
Hz, 2H, OCH 2CH3), 3.92 (q, J = 7.0 Hz, 211, OCH2CH3), 2.33 (s, 3H, CH3), 1.29 
(t, J = 7.0 Hz, 3H, OCH2 CH3), 0.97 (t, J = 7.0 Hz, 3H, OCH2 CH3). HRMS (EI) 
found m/z 307.1050 (M), C 15H 17N06 requires 307.1056. 




2-(2-Methyl-1-phenylpropylidene) malonic acid diethyl ester was prepared using the 
general procedure C. POPd, (10 mg, 0.012 mmol, 1 mol %), 2-(1-Chloro-2-methyl 
propylidene) malonic acid diethyl ester (0.5 g, 2.0 mmol), 3-phenyl boronic acid 
(0.29 g, 2.4 mmol), and K 2CO3 (0.83 g, 6.03 mmol) in THF (3 mL) yielded 0.25 g 
(71 %) of the title product as a colourless liquid. Rj = 0.4 (Hexane/EtOAc = 9:1). 
1 H NMR (250 MHz, CDC13): 8 7.37-7.46 (m, 3H, AM), 7.12-7.28 (m, 2H, AM), 
4.40 (q, J= 7.0 Hz, 2H, OCH 2CH3), 3.94 (q, J= 7.0 Hz, 211, OCH2CH3), 3.57-3.66 
(m, 1H, CH), 1.40 (t, J= 7.0 Hz, 3H, OCH 2CH3), 1.07 (d, J = 7.0 Hz, 6H, 2 x  CH3), 
0.99 (t, J = 7.0 Hz, 311, OCH2CH3). MS (ES) found m/z 313 (MNa, 100 
163 (25). 
5.3.8.8 2-L1-(3-Chlorophenyl)-2-methylpropylidene] malonic acid diethyl ester 
107h 
0 
-C  OEt 
- 	OEt 
C11- / 0 
2-[1-(3-Chlorophenyl)-2-methylpropylidene] malonic acid diethyl ester was prepared 
using the general procedure C. POPd, (6 mg, 0.012 mmol, 1 mol %), 2-(1-Chloro-2- 
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methyl propylidene) malonic acid diethyl ester (0.3g, 1.2 mmol), 3-chiorophenyl 
boronic acid (0.28 g, 0.18 mmol) K2CO3  (0.5 g, 3.6 mmol) in THF (2 mL) yielded 
(0.15 g, 57 %) of the title product as a colorless liquid. IR (Neat): 2978, 1726, 1624, 
1563, 1466, 1446 cm- '. 'H NMR (250 MHz, CDC1 3): 6 7.45-7.54 (m, 2H, ArH), 
7.26-7.40 (m, 1H, Aril), 7.01-7.14 (m, 1H, ArH), 4.49 (q, J = 3.5 Hz, 2H, 
OCH2CH3), 4.07 (q, J = 7.0 Hz, 2H, OCH 2CH3), 3.60 (m, 1H, CH), 1.52 (t, J= 3.5 
Hz, 3H, OCH 2CH3), 1.20 (s, 3H, CH3), 1.87 (s, 3H, CH 3), 1.13 (t, J= 7.0 Hz, 3H, 
OCH2CH3); HRMS (Ef) found m/z 324.1297 (Mt), C 17H21 C104 requires 324.1128. 







2-[1-(3-Fluorophenyl)-2-methyl propylidene] malonic acid diethyl ester was 
prepared using the general procedure C. POPd, (10 mg, 0.02 mmol, 1 mol %), 
2-(1-chloro-2-methyl propylidene) malonic acid diethyl ester (0.5 g, 2.0 mmol), 
3-fluorophenyl boronic acid (0.34 g, 2.4 mmol), and K2CO3  (0.83 g, 6.0 mmol) in 
THF (3mL) yielded 0.34 g (55 %) of the title product as a colourless liquid. 
Rj= 0.6 (Hexane/EtOAc = 9:1). 'H NMR (250 MHz, CDC1 3): 6 7.28-7.40 (m, 1H, 
ArH), 7.02-7.18 (m, 1H, ArH), 6.84-6.95 (m, 2H, ArH), 4.30 (q, J = 7.0 Hz, 2H, 
OCH2CH3), 3.92 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.46 (septet, J= 7.0 Hz, 1H, CH), 
1.04 (d, J = 7.0 Hz, 6H, 2 x  CH3), 1.21 (t, J = 7.0 Hz, 3H, OCH2CH3), 0.96 
(t, J= 7.0 Hz, 3H, OCH2CH3). 13 C NMR (63 MHz, CDC1 3): 6 164.8 (CO), 163.8 
(C=O), 159.9 (C=C), 138.3 (C=C), 129.0 (ArC), 128.8 (ArC), 126.1 (ArC), 123.6 
(ArC), 115.2 (ArC), 114.9 (ArC), 61.2 (OCH 2CH3), 60.7 (OCH2CH3), 31.9 (CH), 
20.5 (2 x  CH3), 13.9 (OCH2CH3), 13.5 (OCH2CH3). MS (ES) found m/z 331 
(MNa, 5 %),300 (40), 198 (18), 130 (100), 73 (10), 61 (50). 
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5.3.8.10 2-I1-(5-Fluoro-2-methoxyphenyl)-2-methylpropylidene]  malonic acid 








2-[ 1 -(5 -Fluoro-2-methoxyphenyl)-2-methylpropylidene] malonic acid diethyl ester 
was prepared using the general procedure C. POPd, (10 mg, 0.02 mmol, 1 mol %), 
2-(1-Chloro-2-methyl propylidene) malonic acid diethyl ester (0.5 g, 2.0 mmol), 
2-methoxy-5-fluorophenyl boronic acid (0.68 g, 4.0 mmol), and K2CO3 
(0.83 g, 6.0 mmol) in THF (3 mL) yielded 0.25 g (52 %) of the title product as a 
colourless liquid. R = 0.5 (Hexane/EtOAc = 9:1); IR (Neat): 2979, 1726, 1628, 
1607, 1495, 1465 cm- '. 'H NMR (250 MHz, CDC13): 5 7.18-7.26 (m, 1H, ArH), 
6.84-6.98 (m, 1H, ArH), 6.70-6.80 (m, 1H, ArH), 4.51-4.66 (m, 2H, OCH2CH3), 
4.11 (q, J= 7.0 Hz, 2H, OCH2CH3), 3.96 (s, 3H, OCH3), 3.57-3.65 (m, 1H, CH), 
1.35 (t, J= 7.0 Hz, 3H, OCH2CH3), 1.21 (m, 9H, 2 x  CH3 and OCH2CH3). HRMS 
(Ef) found m/z 338.1528 (M), C 18H23F05 requires 338.1530. 








2-[(3-Chloro-phenyl)-phenylmethylene] malonic acid diethyl ester was prepared 
using the general procedure C. POPd, (3.5 mg, 0.007 mmol, 1 mol %), 
2-(chloro-phenyl methylene) malonic acid diethyl ester (0.2 g, 0.7mmol), 
3-chlorophenyl boronic acid (0.17 g, 1.06 mmol), and K2CO3  (0.29 g, 2.3 mmol) in 
THF (2 mL) yielded 0.14 g (55 %) of the title product as a colourless liquid. R= 0.5 
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(Hexane/EtOAc = 9:1); JR (Neat): 2982, 1728, 1591, 1472, 1444 cm 1 . 
'H NMR (250 MHz, CDC13): 6 7.18-7.26 (m, 9H, ArH), 4.04-4.12 (m, 4H, 2 
OCH2CH3), 0.86-0.97(m, 6H, 2 x  OCH2CH3). HRMS (EI[) found m/z 358.0975 
(M+), C20H, 9C104 requires 358.0972. 








2-[(5-Fluoro-2-methoxyphenyl) phenylmethylene] malonic acid diethyl ester was 
prepared using the general procedure C. POPd, (9 mg, 0.017 mmol 1 mol %), 
2-(chloro-phenyl methylene) malonic acid diethyl ester (0.5 g, 1.7 mmol), 
2-methoxy-5-fluorophenyl boronic acid (0.6 g, 3.53 mmol), and K 2CO3 
(0.73 g, 5.3 mmol) in THF (3mL) yielded 0.2 g (50 %) of the title product as a 
colourless liquid. Rf= 0.5 (Hexane/EtOAc = 8.5:1.5); JR (Neat): 2982, 1728, 1619, 
1591, 1494 cm- '. 'H NMR (250 MHz, CDC1 3): 6 7.17-7.26 (m, 6H, ArH), 6.72-6.86 
(m, 2H, ArH), 3.97-4.09 (m, 4H, 2 x  OCH2CH3), 3.59 (s, 3H, OCH3), 0.90-1.01 
(m, 6H, 2 x  OCH2CH3). 13 C NMR (63 MHz, CDC13): 6 166.0 (C=O), 164.6 (C=O), 
158.4 (ArC), 154.6 (ArC), 152.5 (ArC), 150.5 (C=C), 139.5 (C=C), 130.2 (ArC), 
128.8 (ArC), 128.2 (ArC), 127.9 (ArC), 126.7 (ArC), 116.9 (ArC), 116.0 (ArC), 
115.6 (ArC), 112.1 (ArC), 61.8 (OCH 2CH3), 60.9 (OCH2 CH3), 56.1 (OCH 3), 13.6 
(OCH2CH3), 13.5 (OCH2 CH3). HRMS (Ef) found m/z 372.1368 (M), C21 H21 F05 
requires 372.1373. 
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F3C \ / 0 
2-[phenyl- (3-trifluoromethyl-phenyl)-methylene] malonic acid diethyl ester was 
prepared using the general procedure C. POPd, (3.5 mg, 0.007 mmol, 1 mol %), 
2-(chloro-phenyl methylene) malonic acid diethyl ester (0.2 g, 0.7 mmol), 
3-trifluorophenyl boronic acid (0.16 g, 0.84 mmol), and K2CO3  (0.29 g, 2.12 mmol) 
in THF (2 mL) yielded 0.19 g (68 %) of the title product as a pale brown solid. 
R= 0.3 (Hexane/EtOAc = 9.5:0.5), nip = 58-59.5 °C. IR (KBr): 2980, 1721, 1698, 
1604, 1444 cm- '. 'H NIMR (250 MHz, CDC1 3): 6 7.64-7.86 (m, 9H, Am), 4.27-4.40 
(m, 4H, 2 x  OCH 2CH3), 1.10-1.21 (m, 6H, 2 x  OCH2CH3). ' 3 C NMR (63 MHz, 
CDC13): 6 153.2 (2 x  C=O), 140.1 (C=C), 138.5 (C=C), 131.8 (ArC), 128.9 
(2 x  ArC), 128.4 (3 x  ArC), 128.1 (2 x  ArC), 127.7 (2 x  ArC), 125.1 (2 x  ArC), 
60.9 (2 x  OCH2CH3), 12.9 (2 x  OCH2CH3). HRMS FAB (+ve) found m/z 392.1336 
(M), C21 H 1 9F304, requires 392.1335. 







2-[(3-Amino-phenyl)-phenylmethylene] malonic acid diethyl ester was prepared 
using the general procedure C. POPd, (9 mg, 0.017 mmol, 1 mol %), 2-(chloro- 
phenyl methylene) malonic acid diethyl ester (0.5 g, 1.76 mmol), 3-aminophenyl 
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boronic acid (0.49 g, 2.65 mmol), and K2CO3  (0.73 g, 5.3 mmol) in THF (3 mL) 
yielded 0.25 g (60 %) of the title product as a light brown solid. Rj = 0.5 
(Hexane/EtOAc = 7:3), nip = 73-74 °C. TIP. (KBr): 3462, 3372, 2988, 1731, 1597, 
1488, 1445 cm 1 . 'H NMR (250 MHz, CDC1 3): ö 7.14-7.20 (m, 6H, ArH), 6.46-6.54 
(m, 2H, ArH), 6.37 (s, IH, Am), 4.00-4.12 (m, 4H, 2 x  OCH2CH3), 3.56 (bs, 2H, 
NH), 0.95-1.09 (m, 6H, 2 x  OCH2CH3). 13 C NMR (63 MHz, CDC1 3): ö 166.0 (C=O), 
165.8 (C=O), 155.7 (ArC), 146.0 (ArC), 142.0 (C=C), 139.8 (C=C), 128.9 
(2 x  ArC), 127.9 (2 x  ArC), 125.9 (2 x  ArC), 119.3 (ArC), 115.7 (2 x  ArC), 115.4 
(ArC), 61.0 (2 x  OCH2CH3), 13.5 (2 x  OCH2CH3). HRMS FAB (+ve) found m/z 
339.1468 (M), C20H21N04 requires 339.1471. 








2-[(3-Hydroxy-phenyl)-phenyl methylene] malonic acid diethyl ester was prepared 
using the general procedure C. POPd, (9 mg, 0.017 mmol, 1 mol %), 2-(chloro-
phenyl methylene) malonic acid diethyl ester (0.5 g, 1.76 mmol), 3-hydroxyphenyl 
boronic acid (0.36 g, 2.6 mmol), and K2CO3  (0.73 g, 5.3 mmol) in THF (3 mL) 
yielded 0.38 g (63 %) of the title product as a white colour solid. Rf = 0.5 
(Hexane/EtOAc = 7:3), nip = 94-95.5 °C. JR (KBr): 3389, 2989, 1707, 1673, 1578, 
1444 cm- '. 'H NMR (250 MHz, CDC1 3): ö 7.32-7.44 (m, 6H, ArH), 6.66-6.72 
(m, 2H, ArH), 6.43 (s, 1H, ArH), 5.70 (bs, 1H, OH), 4.14-4.20 
(m, 2H, 2 x  OCH2CH3), 1.10-1.20 (m, 6H, 2 x  OCH2CH3). 13C NIMR (63 MHz, 
CDC1 3): 8 166.3 (2 x  C=O), 155.6 (ArC), 141.2 (C=C), 139.6 (C=C), 129.2 
(2 x  ArC), 129.1 (2 x  ArC), 129.0 (2 x  ArC), 128.0 (ArC), 121.2 (2 x  ArC), 116.3 
(2 x  ArC), 61.2 (2 x  OCH2 CH3), 13.5 (2 x  OCH2CH3). HRMS FAB (+ve) found m/z 
340.1314 (M), C 20H2005 requires 340.1311. 
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5.3.8.16 2- [1 -(3 '-Nitro-biphenyl-3-yl) ethylidene] malonic acid diethyl ester 116 
H 3C 	' -OEt 
02N  
OEt 
2-[1-(3'-Nitro-biphenyl-3-yl) ethylidene] malonic acid diethyl ester was prepared 
using the general procedure C. POPd, (6.0 mg, 0.01 mmol, 1 mol %), 
2-[1-(3-Chlorophenyl) ethylidene] malonic acid diethyl ester (0.35 g, 1.18 mmol), 
3-nitrophenyl boronic acid (0.39 g, 2.36 mmol), and K2CO3  (0.49 g, 3.54 mmol) in 
THF (2 mL) yielded 0.2 g (77 %) of the title product as a colourless liquid. 
Rj= 0.3 (Hexane/EtOAc = 9:1); 1 H NMR (250 MHz, CDC1 3): 6 8.42-8.44 (m, 2H, 
ArIl), 8.23 (d, J = 8.0 Hz, 2H, ArH), 7.92 (d, J = 8.0 Hz, 2H, ArH), 7.60-7.67 
(m, 2H, ArH), 4.24 (q, J = 7.0 Hz, 2H, OCH 2CH3), 3.92 (q, J = 7.0 Hz, 2H, 
OCH2CH3), 2.42 (s, 3H, CH3), 1.26 (t, J= 7.0 Hz, 3H, OCH2CH3), 0.90 (t, J= 7.0 
Hz, 3H, OCH2CH3). HRMS (El) found m/z 383.1365 (M), C21 H21 N06 requires 
383.1369. 
5.3.9 5-Fluoro-3-isopropyl-1-oxo-1H-indene-2- carboxylic acid ethyl ester 117 
0 
2-[ 1 -(3-Fluoro phenyl)-2-methyl propylidene] malonic acid diethyl ester (0.31 g, 1.0 
mmol), and polyphosphoric acid (3.10 g) were heated for 1 h with stirring at 100 °C, 
then poured into ice water, extracted with chloroform (3 x  20 mL), and concentrated 
in vacuo. The residue was purified on column chromatography by eluting with 
10-30 % EtOAc/hexane to give the product (0.12 g, 46 %). Rj = 0.3 (Hexane/EtOAc 
= 8.5:1.5). 'H NMR (250 MHz, CDC13): 6 7.25 (dd, J= 8.0 Hz and J= 8.0 Hz, 1H, 





OCH2CH3), 1.50 (s, 3H, CH3), 1.14 (t, J = 7.0 Hz, 3H, OCH2CH3), 1.02 (s, 3H, 
CH3). MS (ES) found m/z 262 (MH, 25%), 216 (22). 
5.3.10 Synthesis of malonic ester derivatives via Knoevenagel condensation 
5.3.10.1 2-(1H-Indol-3-ylmethylene)-malonic acid diethyl ester 126 
OEt 
OEt 
A mixture of diethylmalonate (0.2 g, 1.25 mmol), indole-3-carboxaldehyde 
(0.22 g, 1.5 mmol) and a catalytic amount of piperidine in MeOH (10 mL) were 
refluxed for 10 h. Reaction mixture was then cooled to room temperature and the 
precipitate was filtered and dried to afford title compound as a yellow solid. 'H NMR 
(250 MHz, CDC1 3) ö 9.18 (bs, 1H, NH), 8.32 (s, 1H, C=H), 7.95-8.08 (m, 2H, AM), 
7.57-7.69 (m, 1H, ArH), 7.42-7.49 (m, 2H, Aril), 4.47-4.59 (m, 4H, 2 x  OCH2CH3), 
1.49-1.58 (m, 6H, 2 x  OCH2CH3). 
5.3.10.2 2-(2, 3, 4-Trimethoxy-benzylidene) malonic acid diethyl ester 127 
Et 
Et 
A mixture of diethylmalonate (0.2 g, 1.25 mmol), 2,3,4-trimethoxybenzaldehyde 
(0.29 g, 1.5 mmol) and a catalytic amount of piperidine in MeOH (10 mL) were 
refluxed for 10 h. Reaction mixture was then cooled to room temperature and the 
precipitate was filtered and dried to afford title compound as a yellow solid. 'H NMR 
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(250 MHz, CDC13) 6 7.98 (s, 1H, C=H), 7.20 (d, J = 9.0 Hz, 1H, ArH), 
6.67 (d, J = 9.0 Hz, 1H, ArH), 4.29-4.38 (m, 4H, 2 x  OCH 2CH3), 3.93 (s, 3H, 
OCH3), 3.92 (s, 3H, OCH 3), 3.90 (s, 3H, OCH3), 1.26-1.39 (m, 6H, OCH2CH3). 
5.3.10.3 5-(2, 3, 4-Trimethoxybenzylidene)-pyrimidine-2, 4, 6-trione 128 
0 
A mixture of barbitunc acid (0.5 g, 3.9 mmol), trimethoxybenzaldehyde 
(0.76 g, 3.9 mmol) and a catalytic amount of piperidine in MeOH (10 mL) were 
refluxed for 10 h. Reaction mixture was then cooled to room temperature and the 
precipitate was filtered and dried to afford title compound as a yellow solid 
(0.75 g, 63 %). 'H NMR (250 MHz, CDC13) 6 11.27 (bs, 1H, NH), 11.11 (bs, 1H, 
NH), 8.44 (s, 1H, C=H), 8.27 (d, J = 9.0 Hz, 1H, ArH), 6.88 (d, J = 9.0 Hz, 1H, 
ArH), 3.85 (s, 3H, OCH 3), 3.83 (s, 3H, OCH3), 3.72 (s, 3H, OCH3). 
5.3.10.4 5-[1-(4-Methoxyphenyl)-propylidene]-pyrimidine-2, 4, 6-trione 131 
H3 
A mixture of barbituric acid (0.66 g, 5.15 mmol), 4-methoxy propiophenone (0.84 g, 
5.15 mmol) and a catalytic amount of piperidine in MeOH (high dilution-i mmol = 
20 mL) were refluxed for 15 h. Reaction mixture was then cooled to room 
temperature and excess solvent was removed on rotary evaporator, separated solid 
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was filtered and dried to afford title compound as a white coloured solid. 
Vmax IR (neat, cm -1 ) 3418 (broad), 1717, 1677, 1601, 1257, 1227. 1 H NMIR 
(250 MHz, CDC13) 6 7.88 (d, J = 9.0 Hz, 2H, ArH), 6.88 (d, J = 9.5 Hz, 2H, ArH), 
3.74 (s, 3H, OCH3), 2.89 (q, J= 7.0 Hz, 2H, CH 2), 1.05 (t, J= 7.0 Hz, 3H, CH3). 
MS (EI[) found m/z 297 (MNa, 15 %), 165 (100). 
5.3.10.5 5-[1-(4-Methoxy-phenyl)-propytidene]-pyrimidine-2, 4, 6-trione 133 
H3CO 
HN NH 
A mixture of barbituric acid (0.66 g, 5.15 mmol), 4-methoxy propiophenone 
(0.845 g, 5.15 mmol) and a catalytic amount of piperidine in MeOH 
(high dilution- 1 mmol = 20 mL) were refluxd for 15 h. Reaction mixture was then 
cooled to room temperature and excess solvent was removed on rotary evaporator, 
separated solid was filtered and dried to afford title compound as a white coloured 
solid. 'max IR (neat, cm) 3418 (broad), 1717, 1677, 1601, 1257, 1227. 1 H NMIR 
(250 MHz, CDC1 3) 6 7.88 (d, J= 9.0 Hz, 2H, Ar!!), 6.89 (d, .1= 9.5 Hz, 2H, ArH), 
3.74 (s, 3H, OCH3), 1.10 (s, 3H, CH3). MS (El 4 ) found m/z 297 (MNa, 15 %),165 
(100). 
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5.3.11 Synthesis of alloxan and its derivatives 
5.3.11.1 Pyrimidine-2, 4, 5, 6-tetraone (alloxan) 134 
°rr° 
HNj. NH 
Alloxan monohydrate (10.0 g, 62.5 mmol) was suspended in a mixture of AcOH 
(200 mL) and Ac 20 (6.5 g, 64.0 mmol). The mixture was boiled under reflux, with 
occasional swirling, until the solid dissolved giving a yellow solution (ca. 30mm). 
The solution was cooled and then rotary evaporated to near dryness. The solid yellow 
residue was broken up with the aid of a spatula and washed with dry ether 
(3 x  40 mL). The ether was decanted and discarded. The yellow solid was dreid to 
give the product in vacuo. (8.0 g, 90 %). 'H NMR (250 MHz, CDCI3) 6 11.80 
(bs, 1H, NH), 11.43 (bs, 1H, Nil). ' 3 C NMR (63 MHz, CDC1 3) 6 168.8 (C-i), 166.7 
(C-2), 156.9 (C-4),149.8 (C-3). MS (Ef) found m/z 143 (Mt ' , 60%), 139 (30), 114 
(100). 
5.3.11.2 3-Oxo-2- (2, 4, 6-trioxo-tetrahydro-pyrimidine-5-ylidene)-butyric acid 
methyl ester 136a 
o OCH 3 
H 3CyO 
RN NH 
A mixture of alloxan monohydrate (0.4 g, 2.5 mmol) and methylacetoacetate 
(0.58 g, 5.0 mmol) in anhydrous dimethoxyethane (3 mL) were stirred at room 
temperature for 30 h. The solvent was evaporated and the residue was 
chromatographed on silica gel by eluting with CHC1 3/MeOH (99:1) to give 0.2 g 
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(35 % yield). 'H NMR (250 MHz, CDC1 3 ) 5  11.80 (bs, 2H, 2 x  NH), 3.82 (s, 3H, 
OCH3), 2.55 (s, 3H, CH,). 13C NMR (63 MHz, CDC13) ö 201.9 (CH3C=O), 169.9 
(ester-C=O), 169.1 (NHC=ONH), 168.9 (2 x  NHC=O), 149.5 (CC), 71.7 (CC), 
62.3 (OCH 3), 30.1 (CH3). MS (EI) found m/z 240 (Mt, 65 %),139 (35), 114 (100). 





H N NH 
A mixture of alloxan monohydrate (0.4 g, 2.5 mmol) and methylacetoacetamide 
(0.5 g, 5.0 mmol) in anhydrous dimethoxyethane (3 mL) were stirred at room 
temperature for 30 h. Solvent was evaporated under reduced pressure and residue 
was triturated with diethyl ether, and the solid was filtered and dried at 80 °C under 
vacuum: 0.39 g, (69 % yield). 'H NMR (250 MHz, CDC1 3) ö 11.06 (s, 2H, 2 x  NH), 
7.29 (s, 1H, H of NH2), 6.98 (s, 111, H of NIH 2), 2.08 (s, 3H, CH3). 13C NMR 
(63 MHz, CDC13) 5 202.2 (CH3CO), 170.5 (NHCONH), 169.8 (2 x  NHCO), 
169.5 (C=ONH2), 149.2 (C=C), 149.8 (C=C), 31.1 (CH 3). MS (Ef) found m/z 225 
(M, 25 %),210 (50), 182 (100), 168 (30), 154 (80). 
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5.3.11.4 3-Oxo-2-(2, 4, 6-trioxo-tetrahydro-pyrimidine-5-ylidene)-butyric acid 




H Ny NH 
A mixture of alloxan monohydrate (0.5 g, 3.12 mmol) and allyl ester 
(0.66 g, 4.7 mmol) in anhydrous dimethoxyethane (3 mL) were stirred at room 
temperature for 30 h. Solvent was evaporated under reduced pressure and residue 
was triturated with diethyl ether and dried at 80 °C in vacuum: 0.5 g, (60 % yield). 
'H NMR (250 MHz, DMSO-d6) 6 11.54 (s, 2H, 2 x  NH), 5.67-5.83 (m, 1H, 
CH2CHCH2), 5.20 (dd, J = 6.0 Hz, 6.0 Hz, 2H, C=HCH 2), 4.52 (d, J= 6.0 Hz, 2H, 
CH2C=H), 2.29 (s, 3H, CH3). 
5.3.11.5 3-Oxo-2- (2, 4, 6-trioxo-tetrahydro-pyrimidine-5-ylidene)-butyric acid 




O r O 
H N . NH 
A mixture of alloxan monohydrate (0.5 g, 3.12 mmol) and benzylacetoacetate 
(0.9 g, 4.7 mmol) in anhydrous dimethoxyethane (3 mL) were stirred at room 
temperature for 30 h. Solvent was evaporated under reduced pressure and residue 
was triturated with diethyl ether, separated solid was filtered and dried at 80 °C in 
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vacuum: 0.85 g, (86 % yield). 'H NMR (250 MHz, CDC13) 8  11.84 (s, 2H, 2 x  NH), 
7.53-7.63 (m, 5H, ArH), 5.36 (s, 211, benzyl CH2), 2.58 (s, 3H, CH,). 13C NMR 
(63 MHz, CDC1 3) ö 201.8 (CH 3C=O), 170.0 (NHCONH), 169.1 (2 x  NHCO), 
168.3 (ester-C=O), 149.4 (ArC), 135.1 (ArC), 128.2 (2 x  ArC), 127.9 (ArC), 127.6 
(ArC), 30.9 (CH 3). MS (Ef) found m/z 315 [M-H], (5 %), 190 (12), 166 (15), 140 
(100), 97 (90),61 (30). 




H Ny NH 
A mixture of alloxan monohydrate (0.5 g, 3.12 mmol) and 2-nitro- 1 -phenyl ethanone 
(0.77 g, 4.7 mmol) in anhydrous 1 ,2-dimethoxyethane (3 mL) were stirred at room 
temperature for 30 h. Solvent was evaporated under reduced pressure and residue 
was triturated with diethyl ether, separated solid was filtered and dried at 80 °C in 
vacuum: 0.82 g, (91 % yield). 'H NMR (250 MHz, CDC1 3) 8 11.84 (s, 1H, NH), 
11.77 (s, 1H, NH), 7.84-7.95 (m, 211, ArH), 7.56-7.67 (m, 111, ArH), 7.40-7.52 
(m, 2H, ArH). 13 C NIvIR (63 MHz, CDC1 3) 8 189.8 (ArC=O), 168.8 (NHC=ONH), 
168.5 (2 x  NHC=O), 149.1 (C=C), 135.5 (C=C), 129.4 (2 x  ArC), 128.9 (ArC), 
128.2 (ArC), 128.1 (2 x  ArC). HRMS FAB (+ve) found m/z 289.0336 (Mt), 
C 12H7N306 289.0335. 
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5.3.12 2-Ethoxycarbonylmethyl-benzoic acid 139 
CcR 
Sodium metal (2.2 g. 97.0 mmol) was dissolved in 300 mL of absolute ethanol. To 
this solution were added ethyl acetoacetate (8.3 mL, 64.7 mmol), copper (I) bromide 
(4.6 g, 32.3 mmol), and 2-bromobenzoic acid (6.5 g, 32.3 mmol). This mixture was 
heated at reflux for 3 h, cooled to room temperature, and filtered through a Celite 
pad. The solvent was removed in vacuo and the residue was partitioned between 
2 N HC 1 and chloroform. The layers were separated and the milky chloroform 
solution was diluted with a little methanol. This solution was dried (MgSO 4), filtered, 
and concentrated in vacuo. The crude product was chromatographed on silica gel by 
using CHC13/MeOH as eluent (97:3). The tan solid obtained was recrystallised from 
hexane/EtOAc to afford title compound as a brown solid (3.5 g, 52 % yield): 
mp 156-157 °C; Rj= 0.6 (CHC1 3/MeOH = 9.5:0.5); 'H NMR (250 MHz, CDC13): 
8.05 (d, J= 8.0 Hz, 1H, ArH), 7.45 (t, J= 7.0 Hz, 1H, ArH), 7.33 (t, J= 8.0 Hz, 1H, 
ArH), 7.20 (d, J= 7.0 Hz, ArH), 4.10 (q, J= 7.0 Hz, 2H, CH2CH3), 3.95 (s, 2H, 
CH2), 1.20 (t, J = 7.0 Hz, 3H, CH2CH3). MS ES (+ve) found m/z 231 
(MNa, 100 %), 209 (MH, 85), 191 (35), 163 (45). 
5.3.12.1 4H-Isoquinoline-1,3-dione 140 
L*LNH 
0 
Half-ester (2.1 g, 10.0 mmol) and urea (15.0 g, 250.0 mmol) were ground together in 
a mortar. The mixture was melted in a 150 °C oil bath for 45 mm. The melt was 
cooled to room temperature and the solid was suspended in water (20 mL). The 
product was collected by filtation and the filter cake was washed with water 
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(3 x  50 mL). The crude product was dried in vacuo and chromatographed on silica 
gel using chloroform as eluant. The product was obtained as an off-white solid 
(0.5 g, 31 %). (CHC1 3/MeOH = 9.5:0.5), Rj = 0.5; mp = 230-232 °C. 'H NMR (250 
MHz, DMSO-d6): 6 11.45 (s, 1H, NH), 8.15 (d, J = 7.5 Hz, 1H, ArH), 7.80 
(t, J = 7.5 Hz, 1H, ArH), 7.5 1-7.63 (m, 2H, ArH), 4.19 (s, 2H, CH2). ' 3C NMR 
(63 MHz, DMSO-d6): 6 175.1 (Ar-C=ONH), 166.0 (Ar-CH 2-C=ONH), 132.6 (ArC), 
131.0 (ArC), 128.1 (ArC), 127.2 (ArC), 63.2 (CH 2). MS ES (+ve) found m/z 162 
(MH, 25 %),161 (100). 
5.3.13 Synthesis of isoquinoline derivatives via Knoevenagel condensation 
5.3.13.1 4-(1H-Pyrrole-2-ylmethylene)-4H-isoquinoline-1 ,3-dione 141 
i) 
4H 
A mixture of 4H-isoquinoline-1,3-dione (0.1 g, 0.62 mmol), pynole-2-
carboxaldehyde (0.06 g, 0.6 mmol) and KF/A1203 (0.11 g) in acetonitrile (1 mL) was 
subjected to microwave irradiation for 10 min at 100 °C with stirring. At the end of 
irradiation, the reaction mixture was cooled and concentrated under vacuum. The 
crude product was purified by column chromatography to afford title compound as a 
pale yellow solid (0.09 g, 61 % yield). Rf = 0.6 (Hexane/EtOAc = 8:2); 'H NMR (250 
MHz, CDC13): 6 8.84 (bs, 1H, NH), 8.20 (d, J= 8.0 Hz, 1H, ArH), 7.81 (t, J = 4.0 
Hz, 1H, ArH), 7.61 (t, J = 7.0 Hz, 1H, ArH), 7.35 (t, J = 7.0 Hz, 1H, Aril), 7.20 
(s, 1H, C=CH), 6.86-6.89 (m, 1H, ArH), 6.39-6.42 (m, 1H, ArH). MS ES (+ve) 
found m/z 239 (MH', 100 %). 
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5.3.13.2 5-(1H-Indol-3-ylmethylene)-pyrimidine-2,4,6-trione 141a 
NH 
A mixture of pyrimidine-2,4,6-trione (1.1 g, 8.6 mmol), indole-3-carboxaldehyde 
(1.24 g, 8.6 mmol) and a catalytic amount of piperdine (0.2 mL) in ethanol (15 mL) 
were refluxed for 10 h. Reaction mixture was then cooled to room temperature and 
the precipitate was filtered and dried under vacuum to afford title compound as a 
pale yellow solid (2.0 g, 91 % yield). Rj = 0.6 (Hexane/EtOAc = 8:2); 'H NMR 
(250 MHz, DMSO-d3): 611.18 (bs, 1H, NH), 11.09 (bs, 1H, NH), 9.55 
(s, 1H, C=CH), 8.76 (s, 1H, indole-H), 7.91-7.94 (m, 1H, ArH), 7.60-7.66 (m 1H, 
ArH), 7.33-7.40 (m, 2H, ArH). 13C NMR (63 MHz, CDC13 ): 6 164.4 (C-i), 163.0 
(C-2), 150.2 (C-3), 143.6 (C-4), 139.6 (C-5), 136.2 (C-7), 129.0 (C-6), 123.5 
(C-13), 122.5 (C-8), 117.5 (C-9), 113.0 (C-b), 111.2 (C-li), 108.4 (C-12). 
MS ES (+ve) found m/z 278 25 %), 255 (MH, 45), 214 (40), 128 (55), 117 
(80), 85 (100), 58 (35). 
5.3.14 General procedure D for the synthesis of amides 
The synthesis of amides was performed under microwave irradiation. A mixture of 
amine (1.0 mmol) and carboxylic acid (1.0 mmol) was placed in a microwave tube, 
equipped with a magnetic stirrer bar, and sealed with a silicon septum. The mixture 
was then homogenized and subjected to microwave irradiation (3 00W power) for 30 
min at 150 °C with stirring. At the end of irradiation, the reaction mixture was cooled 
to room temperature and extracted with chloroform. The extracts were washed 
successively with a solution of 2M HC1 (15 mL) and a solution of saturated NaHCO 3 
(15 mL). The organic layer was dried over anhydrous MgSO 4 and concentrated under 
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vacuum. The crude product was purified by washing with pentane and in some cases 
the amide was used for the next step without further purification. 
5.3.14.1 N-Allyl-benzamide 142a 
H _- 	N..- 
0 
N-Allyl-benzamide was prepared using general procedure D. Benzoic acid 
(0.75 g, 6.1 mmol) and allylamine (0.35 g, 6.1 mmol) yielded 0.45 g (45 %) of the 
title product as a colourless solid. Rf = 0.5 (CHC13/MeOH = 9.5:0.5); 'H NMR 
(250 MHz, CDC1 3): 6 8.02-8.06 (m, 2H, ArH), 7.64-7.75 (m, 3H, ArH), 6.24 
(bs, 1H, NH), 6.13-6.20 (m, 1H, C=HCH 2), 5.40 (dd, J = 6.0 Hz, 6.0 Hz, 2H, 
CHCH2), 4.30-4.36 (m, 2H, N-Cl 2). MS ES (+ve) found m/z 184 (MNa, 10 %) 
161 (MH, 100), 104 (15), 82 (7). 
5.3.14.2 N-Butyl-benzamide 142b 
H - 	N-.- 
0 
N-Butyl-benzamide was prepared using the general procedure D. Benzoic acid 
(0.75 g, 6.1 mmol) and n-butylamine (0.45 g, 6.1 mmol) yielded 0.58 g (53 %) of the 
title product as a colourless solid. R = 0.6 (CHC1 3/MeOH = 9.5:0.5); 'H NMR 
(250 MHz, CDC13 ): 6 7.67-7.70 (m, 2H, ArH), 7.31-7.41 (m, 3H, ArH), 6.14 
(bs, 1H, NH), 3.38 (q, J = 7.0 Hz, 2H, N-CH 2), 1.47-1.56 (m, 1H, CH 2), 1.29-1.36 
(m, 2H, Cl 2), 0.90 (t, J= 7.0 Hz, 3H, CH,). 13 C NMR (63 MHz, CDC13): 6 161.4 
(C=ONH, 134.7 (ArC), 131.1 (ArC), 128.4 (ArC), 126.7 (ArC), 39.7 (N-CH 2), 31.6 
(CH2), 20.0 (CH 2), 13.6 (CH 3). MS ES (+ve) found m/z 177 (MH, 100 %). 
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5.3.14.3 N-Isobutyl-benzamide 142c 
N-Isobutyl-benzamide was prepared using the general procedure A. Benzoic acid 
(0.75 g, 6.1 mmol) and isobutylamine (0.45 g, 6.1 mmol) yielded 0.7 g (64 %) of the 
title product as a colourless solid. Rj = 0.45 (CHCI3/MeOH = 9.5:0.5); 'H NMR 
(250 MHz, CDC13): 8 8.01-8.05 (m, 2H, Ar!!), 7.64-7.75 (m, 3H, ArH), 6.54 
(bs, 1H, NH) 3.54 (t, J = 6.5 Hz, 2H, N-CH2), 2.20 (septet, J = 6.5 Hz, 1H, CH), 
1.21 (d, J = 6.5 Hz, 6H, 2 x  CH3). MS ES (+ve) found m/z 199 (MNa, 5 %) 177 
(MH, 100). 
5.3.14.4 4- Flu oro-N-isobutyl-benzamide 142d 
4-Fluoro-N-isobutyl-benzamide was prepared using the general procedure A. 
4-Fluoro-benzoic acid (0.75 g, 5.35 mmol) and isobutylamine (0.39 g, 5.35 mmol) 
yielded 0.75 g (72%) of the title product as a colourless solid. R = 0.5 
(CHC1 3/MeOH = 9:1); 'H NTVIR (250 MHz, CDC1 3): 6 7.68-7.73 (m, 2H, ArH), 
6.96-7.03 (m, 2H, Ar!!), 6.37 (bs, 1H, NH), 3.19 (t, J = 6.0 Hz, 2H, N-CH2), 1.84 
(septet, J = 6.5 Hz, 1H, CH), 0.92 (d, J = 6.5 Hz, 6H, 2 x  CH3). MS ES (+ve) found 
m/z 217 (MNa, 10%) 195 (MH, 5). 
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5.3.14.5 3- Chloro-N-isobutyl-benzamide 142e 
3-Chloro-N-isobutyl-benzamide was prepared using the general procedure A. 
4-Fluoro-benzoic acid (0.75 g, 5.35 mmol) and isobutylamine (0.39 g, 5.35 mmol) 
yielded 1.0 g (74 %) of the title product as a colourless solid. Rf = 0.5 (CHC13/MeOH 
= 9:1); 'H NIMR (250 MHz, CDC13): 6 7.89 (s, 1H, AM), 7.68-7.77 (m, 1H, ArH), 
7.14-7.60 (m, 2H, ArH), 6.36 (bs, 1H, NH), 3.44 (t, J = 6.0 Hz, 211, N-CH 2), 
2.10 (septet, J = 6.5 Hz, 1H, CH), 1.12 (d, J = 6.5 Hz, 6H, 2 x  CH3). 
MS ES (+ve) found m/z 212 (MH, 100 %), 213 (MH, 33). 
5.3.14.6 N-Isobutyl-3,4-dimethoxy-benzamide 142f 
H3CO 
N-Isobutyl-3,4-dimethoxy-benzamide was prepared using the general procedure A. 
3,5-dimethoxy benzoic acid (1.0 g, 5.5 mmol) and isobutylamine (0.40 g, 5.5 mmol) 
yielded 0.75 g (57 %) of the title product as a colourless solid. R = 0.6 
(CHC1 3/MeOH = 9.5:0.5); 'H NIMR (250 MIHz, CDC1 3 ): 6 7.35 (s, 1H, AM), 
7.16-7.28 (m, 1H, AM), 6.81-6.89 (m, 1H, AM), 6.22 (bs, 1H, NH), 3.80 
(s, 6H, 2 x  0CH3), 3.18 (t, J= 6.0 Hz, 2H, N-CH 2), 1.78 (septet, J= 6.5 Hz, 1H, 
CH), 0.87 (d, J= 6.5 Hz, 6H, 2 x  Cl3). MS ES (+ve) found m/z 238 (MH, 100 %). 
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5.3.14.7 N-Isobutyl-3,5-dimethoxy-benzamide 142g 
OCH3 
H 3CO ( N 
N-Isobutyl-3,5-dimethoxy-benzamide was prepared using the general procedure A. 
3,5-dimethoxy benzoic acid (1.0 g, 5.5 mmol) and isobutylamine (0.40 g, 5.5 mmol) 
yielded 0.75 g (57 %) of the title product as a colourless solid. R = 0.5 
(CHC13/MeOH = 9.5:0.5); 'H NMR (250 MHz, CDC13): 5 7.51 (s, 1H, ArH), 7.13 
1H, ArH), 6.84 (s, 1H, ArH), 6.48 (bs, 1H, NH), 4.06 (s, 3H, 2 x  OCH3), 3.52 
J= 7.0 Hz, 2H, N-CH2), 2.10 (septet, J= 7.0 Hz, 1H, CH), 1.21 (d, J= 6.5 Hz, 
6H, 2 x  Cl3). MS ES (+ve) found m/z 238 (MH, 100 %), 157 (10). 
5.3.15 Synthesis of chioroacetamides 
5.3.15.1 N-(2-Chloro-acetyl)-benzamide 143a 
CI 
0 NrH 
A mixture of benzamide (3.0 g, 24.8 mmol) and chioroacetyl chloride 
(2.9 g, 25.5 mmol) were heated to 110 °C for 30 mm. Then the reaction mixture was 
cooled to room temperature and the crude product was purified by simple washing 
with pentane to afford title compound as a white solid (3.95 g, 80 %). Rf = 0.45 
(Hexane/EtOAc = 7:3); 'H NMR (250 MHz, CDC1 3): 6 11.64 (s, 1H, NH), 8.10-8.14 
(m, 2H, Am), 7.81-7.88 (m, 1H, ArH), 7.69-7.75 (m, 2H, Am), 4.97 (s, 2H, CH2). 
MS ES (+ve) found m/z 198 (MH, 10 %), 105 (100). 
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A mixture of 2-nitro-benzamide (0.5 g, 3.0 mmol) and chloroacetyl chloride 
(0.35 g, 3.1 mmol) were heated to 110 °C for 30 mm. Then the reaction mixture was 
cooled to room temperature and the crude product was purified by simple washing 
with pentane to afford title compound as a white solid (0.6 g, 82 %). R f = 0.6 
(Hexane/EtOAc = 7:3); 'H NMR (250 MHz, CDC13): 6 8.46 (d, J = 8.0 Hz, 2H, 
ArH), 7.87-8.13 (m, 3H, Am), 4.77 (s, 2H, CH2). MS ES (+ve) found m/z 242 
(MH, 100 %). 
5.3.15.3 N-Benzyl-N-(2-Chloro-acetyl)-benzamide 143c 
CI 
ccc 
N-Benzylbenzamide (0.5 g, 2.36 mmol) was refluxed in toluene (5 mL) in the 
presence of chloroacetyl chloride (0.4 g, 3.55 mmol) until reaction was complete by 
TLC. The reaction mixture was cooled and the precipitated chloroacetamide filtered, 
and dried under vacuum to afford title compound as a white solid (0.45 g, 66 %). 
R= 0.7 (Hexane/EtOAc = 7:3); 'H NMR (250 MHz, CDC1 3 ): ö 7.47-7.51 (m, 3H, 
ArH), 7.37-7.40 (m, 2H, ArH), 7.17-7.20 (m, 3H, ArH), 7.02-7.05 (m, 2H, Aril), 





5.3.15.4 N-(2-Chloro-acetyl)-N-phenyl-benzamide 143d 
CI 
0 
N-Benzylbenzamide (1.0 g, 5.07 mmol) was refluxed in toluene (10 mL) in the 
presence of chloroacetyl chloride (0.86 g, 7.6 mmol) until complete reaction. The 
reaction mixture was cooled and the precipitated chioroacetamide filtered, dried 
under vacuum to afford title compound as a white solid (0.6 g, 43 %). Rf = 0.7 
(Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC13): 6 8.05 (d, J = 7.0 Hz, 2H, 
ArH), 7.05-7.53 (m, 8H, ArH), 4.54 (s, 2H, CH2). 
5.3.15.5 4-Chloro-N-(2-Chloro-acetyl)-benzamide 143e 
CI 
CI 
4-Chlorobenzamide (1.0 g, 6.43 mmol) was refluxed in toluene (10 mL) in the 
presence of chioroacetyl chloride (0.74 g, 6.55 mmol) until complete reaction. The 
reaction mixture was cooled and the precipitated chloroacetamide filtered, dried to 
afford title compound as a white solid (0.8 g, 53 %). R= 0.5 (Hexane/EtOAc = 7:3); 
'H NIMR (250 MHz, CDCI3): 5 11.57 (s, 1H, NH), 8.00 (d, J= 9.0 Hz, 2H, ArH), 
7.68 (d, J = 9.0 Hz, 2H, ArH), 4.83 (s, 2H, CH2). MS ES (+ve) found m/z 255 
(MNa, 10 %), 138 (20), 107 (25), 90 (100). 
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N-Allylbenzamide (0.45 g, 2.8 mmol) was refluxed in toluene (5 mL) in the presence 
of chioroacetyl chloride (0.47 g, 4.2 mmol) until complete reaction. The reaction 
mixture was cooled and the precipitated chloroacetamide filtered, dried to afford title 
compound as a white solid (0.3 g, 45 %). Rf = 0.6 (Hexane/EtOAc = 8:2); 'H NMR 
(250 MHz, CDC13): 8 7.73-7.80 (m, 3H, Ar!!), 7.59-7.65 (m, 2H, ArH), 5.90 
(m, 1H, CH=CH2), 5.18 (dd, J = 11.0 Hz, and 11.0 Hz, 2H, CH=CH2), 4.66 
2H, Cl-CH 2), 4.47 (d, J = 5.5 Hz, N-CH 2=CH). 13 C NMR (63 MHz, CDCI 3): 6 
173.8 (CI-CH2-C=ONH), 169.9 (ArC=ON-), 133.9 (CH=CH 2), 132.5 (ArC), 131.9 
(ArC), 128.6 (ArC), 128.1 (ArC), 117.8 (CH=CH 2), 49.1 (CI-CH2), 44.8 (N-CH 2). 
MS ES (+ve) found m/z 237 (MH, 10 %), 183 (15), 161 (100), 104 (80). 




N-Butylbenzamide (0.55 g, 3.1 mmol) was refluxed in toluene (5 mL) in the presence 
of chioroacetyl chloride (0.53 g, 4.6 mmol) until complete reaction. The reaction 
mixture was cooled and the precipitated chloroacetamide filtered, dried to afford title 
compound as a white solid (0.34 g, 43 %). Rj= 0.5 (Hexane/EtOAc = 8:2); 'H NMR 
(250 MHz, CDC13): 6 7.57-7.76 (m, 5H, ArH), 4.53 (s, 2H, C1CH 2), 3.83 
J= 7.5 Hz, 2H, N-Cl 2), 1.58-1.65 (m, 2H, CH2), 1.30 (q, J= 7.5 Hz, 2H, CH 2), 
0.92 (t, J = 7.0 Hz, 3H, CH3). 13C NMR (63 MHz, CDC1 3): 6 174.2 (C1-CH 2 -
C=ONH), 170.0 (ArC=ON), 134.2 (ArC), 132.5 (ArC), 128.8 (ArC), 128.2 (ArC), 
47.2 (Cl-CH2C=O), 44.9 (N-CH), 30.7 (CH 2), 19.7 (CH2), 13.4 (CH3). 
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MS ES (+ve) found m/z 254 (MH, CI-35, 80 %) and 256 (MH, CI-37, 20 %), 242 
(70), 177 (45), 104 (100), 78 (35). 
5.3.15.8 N-(2-Chloro-acetyl)-N-isobutyl-benzamide 143g 
CI 
OL 
N-Isobutylbenzamide (0.3 g, 1.7 mmol) was refluxed in toluene (5 niL) in the 
presence of chioroacetyl chloride (0.29 g, 2.54 mmol) until complete reaction. The 
reaction mixture was cooled and the precipitated chioroacetamide filtered, dried to 
afford title compound as a white solid (0.18 g, 42 %). R = 0.5 (Hexane/EtOAc 
8:2); 'H NMR (250 MHz, CDC13): 8 7.73-7.93 (m, 5H, ArH), 4.69 (s, 2H, C1CH 2), 
3.87 (d, J = 7.0 Hz, 2H, N-CH 2), 2.24 (septet, J = 7.0 Hz, 1H, CH), 1.07 
(d, J = 7.0 Hz, 6H, 2 x  CH,). 13C NMR (63 MHz, CDC1 3 ): ö 174.5 
(Cl-CH2-C=ONH), 169.9 (ArC=ON), 134.0 (ArC), 132.7 (ArC), 128.8 (ArC), 128.7 
(ArC), 54.5 (CH), 44.6 (N-CH 2), 28.2 (CH2), 19.8 (2 x  CH3). MS ES (+ve) found 
m/z 276 (MNa, 50 %) and 254 (MH, 20 %),218 (30), 199 (100), 177 (80). 
5.3.15.9 N-(2-Chloro-acetyl)-4-fluoro-N-isobutyl-benzamide 143h 
CI 
FO 
4-Fluoro-N-isobutylbenzamide (0.5 g, 2.56 mmol) was refluxed in toluene (5 mL) in 
the presence of chloroacetyl chloride (0.43 g, 3.84 mmol) until complete reaction. 
The reaction mixture was cooled and the precipitated chloroacetamide filtered, dried 
to afford title compound as a white solid (0.25 g, 36 %). Rj= 0.6 (Hexane/EtOAc = 
8:2); 'H NMR (250 MHz, CDC1 3): 6 7.45-7.50 (m, 2H, ArH), 6.94-6.98 
(m, 2H, ArH), 4.21 (s, 2H, Cl-CH2), 3.37 (d, J = 7.0 Hz, 2H, N-CH2), 1.75 
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(septet, J = 7.0 Hz, 1H, CH), 0.60 (d, J = 7.0 Hz, 6H, 2 x  Cl3). 13C NMR 
(63 MHz, CDC13): ö 173.4 (Cl-CH 2-CONH), 169.8 (ArC=ON), 131.4 (ArC), 130.0 
(ArC), 116.3 (ArC), 116.0 (ArC), 54.6 (CH), 44.3 (N-CH 2), 28.3 (CH2), 19.8 
(2 x  CH3). MS ES (+ve) found m/z 294 (MNa, 100 %), 272 (MH, 20), 196 (125), 
59(35). 
5.3.15.10 N-(2-Chloro-acetyl)-N-methyl-benzamide 1431 
CI 
0(0 
N-Methylbenzamide (3.0 g, 22.2 mmol) was refluxed in toluene (30 mL) in the 
presence of chioroacetyl chloride (3.76 g, 33.3 mmol) until complete reaction. The 
reaction mixture was cooled and the precipitated chloroacetamide filtered, dried to 
afford title compound as a white solid (2.7 g, 57 %). Rj= 0.7 (Hexane/EtOAc = 8:2); 
'H NIMR (250 MHz, CDC13): 6 7.59-7.76 (m, 5H, ArH), 4.71 (s, 2H, C1CH 2), 3.35 
(s, 3H, N-CH3). ' 3C NMR (63 MHz, CDC1 3): ö 173.6 (Cl-CH2-CONH), 170.1 
(ArC=ON), 133.7 (ArC), 132.6 (ArC), 128.7 (ArC), 128.3 (ArC), 45.2 
(Cl-CH2C=O), 35.3 (N-CH). MS ES (+ve) found m/z 235 (MNa, 15 %), 211 
(MH, 20 %), 175 (100), 104 (19). 
5.3.16 General procedure E for palladium-catalysed homopthalimide formation 
An oven-dried Schlenk tube equipped with a magnetic stir bar and a Teflon stopcock 
was evacuated while hot and cooled under nitrogen. The tube was charged with 
Pd(OAc)2 (1.0 to 3.0 mol %), 2-(di-tert-butylphosphino) biphenyl (Pd : ligand = 2:1), 
and the chloroacetamide substrate (1.0 mmol). The tube was evacuated and 
backfilled with nitrogen, and the Teflon stopcock was replaced with a rubber septum. 
Anhydrous triethylamine (0.21 mL, 1.5 mmol) was added, followed by anhydrous 
toluene (1.0 mL). The septum was replaced by the Teflon stopcock under a positive 
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pressure of nitrogen, and the sealed tube was placed in an oil bath preheated to 
80 °C. After the designated time period, the reaction was allowed to cool to room 
temperature and was diluted with ethyl acetate (10 mL). The mixture was filtered 
through a plug of Celite and concentrated on a rotary evaporator. The crude material 
thus obtained was purified by silica gel chromatography to give the product. 




General procedure E was followed. Reaction time 5 h, using 3 mol % Pd, the product 
was obtained as a brown liquid (0.06 g, 28 %) by silica gel chromatography 
(CHC13/MeOH = 9:1, Rf= 0.5); 'H NMR (250 MHz, CDC13): ö 8.74 (s, 1H, NH), 
8.15 (d, J= 7.0 Hz, 1H, ArH), 7.57-7.72 (m, 2H, ArH), 7.42 (d, J= 7.0 Hz, 1H, 
ArH), 4.80 (s, 2H, Cl 2), 2.12 (s, 3H, CH3). MS ES (+ve) found m/z 266 
(MH, 20 %), 221 (22), 206 (75), 149 (100). 




General procedure E was followed. Reaction time 4 h, using 3 mol % Pd, the product 
was obtained as a brown liquid (0.110 g, 31 %) by silica gel chromatography 
(Hexane/EtOAc = 8:2, Rf= 0.6); 'H NMR (250 MHz, CDC1 3): 6 7.33-7.46 (m, 5H, 
ArH), 7.16-7.18 (m, 3H, ArH), 6.96-6.99 (m, 2H, ArH), 4.94 (s, 2H, CH2), 4.88 
(s, 21), 2.08 (s, 3H, CH,). 13 C NMR (63 MHz, CDCI 3): 6 173.9 (OCOCH3), 170.9 
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(ArC=ON), 170.4 (NC=OCH2), 136.3 (ArC), 134.3 (ArC), 132.2 (ArC), 128.6 
(ArC), 128.5 (ArC), 127.9 (ArC), 127.4 (ArC), 127.1 (ArC), 64.7 (OCH2C=O), 49.6 
(N-CR2), 20.4 (CH3). MS ES (+ve) found m/z 251 (MH-OAc, 80 %), 90 (100). 





General procedure E was followed. Reaction time 5 h, using 3 mol % Pd, the product 
was obtained as a brown colour solid (0.05 g, 24 %) by silica gel chromatography 
(Hexane/EtOAc = 8:2, R1= 0.6); 'H NMR (250 MHz, CDC1 3): 8 7.37-7.54 (m, 5H, 
ArH), 5.02 (s, 2H, CH2), 3.12 (s, 3H, N-CH3), 2.10 (s, 3H, C=OCH 3). ' 3 C NMR 
(63 MHz, CDC13): ö 173.5 (OC=OCH 3), 171.0 (ArC=ON), 170.5 (NC=OCH2), 
134.1 (ArC), 132.2 (ArC), 128.7 (ArC), 128.0 (ArC), 64.8 (OCH 2CO), 34.7 
(N-CH3), 20.4 (CH3). MS ES (+ve) found m/z 175 (MHtOAc, 70 %),117 (100). 




General procedure E was followed. Reaction time 3 h, using 3 mol % Pd, the product 
was obtained as a light brown liquid (0.08 g, 31 %) by silica gel chromatography 
(Hexane/EtOAc = 8:2, Rj = 0.6);'H NMR (250 MHz, CDC13): 8 7.35-7.54 (m, 5H, 
ArH), 4.88 (s, 2H, CH2), 3.62 (t, J = 7.5 Hz, 2H, N-CH 2), 2.08 (s, 3H, COCH3), 
1.38-1.47 (m, 2H, CH2), 1.12 (q, J= 7.5 Hz, 2H, CH2CH3), 0.80 (t, J= 7.0 Hz, 3H, 
CH2CH3). 13C NMR (63 MHz, CDC13): 5  173.1 (OC=OCH3), 170.7 (ArC=ON), 
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170.4 (NC=0CH2), 134.5 (ArC), 132.1 (ArC), 128.7 (ArC), 128.4 (ArC), 127.8 
(ArC), 126.7 (ArC), 64.9 (OCH2C=O), 46.6 (N-CH2), 30.7 (CH2), 20.4 (CH2), 19.7 
(OC=OCH3), 13.6 (CH3). MS ES (+ve) found m/z 277 (MH, 25 %), 217 
(MH-OAc, 100), 177 (90). 




General procedure E was followed. Reaction time 5 h, using 3 mol % Pd, the product 
was obtained as a light brown liquid (0.07 g, 30 %) by silica gel chromatography 
(Hexane/EtOAc = 8:2, Rf= 0.5); 'H NMR (250 MHz, CDC1 3): 6 7.36-7.55 (m, 5H, 
ArH), 5.70 (septet, J= 5.5 Hz, 1H, C=CH), 4.97 (s, 2H, Cl 2), 5.02 (dd, J= 10.0 Hz, 
and 10.0 Hz, 2H, CH=CH 2), 4.22 (d, J = 5.5 Hz, 2H, N-Cl2), 2.10 (s, 3H, 
C=OCH3). MS ES (+ve) found m/z 201 (MH-OAc, 20 %),161 (MH-allyl, 90). 




General procedure E was followed. Reaction time 3 h, using 3 mol % Pd, the product 
was obtained as a light brown liquid by silica gel chromatography (Hexane/EtOAc = 
9:1, Rf = 0.5); 'H NMR (250 MHz, CDCI3): 6 7.3 8-7.56 (m, SH, ArH), 4.86 (s, 2H, 
Cl2), 3.52 (d, J= 7.0 Hz, 2H, N-CH2), 2.06 (s, 3H, C=OCH 3), 1.85 (septet, J= 7.0 
Hz, 1H, CH), 0.71 (d, J = 7.0 Hz, 6H, 2 x  CH3). 13C NMIR (63 MHz, CDC1 3): 6 
174.5 (OC=OCH3), 170.6 (ArC=ON), 170.4 (NC=OCH 2), 134.3 (ArC), 132.3 
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(ArC), 128.7 (ArC), 128.4 (ArC), 64.3 (OCH2C=O), 53.9 (N-CH), 28.1 (CH), 20.4 
(CH3), 19.8 (CH3). MS ES (+ve) found m/z 300 (MNa, 100 %), 278 (MH, 15), 218 
(MHtOAc, 20),102 (30). 
5.3.16.7 Acetic acid 2- I(4-fluoro-benzoyi)-isobutyl-amino] -2-oxo-ethyl ester 
146g 
OAc 
F 	 r° 
0 
General procedure E was followed. Reaction time 6 h, using 3 mol % Pd, the product 
was obtained as a brown liquid (0.07 g, 27 %) by silica gel chromatography 
(Hexane/EtOAc = 8:2, Rf = 0.5); 1 H NMR (250 MHz, CDC13): 8 7.55-7.61 
(m, 2H, ArH), 7.07-7.14 (m, 211, ArH), 4.84 (s, 2H, CH2), 3.50 (d, J= 7.0 Hz, 2H, 
N-Cl2), 2.08 (s, 3H, C=0CH 3), 1.85 (septet, J = 7.0 Hz, 1H, CH), 0.71 
(d, J = 7.0 Hz, 611, 2 x  CH3). MS ES (+ve) found m/z 319 (MNa, 100 %), 296 
(MH, 25), 235 (MHtOAc, 60), 99 (30). 
5.3.16.8 N-Benzyl-2-(2-iodo-phenyl)-acetamide 228a 
H ,'01 
LL8 
N-Benzyl-2-(2-iodo-phenyl)-acetamide was prepared using the general procedure D. 
2 -iodophenyl acetic acid (0.5 g, 1.9 mmol) and benzylamine (0.2 g, 1.9 mmol) 
yielded 0.62 g (92 %) of the title product as a light brown colour solid. Rj = 0.5 
(Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC1 3): ö 7.79 (d, J = 7.79 Hz, 1H, 
ArH), 7.13-7.29 (m, 8H, ArH), 6.80-6.92 (m, 1H, ArH), 5.62 (bs, 111, NH), 4.37 
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(d, J = 6.0 Hz, 2H, N-CH2), 3.70 (s, 2H, Cl2). MS ES (+ve) found m/z 351 
(MH, 100 %) 197 (30). 
5.3.16.9 N-Benzyl-2-(2-bromo-phenyl)-acetamide 228b 
H 
N-Benzyl-2-(2-bromo-phenyl)-acetamide was prepared using the general procedure 
D. 2-bromophenylacetic acid (0.5 g, 2.3 mmol) and benzylamine (0.25 g, 2.3 mmol) 
yielded 0.67 g (95 %) of the title product as a light brown colour solid. R = 0.5 
(Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC1 3): ö 7.50 (d, J = 8.0 Hz, 1H, 
ArH), 7.13-7.29 (m, 8H, ArH), 5.66 (bs, 1H, NT!), 4.37 (d, J = 6.0 Hz, 2H, N-CH2), 
3.70 (s, 2H, Cl2). ' 3 C NMR (63 MHz, CDC1 3 ): 8  169.3 (CONH), 137.9 (ArC), 
134.6 (ArC), 133.1 (ArC), 131.6 (ArC), 129.1 (ArC), 128.5 (ArC), 127.9 (ArC), 
127.4 (ArC), 127.3 (ArC), 124.8 (ArC), 43.9 (N-CH 2), 43.5 (CH). MS ES (+ve) 
found m/z 327 (MNa 1 , 100 %) 197 (70), 176 (35), 107 (22). 
5.3.16.10 N-Benzyl-2-(2-chloro-phenyl)-acetamide 228c 
H 
N-Benzyl-2-(2-chloro-phenyl)-acetamide was prepared using the general procedure 
D. 2-chlorophenylacetic acid (0.5 g, 2.9 mmol) and benzylamine (0.31 g, 2.9 mmol) 
yielded 0.7 g (92 %) of the title product as a white colour solid. Rf = 0.5 
(Hexane/EtOAc = 9:1); 'H NMR (250 MHz, CDC13 ): 6 7.13-7.29 (m, 9H, ArH), 5.54 
(bs, 1H, NH), 4.37 (d, J = 6.0 Hz, 2H, N-CH2), 3.67 (s, 2H, CH 2). MS ES (+ve) 
found m/z 283 100 %) 101 (15). 
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5.3.16.11 N-Benzyl-2-(2-hydroxy-phenyl)-acetamide 
H 
N-Benzyl-2-(2-hydroxy-phenyl)-acetamide was prepared using the general procedure 
D. 2-hydroxyphenylacetic acid (0.5 g, 3.3 mmol) and benzylamine 
(0.35 g, 3.3 mmol) yielded 0.7 g (88 %) of the title product as a white colour solid. 
Rf = 0.5 (Hexane/EtOAc = 7:3); 'H NMR (250 MHz, CDC13): 6 7.09-7.24 
(m, 6H, ArH), 6.89 (t, J = 8.0 Hz, 2H, ArH), 6.75 (t, J = 7.5 Hz, 1H, ArH), 6.30 
(bs, 1H, NH), 4.32 (d, J = 6.0 Hz, 2H, N-CH 2), 3.50 (s, 2H, CH2). 
MS ES (+ve) found m/z 241 (MH, 100 %). 
5.3.16.12 2-(2-Bromo-phenyl)-N-isobutyl-acetamide 228d 
2-(2-Bromo-phenyl)-N-isobutyl-acetamide was prepared using the general procedure 
D. 2-bromophenylacetic acid (0.5 g, 2.3 mmol) and isobutylamine (0.17 g, 2.3 mmol) 
yielded 0.6 g (95 %) of the title product as a brown colour solid. Rj = 0.5 
(Hexane/EtOAc = 8:2); 'H NIMR (250 MHz, CDC1 3): 6 7.50 (d, J = 8.0 Hz, 1H, 
ArH), 7.24-7.28 (m, 2H, ArH), 7.06-7.17 (m, 1H, ArH) 5.42 (bs, 1H, NH), 3.64 
(s, 2H, Cl2) 4.37 (t, J= 7.0 Hz, 2H, N-Cl 2), 1.65 (septet, J= 7.0 Hz, 1H, CH), 0.78 
(d, J= 7.0 Hz, 6H, 2 x  CH3). 13 C NMR (63 MHz, CDC13): 6 169.3 (C=ONH), 134.9 
(ArC), 133.0 (ArC), 131.6 (ArC), 129.0 (ArC), 127.9 (ArC), 124.7 (ArC), 46.8 
(CH), 44.0 (N-CH 2), 28.3 (CH2), 19.8 (2 x  CH3). MS ES (+ve) found m/z 293 
(MNa, 100 %) 176 (20), 82 (10). 
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5.3.16.13 2-(2-Bromophenyl)-N-phenyl-acetamide 228e 
2-(2-Bromophenyl)-N-phenylacetamide was prepared using the general procedure D. 
2-bromophenylacetic acid (0.5 g, 2.3 mmol) and aniline (0.216 g, 2.3 mmol) yielded 
0.6 g (89 %) of the title product as a white colour solid. R = 0.5 (Hexane/EtOAc = 
8:2); 'H NMR (250 MHz, CDC13): 8 7.50 (d, J = 8.0 Hz, 1H, ArH), 6.84-7.34 
(m, 9H, ArH), 3.74 (s, 2H, CH,). 13 C NIMR (63 MHz, CDC13): 8  167.6 (C=ONH), 
137.5 (ArC), 134.4 (ArC), 133.1 (ArC), 131.6 (ArC), 129.3 (ArC), 128.8 (ArC), 
128.0 (ArC), 124.8 (ArC), 124.4 (ArC), 119.9 (ArC), 43.9 (CH 2). MS ES (+ve) 
found m/z 313 (MNa, 100 %) 176 (35), 82 (22). 
5.3.16.14 2-(2-Bromophenyl)-N-butyl-acetamide 228f 
H 
Br 0 
2-(2-Bromophenyl)-N-butyl-acetamide was prepared using the general procedure D. 
2-bromophenylacetic acid (0.5 g, 2.3 mmol) and n-butylamine (0.17 g, 2.3 mmol) 
yielded 0.6 g (95 %) of the title product as a white colour solid. Rf = 0.5 
(Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC13): 8 7.45 (d, J = 8.0 Hz, 1H, 
ArH), 7.14-7.23 (m, 2H, ArH), 6.99-7.06 (m, 1H, ArH), 5.36 (bs, 1H, NH), 3.56 
(s, 2H, CH2), 3.10 (q, J= 7.0 Hz, 2H, N-CH2), 1.24-1.35 (m, 2H, CH 2), 1.09-1.18 
(m, 2H, CH2), 0.75 (t, J = 7.0 Hz, 3H, CH3). ' 3 C NMR (63 MHz, CDC13): 6 169.2 
(C=ONH), 134.9 (ArC), 132.9 (ArC), 131.6 (ArC), 128.9 (ArC), 127.8 (ArC), 124.8 
(ArC), 43.9 (N-CH 2), 39.3 (CH2), 31.4 (CH2), 19.8 (CH2), 13.6 (CH3 ). 
MS ES (+ve) found m/z 293 (MNa, 100 %). 
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5.3.16.15 N-Benzyl-2-(2, 6-dichlorophenyl)-acetamide 228g 
CI H ~~ 0~1 C1 0 
N-Benzyl-2-(2,6-dichloro-phenyl)-acetamide was prepared using the general 
procedure D. 2,6-dichiorophenylacetic acid (0.5 g, 2.43 mmol) and benzylamine 
(0.26 g, 2.43 mmol) yielded 0.65 g (90 %) of the title product as a white colour solid. 
Rf = 0.6 (Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC13): 6 7.13-7.29 
(m, 8H, ArH), 5.57 (bs, 1H, NH), 4.36 (d, J = 6.0 Hz, 2H, N-CH2), 3.90 
(s, 2H, CH2). 13C NMR (63 MHz, CDC13): 6 168.0 (C=ONH), 137.9 (ArC), 136.2 
(ArC), 131.4 (ArC), 129.1 (ArC), 128.5 (ArC), 128.3 (ArC), 127.6 (ArC), 127.3 
(ArC), 127.3 (ArC), 43.5 (N-CH2), 38.7 (CH2). MS ES (+ve) found m/z 317 
(MNa, 10 %) 197 (100), 129 (5), 90 (17). 
5.3.16.16 N-Benzyl-2-(2, 4-dichloro-phenyl)-acetamide 228h 
H O CIO N 
N-Benzyl-2-(2,4-dichloro-phenyl)-acetamide was prepared using the general 
procedure D. 2, 4-dichiorophenylacetic acid (0.5 g, 2.43 mmol) and benzylamine 
(0.26 g, 2.43 mmol) yielded 0.62 g (86 %) of the title product as a white colour solid. 
R = 0.6 (Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC13): 6 7.32 (s, 1H, ArH) 
7.13-7.24 (m, 7H, ArH), 5.79 (bs, IH, NH), 4.34 (d, J = 6.0 Hz, 2H, N-CH2), 
3.59 (s, 2H, CH 2). 13 C NIMR (63 MHz, CDC1 3): 6 168.9 (C=ONH), 137.7 (ArC), 
134.8 (ArC), 133.9 (ArC), 132.3 (ArC), 131.4 (ArC), 129.4 (ArC), 128.6 (ArC), 
127.5 (ArC), 127.4 (ArC), 43.6 (N-CH 2), 40.6 (CH2). MS ES (+ve) found m/z 317 
(MNa, 15 %) 197 (100), 129 (10), 90 (37). 
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5.3.16.17 N-Benzyl-2-(2-chloro-6-fluorophenyl)-acetamide 2281 
1LL
C1 0 
N-Benzyl-2-(2-chloro-6-fluoro-phenyl)-acetamide was prepared using the general 
procedure D. 2-chloro-6-fluoro-phenylacetic acid (0.5 g, 2.65 mmol) and 
benzylamine (0.28 g, 2.65 mmol) yielded 0.75 g (95 %) of the title product as a white 
colour solid. R1 = 0.5 (Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC1 3 ): 6 
7.12-7.24 (m, 7H, ArH), 6.91-6.95 (m, 1H, ArH), 5.76 (bs, 1H, NH), 4.36 
(d, J = 6.0 Hz, 2H, N-Cl 2), 3.72 (s, 2H, CH2). 13C NMR (63 MHz, CDC13): 6 168.7 
(C=ONH), 159.9 (ArC-F) 138.4 (ArC), 129.8 (ArC), 129.6 (ArC), 129.0 (ArC), 
127.9 (ArC), 127.8 (ArC), 125.8 (ArC), 125.8 (ArC), 122.0 (ArC), 114.8 (ArC), 
114.5 (ArC), 44.1 (N-CH 2), 34.4 (CH). MS ES (+ve) found m/z 277 (MH, 75 
101 (100). 




2-(2-Bromo-phenyl)-N-ethyl-acetamide was prepared using the general procedure D. 
2-bromophenylacetic acid (0.5 g, 2.3 mmol) and ethylamine (0.16 g, 2.3 mmol) 
yielded 0.6 g (95 %) of the title product as a light brown colour solid. Rj = 0.6 
(Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC1 3): 6 7.51 (d, J = 8.0 Hz, 1H, 
ArH), 7.21-7.29 (m, 2H, ArH), 7.06-7.12 (m, 1H, ArH), 5.41 (bs, 1H, NH), 3.62 
(s, 2H, CH 2), 3.18 (q, J = 7.0 Hz, 2H, N-CH2), 1.00 (t, 3H, J = 7.0 Hz, CH3). 
13 C NMR (63 MHz, CDC1 3): 6 169.2 (C=ONH), 134.8 (ArC), 133.0 (ArC), 131.6 
(ArC), 128.9 (ArC), 127.8 (ArC), 124.8 (ArC), 43.9 (N-CH 2), 34.5 (CH), 14.6 
179 
Chapter 5 	 Experimental 
(CH3). MS ES (+ve) found m/z 264 (MNa, Br-79, 100 %) and 266 
(MNa, Br-81, 100 %), 241 and 243 (75), 129 (20), 87 (22), 73 (20). 
5.3.16.19 2-(2-Bromo-phenyl)-N-cyclopentyl-acetamide 228k 
2-(2-Bromo-phenyl)-N-cyc lop entyl-acetamide was prepared using the general 
procedure D. 2-bromophenylacetic acid (0.25 g, 1.16 mmol) and cyclopentylamine 
(0.1 g, 1.16 mmol) yielded 0.25 g (76 %) of the title product as a colourless liquid. 
R= 0.6 (Hexane/EtOAc = 7:3); 1 H NIMR (250 MHz, CDC13 ): ö 7.51 (d, J= 8.0 Hz, 
1H, ArH), 7.19-7.27 (m, 2H, ArH), 7.05-7.12 (m, 1H, ArH), 5.33 (bs, 1H, NH), 4.13 
(quintet, J = 7.0 Hz, 1H, N-CH), 3.60 (s, 2H, Cl2), 1.82-1.87 (m, 2H, Cl 2), 
1.46-1.53 (m, 4H, 2 x  CH2), 1.22-1.27 (m, 2H, CH2). ' 3C NMR (63 MHz, CDC1 3 ): ö 
168.8 (C=ONH), 134.9 (ArC), 132.9 (ArC), 131.5 (ArC), 128.9 (ArC), 127.8 (ArC), 
124.7 (ArC), 51.2 (N-CH), 44.0 (CH 2), 32.7 (cyclopentyl-2 x  CH), 23.5 
(cyclopentyl-2 x  CH). MS ES (+ve) found m/z 283 (MH, 100 %). 
5.3.16.20 2-(2-Bromo-phenyl)-N-cyclooctyl-acetamide 2281 
rz"N _0 
2-(2-Bromo-phenyl)-N-cyclooctyl-acetamide was prepared using the general 
procedure D. 2-bromophenylacetic acid (0.25 g, 1.16 mmol) and cyclooctylamine 
(0.15 g, 1.16 mmol) yielded 0.26 g (69 %) of the title product as a colourless solid. 
R1= 0.5 (Hexane/EtOAc = 7:3); 'H NIMR (250 MHz, CDC1 3): 8 7.51 (d, J= 8.0 Hz, 
1H, ArH), 7.19-7.27 (m, 2H, ArH), 7.05-7.12 (m, 1H, ArH), 5.33 (bs, 1H, NH), 3.90 
(quintet, J = 4.0 Hz, 1H, N-CH), 3.60 (s, 2H, Cl2), 1.64-1.69 (m, 2H, CH2), 
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1.38-1.49 (m, 12H, 6 x  Cl2). ' 3 C NMR (63 MHz, CDC1 3): 6 168.0 (C=ONIH), 135.0 
(ArC), 132.9 (ArC), 131.6 (ArC), 128.9 (ArC), 127.8 (ArC), 124.7 (ArC), 49.3 
(N-CH), 44.2 (CH2), 31.9 (cyclooctyl-2 x  CH), 27.0 (cyclooctyl-2 x  CH2), 25.2 
(cyclooctyl-CH2), 23.4 (cyclooctyl-2 x  CH2). MS ES (+ve) found m/z 323 
(MH, Br-79,20 %) and 325 (MH 2 , Br-81, 20 %), 235 and 237 (100). 
5.3.16.21 2-(2-Bromo-phenyl)-N-(4-methoxy-benzyl)-acetamide 228m 
cc0 N,ja 
2-(2-Bromo-phenyl)-N-(4-methoxy-benzyl)-acetamide was prepared using the 
general procedure D. 2-bromophenylacetic acid (0.25 g, 1.16 mmol) and 
4-methoxybenzylamine (0.14 g, 1.04 mmol) yielded 0.67 g (95 %) of the title 
product as a light brown colour solid. Rj = 0.5 (Hexane/EtOAc = 8:2); 'H NMR 
(250 MHz, CDC13 ): 6 7.80 (d, J= 8.0 Hz, 1H, ArH), 7.52-7.57 (m, 3H, ArH), 7.50 
(d, J= 7.0 Hz, 2H, ArH), 7.05 (d, J= 7.0 Hz, 2H, ArH), 5.96 (bs, 1H, NH), 4.59 
(d, J = 6.0 Hz, 2H, N-CH2), 4.01 (s, 3H, OCH3), 3.99 (s, 2H, CH2). 13C NMR 
(63 MHz, CDC13): 6 169.2 (C=ONH), 158.8 (ArC-OCH 3), 134.6 (ArC), 133.0 
(ArC), 131.6 (ArC), 129.9 (ArC), 129.0 (ArC), 128.8 (ArC), 127.9 (ArC), 124.8 
(ArC), 114.2 (ArC), 113.8 (ArC), 55.1 (OCH3), 43.9 (N-CH 2), 43.1 (CH2). 
5.3.16.22 2-(2-Bromo-phenyl)-N-(4-methyl-benzyl)-acetamide 228n 
H JY 3 
2-(2-Bromo-phenyl)-N-(4-methyl-benzyl)-acetamide was prepared using the general 
procedure D. 2-bromophenylacetic acid (0.25 g, 1.16 mmol) and 
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4-methylbenzylamine (0.13 g, 1.04 mmol) yielded 0.3 g (81 %) of the title product as 
a white colour solid. R= 0.6 (Hexane/EtOAc = 8:2); 'H NMR (250 MHz, CDC1 3): 6 
7.50 (d, J = 8.0 Hz, 2H, ArH), 7.22-7.27 (m, 6H, ArH), 5.65 (bs, 1H, NH), 4.31 
(d, J = 6.0 Hz, 2H, N-CH2), 3.67 (s, 2H, Cl 2), 2.27 (s, 3H, Cl3). 13C NMR 
(63 MHz, CDC13): 6 169.2 (C=ONH), 137.0 (ArC), 134.8 (ArC), 134.6 (ArC), 133.0 
(ArC), 131.6 (ArC), 129.2 (ArC), 129.0 (ArC), 127.9 (ArC), 127.4 (ArC), 124.8 
(ArC), 43.9 (N-CH 2), 43.3 (CH2), 20.9 (CH3). MS ES (+ve) found m/z 341 
(MNa, Br-79, 10 %) and 343 (MNa, Br-81, 10 %). 




2-(2-Bromo-phenyl)-N-(4-chloro-benzyl)-acetamide was prepared using the general 
procedure D. 2-bromophenylacetic acid (0.25 g, 1.16 mmol) and 
4-chlorobenzylamine (0.15 g, 1.04 mmol) yielded 0.32 g (81 %) of the title product 
as a light brown colour solid. R = 0.5 (Hexane/EtOAc = 8:2); 'H NMR 
(250 MHz, CDC1 3): 6 7.40 (d, J= 8.0 Hz, 2H, ArH), 6.88-7.18 (m, 6H, ArH), 5.63 
(bs, 1H, NH), 4.21 (d, J = 6.0 Hz, 2H, N-Cl 2), 3.59 (s, 2H, CH,). ' 3C NMR 
(63 MHz, CDC13): 6 169.4 (C=ONH), 136.5 (ArC), 134.5 (ArC), 133.1 (ArC), 131.7 
(ArC), 129.2 (ArC), 128.8 (ArC), 128.6 (ArC), 128.0 (ArC), 124.8 (ArC), 43.9 
(N-CH2), 42.8 (CH2). MS ES (+ve) found m/z 337 (MH, Br-79, 60 %) and 339 
(MH, Br-81, 60 %), 265 (100), 213 (25). 
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5.3.16.24 N-Benzyl-2-(2-chloro-5-trifluoromethyl-phenyl)-acetamide 228p 
H 
F3C - -,, NJ ZI 
N-Benzyl-2-(2-chloro-5 -trifluoromethyl-phenyl)-acetamide was prepared using the 
general procedure D. 2-chloro-(5-trifluoromethyl) phenylacetic acid 
(0.5 g, 2.1 mmol) and benzylamine (0.22 g, 2.1 mmol) yielded 0.5 g (72 %) of the 
title product as a white colour solid. Rj = 0.5 (Hexane/EtOAc = 8:2); 'H NMR 
(250 MHz, CDC13): 6 7.55 (s, 1H, ArH), 7.42 (m, 2H, ArH), 7.14-7.28 (m, 5H, 
ArH), 5.86 (bs, 1H, NH), 4.36 (d, J = 6.0 Hz, 2H, N-Cl2), 3.66 (s, 2H, Cl2). 
13C NMR (63 MHz, CDC13 ): 6 168.4 (C=ONH), 138.0 (ArC), 137.7 (ArC), 133.9 
(ArC), 130.1 (ArC), 128.6 (ArC), 128.4 (ArC), 127.5 (ArC), 127.5 (ArC), 125.6 
(ArC), 43.7 (N-CH2), 41.0 (CH2). 
5.3.16.25 2-(4-Hydroxyphenyl)-N-(5-methylthiazole-2-yl)-acetamide 228 
HOO SR 
CH3 
5-Methyl-thiazol-2-ylamine (0.3 g, 2.63 mmol) were mixed with (0.6 g, 3.94 mmol) 
of 4-hydroxy-phenylacetic acid in a microwave tube, equipped with a magnetic 
stirrer bar, and sealed with a silicon septum. The mixture was then homogenized and 
subjected to microwave irradiation (300W power) for 30 min at 150 °C with stirring. 
At the end of irradiation, the reaction mixture was cooled to room temperature and 
extracted with chloroform. The organic layer was dried over MgSO 4 and 
concentrated under vacuum. The crude product was purified by column 
chromatography to afford title product as a white colour solid. R1 = 0.5 
(CHC1 3/MeOH = 9.5:0.5); 'H NMR (250 MHz, DMSO-d3): 6 12.10 (bs, 1H, OH), 
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9.49 (bs, 1H, NH), 7.18-7.29 (m, 3H, ArH), 6.89 (d, J = 7.0 Hz, 2H, ArH), 3.76 
(s, 2H, CH2), 2.49 (s, 3H, CH3). MS ES (+ve) found m/z 249 (MH, 65 %), 212 (70), 
115 (100). 
5.3.17 General procedure F for the synthesis of substituted oxindoles using 
alkylamines 
A mixture of amine (1.0 mmol) and carboxylic acid (1.0 mmol) was homogenised 
and subjected to microwave irradiation (300W power) for 30 min at 150 °C with 
stirring. At the end of irradiation, the reaction vessel was simply opened and purged 
with nitrogen gas, then added Pd(OAc) 2 (3.0 mol %), X-Phos (6.0 mol %), and 
sealed with a silicon septum. 1 mL of 2M NaOH solution (2.0 mmol) and then 1 mL 
of Toluene were injected into the tube via a syringe and the reaction mixture was 
subjected to microwave irradiation (75W power) for another 30 min at 100 °C. The 
reaction vessel was allowed to cool to room temperature and was diluted with ethyl 
acetate (15 mL). The mixture was filtered through a plug of Celite and concentrated 
on a rotary evaporator. The crude material thus obtained was purified by silica gel 
chromatography to give the product oxindole. 
5.3.17.1 1-Ethyl-1,3-dihydro-indole-2-one 227a 
O:N>=o  
Et 
Product was obtained as a white colour solid (92 %) by silica gel chromatography 
using general procedure F (Hexane/EtOAc = 8:2; R = 0.3), mp = 95-96 °C 
(lit. 337 93-94 °C). JR (KBr): 1712 cm. 1 H NMR (250 MHz, CDC1 3 ): 6 7.45-7.54 
(m, 2H, ArH), 7.21 (t, J = 7.5 Hz, 1H, ArH), 6.99 (d, J = 7.5 Hz, 1H, ArH), 3.95 
(q, J= 7.0 Hz, 2H, CH 2), 3.69 (s, 2H, CH 2), 1.45 (t, J= 7.0 Hz, 3H, CH3). ' 3C NIMR 
(63 MHz, CDC1 3 ): 8 175.1 (NCO), 144.7 (ArC), 128.2 (ArC), 125.1 (ArC), 124.9 
Il M-11 
Chapter 5 	 Experimental 
(ArC), 122.5 (ArC), 108.6 (ArC), 36.2 (N-CH2), 35.0 (CH2), 13.0 (CH3). 
HRMS (Ef) found m/z 161.0840 (Mt), C,0H11N0 requires 161.0841. 
5.3.17.2 1 -Butyl-1 ,3-dihydro-indol-2-one 227b 
O:N~=o  
BU 
Product was obtained as a colourless oil (89 %) by silica gel chromatography using 
general procedure F (Hexane/EtOAc = 8:2; Rj= 0.4). IR (neat): 1700 cm - '. 'H NMR 
(250 MHz, CDC13): 8 7.18-7.26 (m, 2H, ArH), 6.94 (t, J= 7.5 Hz, 1H, ArH), 6.75 
(d, J= 7.5 Hz, 1H, Ar!!), 3.65 (q, J= 7.0 Hz, 2H, CH2), 3.43 (s, 2H, CH2), 1.58 
(m, 2H, CH2), 1.20-1.31 (m, 2H, CH2), 0.88 (t, J= 7.0 Hz, 3H, CH3). ' 3 C NIMR 
(63 MHz, CDC13): 6  174.8 (NC=O), 144.5 (ArC), 127.6 (ArC), 124.5 (ArC), 124.3 
(ArC), 121.9 (ArC), 108.2 (ArC), 39.6 (N-CH2), 35.6 (C=OCH2), 29.4 (CH2), 20.1 
(CH2), 13.6 (CH3). HRMS (EI) found m/z 189.1154 (Mt), C12H15N0 requires 
189.1154. 
5.3.17.3 1-Isobutyl-1,3-dihydro-indol-2-one 227c 
O:N~==o  
H 
Product was obtained as a colourless oil (85 %) by silica gel chromatography using 
general procedure F (Hexane/EtOAc = 8:2; Rf= 0.4). IR (neat): 1700 cm - '. 'H NMR 
(250 MHz, CDC13): 6 7.15-7.26 (m, 2H, ArH), 6.94 (t, J= 7.5 Hz, 1H, ArH), 6.74 
(d, J = 7.5 Hz, 1H, ArH), 3.45 (s, 2H, CH2), 3.43 (d, J = 7.5 Hz, 2H, CH2), 
2.06-2.20 (m, 1H, CH), 0.88 (d, J = 7.0 Hz, 6H, 2 x  CH,). 13C NMR (63 MHz, 
CDC13): 8  175.1 (NCO), 144.9 (ArC), 127.5 (ArC), 124.4 (ArC), 124.2 (ArC), 
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121.9 (ArC), 108.5 (ArC), 47.4 (CH), 35.6 (N-CH2), 26.8 (CH2), 20.1 (CH3). HRMS 
(EI) found m/z 189.1153 (M), C 12H 15N0 requires 189.1154. 
5.3.17.4 1-Benzyl-1,3-dihydro-indol-2-one 231 
O:N>==o  
hn 
Product was obtained as a white colour solid (95 %) by silica gel chromatography 
using general procedure F (Hexane/EtOAc = 8:2; R = 0.4), mp = 67-68 °C 
(lit. 338 66.5-67 °C). IR (neat): 1704 cm - '. 'H NMR (250 MHz, CDC13): 6 7.18-7.25 
(m, 7H, ArH), 7.00 (t, J = 8.0 Hz, 1H, ArH), 6.60 (d, J = 8.0 Hz, 1H, ArH), 4.80 
(s, 2H, benzyl Cl 2), 3.50 (s, 2H, CH 2). ' 3C NMR (63 MHz, CDC1 3): 6 175.0 
(NC=O), 144.1 (ArC), 135.7 (ArC), 128.6 (2 x  ArC), 127.6 (ArC), 127.4 (ArC), 
127.2 (2 x  ArC), 124.3 (ArC), 124.2 (ArC), 122.2 (ArC), 108.9 (ArC), 43.5 
(N-CH2), 35.6 (CH3). HRMS (Ef) found m/z 223.0994 (M), C 1511 13N0 requires 
223.0997. 
5.3.17.5 1 -(4-Methoxy-benzyl)-1 ,3-dihydro-indol-2-one 227d 
O:N~==O  
OCH 3 
Product was obtained as a colourless to pale yellow solid (92 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rj = 0.35), 
mp = 105-106.5 °C (lit.  331  103-104 °C). IR (KBr): 1698 cm - 1 . 'H NMR (250 MHz, 
CDC13): 6 7.10-7.26 (m, 4H, ArH), 6.92 (t, J= 7.5 Hz, 1H, ArH), 6.76 (d, J= 8.5 
Hz, 2H, ArH), 6.67 (d, J= 8.0 Hz, 1H, ArH), 4.77 (s, 2H, benzyl CH2), 3.69 (s, 3H, 
0CH3), 3.53 (s, 21-1, Cl2). 13C NMR (63 MHz, CDC1 3): 8  175.0 (NCO), 158.9 
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(ArC), 144.2 (ArC), 128.6 (2 x  ArC), 127.8 (ArC), 127.6 (ArC), 124.4 (ArC), 124.2 
(ArC), 122.2 (ArC), 113.9 (2 x  ArC), 108.9 (ArC), 55.1 (OCH3), 43.0 (N-CH2), 
36.6 (CH2). HRMS (El) found m/z 253.1102 (Mt), C16H15NO2 requires 253.1103. 
5.3.17.6 1-(4-Methyl-benzyl)-1,3-dihydro-indol-2-one 227e 
O:N~=O  
LCH3 
Product was obtained as a colourless to light brown solid (85 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rf = 0.35), 
mp = 71-72 °C. IR (neat): 1714 cm - '. 'H NMR (250 MHz, CDC13): 6 7.18-7.25 
(m, 6H, ArH), 6.92 (t, J = 8.0 Hz, 1H, ArH), 6.65 (d, J = 8.0 Hz, 1H, ArH), 4.82 
(s, 2H, benzyl CH2), 3.53 (s, 2H, CH 2), 2.25 (s, 3H, CH3). 13 C NMR (63 MHz, 
CDC13): 6 175.0 (NC=O), 144.2 (ArC), 137.2 (ArC), 132.7 (ArC), 129.3 (ArC), 
127.9 (ArC), 127.6 (ArC), 127.2 (ArC), 126.8 (ArC), 124.3 (ArC), 123.9 (ArC), 
122.2 (ArC), 108.9 (ArC), 43.3 (N-CH2), 35.6 (CH 2), 21.0 (CH3). HRMS (E1) 
found m/z 237.1153 (Mt), C 1 6H 15N0 requires 237.1154. 
5.3.17.7 1-(4-Chloro-benzyl)-1 ,3-dihydro-indol-2-one 227f 
O:N~=O  
I-C~ci 
Product was obtained as a colourless to light brown solid (70 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; R1 = 0.4), 
mp = 107-108 °C. IR (KBr): 1700 cm - '. 'H NMR (250 MHz, CDC13): 6 7.16-7.28 
(m, 6H, ArH), 6.95 (t, J = 8.0 Hz, 1H, ArH), 6.61 (d, J = 8.0 Hz, 1H, ArH), 4.80 
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(s, 2H, benzyl Cl2), 3.55 (s, 2H, CH2). 13C NMR (63 MHz, CDC1 3 ): 8  175.0 
(NC=O), 143.8 (ArC), 134.2 (ArC), 133.3 (ArC), 128.8 (2 x  ArC), 128.6 (2 x  ArC), 
127.7 (ArC), 124.4 (ArC), 124.3 (ArC), 122.4 (ArC), 108.7 (ArC), 42.9 (N-CH 2), 
35.6 (CH3). HRMS (EI) found m/z 257.0608 (M), C15H12C1N0 requires 257.0607. 
5.3.17.8 1-Benzyl-4-chloro-1,3-dihydro-indol-2-one 227g 
CI 
b~N~ 0 
Product was obtained as a colourless to pale yellow solid (80 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rf = 0.4), 
mp = 122-123.5 °C. IR (KBr): 1702 cm - '. 1 H NMR (250 MHz, CDC1 3): 8 7.15-7.25 
(m, 5H, ArH), 7.03 (t, J = 8.0 Hz, 1H, ArH), 6.90 (d, J = 8.0 Hz, 1H, ArH), 6.53 
(d, J = 8.0 Hz, 1H, ArH), 4.82 (s, 2H, benzyl CH 2), 3.54 (s, 2H, CH2). ' 3C NMR 
(63 MHz, CDC1 3): 8  173.4 (NC=O), 144.7 (ArC), 134.8 (ArC), 129.8 (ArC), 128.5 
(ArC), 128.2 (2 x  ArC), 127.1 (ArC), 126.7 (2 x  ArC), 122.4 (ArC), 121.9 (ArC), 
106.7 (ArC), 43.4 (N-CH2), 34.6 (CH2). HRMS (EI) found m/z 257.0607 (M), 
C 15H, 2C1NO requires 257.0607. 
5.3.17.9 1-Benzyl-6-chloro-1 ,3-dihydro-indol-2-one 227 
bn 
Product was obtained as a white colour solid (65 %) by silica gel chromatography 
using general procedure F (HexanelEtOAc = 8:2; R = 0.4). 'H NMR (250 MHz, 
CDC13): 8 7.19-7.28 (m, 5H, ArH), 7.09 (d, J= 8.0 Hz, 1H, ArH), 6.90 (d, J= 8.0 
Hz, 1H, ArH), 6.63 (s, 1H, ArH), 4.85 (s, 2H, benzyl CH 2), 3.52 (s, 2H, Cl2). 
HRMS (EI) found m/z 257.0607 (M), C 15H 12C1NO requires 257.0607. 
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5.3.17.10 1-Benzyl-4-fluoro-1,3-dihydro-indol-2-one 227h 
&N~=O  
Product was obtained as a colourless to light brown solid (96 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rf = 0.4), 
mp = 97-99 °C. IR (KBr): 1722 cm. 1 H NMR (250 MHz, CDC13): 5 7.10-7.21 
(m, 5H, ArH), 7.05 (m, 1H, ArH), 6.63 (t, J= 8.5 Hz, 1H, ArH), 6.45 (d, J= 8.0 Hz, 
1H, ArH), 4.82 (s, 2H, benzyl CH2), 3.56 (s, 2H, Cl2). ' 3C NMR (63 MHz, CDC13): 
ö 174.2 (NC=O), 160.3 (ArC), 156.4 (ArC), 146.2 (ArC), 135.4 (ArC), 129.5 (ArC), 
128.7 (ArC), 127.6 (ArC), 127.2 (ArC), 110.4 (ArC), 109.8 (ArC), 109.5 (ArC), 
105.0 (ArC), 44.0 (N-CH 2), 32.5 (CH2). HRMS (Ef) found m/z 241.0902 (M), 
C 15H 12FN0 requires 241.0903. 
5.3.17.11 1-Cyclopentyl-1, 3-dihydro-indol-2-one 227i 
a 
Product was obtained as a colourless to pale yellow solid (50 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rf = 0.25), 
mp = 56-57 °C. JR (KBr): 1716 cm - 1 . 1 H NMR (250 MHz, CDC13): 8 7.19 (t, J = 8.0 
Hz, 2H, ArH), 6.96 (t, J = 7.5 Hz, 1H, ArH), 6.85 (d, J = 8.0 Hz, 1H, ArH), 4.78 
(q, J = 9.0 Hz, 1H, CH), 3.44 (s, 2H, CH2), 1.98-2.10 (m, 2H, CH2), 1.70-1.85 
(m, 4H 2 x  Cl2), 1.65 (m, 2H, CH2). 13C NMR (63 MHz, CDC1 3): 5  174.9 (NC=O), 
143.3 (ArC), 128.2 (ArC), 127.3 (ArC), 124.8 (ArC), 121.6 (ArC), 109.7 (ArC), 
51.7 (CH), 35.8 (CH2), 27.1 (2 x  CH2), 25.0 (2 x  CH2). HRMS (E14 ) found m/z 








Product was obtained as a colourless to light brown solid (30 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rf = 0.25), 
mp = 53-54 °C. IR (neat): 1702 cm - '. 1 H NMR (250 MHz, CDC1 3): 6 7.17-7.25 
(m, 2H, ArH), 6.78-6.90 (m, 2H, ArH), 4.44 (t, J = 9.0 Hz, 1H, CH2CHCH2), 
3.41 (s, 2H, Cl2), 2.05-2.19 (m, 2H, CH2), 1.62-1.75 (m, 12H, 6 x  CH,). 13C NMIR 
(63 MHz, CDC1 3): 6 174.0 (NC=O), 143.4 (ArC), 127.2 (ArC), 124.9 (ArC), 124.3 
(ArC), 121.5 (ArC), 110.1 (ArC), 51.7 (CH), 35.9 (CH2), 31.1 (2 x  CH2), 26.0 (3 
CH2), 25.4 (2 x  CH2). HRMS (EI) found m/z 243.1623 (Mt), C 16H21 N0 requires 
243.1623. 
5.3.17.13 4-fluoro-1-(4-methyl-benzyl)-1 ,3-dihydro-indol-2-one 227k 
H3 
Product was obtained as a colourless to light brown solid (90 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rj = 0.4), 
mp = 104-106 °C. IR (KBr): 1714 cm* 'H NMR (250 MHz, CDC13): 6 7.05-7.20 
(m, 5H, ArH), 6.62 (t, J = 8.5 Hz, 1H, ArH), 6.45 (d, J = 8.0 Hz, 1H, ArH), 4.78 
(s, 2H, benzyl CH2), 3.54 (s, 2H, Cl 2), 2.23 (s, 3H, CH3). 13 C NMR (63 MHz, 
CDC1 3): 6 173.7 (NC=O), 159.8 (ArC), 155.8 (ArC), 145.7 (ArC), 136.8 (ArC), 
131.9 (ArC), 128.8 (ArC), 126.7 (ArC), 109.9 (ArC), 109.5 (ArC), 109.3 (ArC), 
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108.9 (ArC), 104.5 (ArC), 43.3 (N-CH 2), 32.0 (CH2), 20.5 (CH3). HRMS (EI) 
found m/z 255.1058 (Mt), C 1 6H, 4FNO requires 255.1059. 
5.3.17.14 4-choro-1-(4-chloro-benzyl)-1 ,3-dihydro-indol-2-one 2271 
Product was obtained as a colourless to pale yellow solid (54 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; R f = 0.4), 
mp = 123.5-125.5 °C. IR (KBr): 1722 cm - '. 'H NMR (250 MHz, CDC13): 
7.18-7.22 (m, 4H, ArH), 7.03 (t, J = 8.0 Hz, 1H, ArH), 6.92 (d, J = 8.0 Hz, 1H, 
ArH), 6.50 (d, J= 8.0 Hz, 1H, ArH), 4.79 (s, 2H, benzyl CH 2), 3.54 (s, 2H, CH2). 
13 C NIVIR (63 MHz, CDC1 3): 8  173.9 (NC=O), 144.9 (ArC), 133.9 (ArC), 133.5 
(ArC), 130.4 (2 x  ArC), 129.1 (2 x  ArC), 128.9 (ArC), 128.6 (ArC), 122.9 (ArC), 
122.6 (ArC), 107.0 (ArC), 43.3 (N-CH 2), 35.1 (CH2). HRMS (EI) found m/z 
291.0219 (M), C 14H9C12N0 requires 291.0218. 
5.3.17.15 1-Benzyl-5-trifluoromethyl-1 ,3-dihydro-indol-2-one 227m 
ICC'N\>=  
Bn 
Product was obtained as a colourless to pale yellow solid (93 %) by silica gel 
chromatography using general procedure F (Hexane/EtOAc = 8:2; Rf = 0.4), 
mp = 85-86 °C. IR (KBr): 1723 cm- 1.  'H NIMR (250 MHz, CDC13): 6 7.26-7.35 
(m, 2H, ArH), 7.11-7.28 (m, 5H, ArH), 6.58 (d, J = 8.0 Hz, 1H, ArH), 4.74 
(s, 2H, benzyl CH 2), 3.47 (s, 2H, Cl2). ' 3C NMR (63 MHz, CDC13): 6 174.7 
(NC=O), 147.1 (ArC), 135.1 (ArC), 128.8 (2 x  ArC), 127.8 (ArC), 127.2 (ArC), 
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125.5 (ArC), 124.8 (ArC), 124.3 (ArC), 122.0 (ArC), 121.3 (ArC), 108.6 (ArC), 
43.8 (N-CH2), 35.3 (CH). HRMS (El) found m/z 291.0871 (M), C16H12F3N0 
requires 291.0871. 
5.3.18 General procedure G for the synthesis of substituted oxindoles using 
anilines 
1.0 mmol of aniline was mixed with 1.0 mmol of acid. The mixture was then 
homogenised and subjected to microwave irradiation (300W power) for 30 min at 
150 °C with stirring. At the end of irradiation, the reaction mixture was cooled to 
room temperature and extracted with CHC1 3 . The extracts were washed successively 
with a solution of 2M HC1 (15 mL) and a solution of NaHCO 3 (15 mL). The organic 
layer was dried over MgSO 4 and concentrated under vacuum. The crude product was 
used for the next step without further purification. 
Pd(OAc)2 (3.0 mol %), X-Phos (6.0 mol %), the amide (1.0 mmol), and Cs 2CO3 
(1.5 mmol) were weighed in a microwave tube, equipped with a magnetic stirrer bar, 
and sealed with a silicon septum. Toluene (2 mL) was injected into the tube via a 
syringe and the reaction mixture was subjected to microwave irradiation 
(150W power) for 30 min at 100 °C. The reaction vessel was allowed to cool to room 
temperature and was diluted with EtOAc (15 mL). The mixture was filtered through 
a plug of Celite and concentrated on a rotary evaporator. The crude material thus 
obtained was purified by silica gel chromatography to give the product oxindole. 
5.3.18.1 1-Phenyl-1 ,3-dihydro-indol-2-one 227n 
O~N~O 
Product was obtained as a white colour solid (82 %) by silica gel chromatography 
using general procedure G (Hexane/EtOAc = 8:2; R = 0.3), mp = 123-124.5 °C 
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(lit. 340 119-121 °C). IR (KBr): 1712 cm - '. 'H NMR (250 MHz, CDC13): 8 7.65-7.78 
(m, 7H, ArH), 7.32 (t, J = 7.5 Hz, 1H, ArH), 7.03 (d, J = 8.0 Hz, 1H, ArH), 3.97 
(s, 2H, Cl2). ' 3C NMR (63 MHz, CDC13): 6  174.3 (NC=O), 145.1 (ArC), 134.4 
(ArC), 129.5 (2 x  ArC), 128.0 (ArC), 127.6 (ArC), 126.5 (2 x  ArC), 124.5 (ArC), 
124.2 (ArC), 122.7 (ArC), 109.3 (ArC), 36.0 (CH2). HRMS (El 4 ) found m/z 
209.0839 (M), C14H11N0 requires 209.0841. 
5.3.18.2 1-(3-Chloro-phenyl)-1,3-dihydro-indol-2-one 227o 
O~N~ 0 
6,Cl 
Product was obtained as a colourless to light brown solid (80 %) by silica gel 
chromatography using general procedure G (Hexane/EtOAc = 8:2; R = 0.35), 
mp = 112-113 °C. IR (KBr): 1712 cm - . 1 H NMR (250 MHz, CDCI3): ö 7.09-7.20 
(m, 6H, ArH), 6.73 (d, J= 8.0 Hz, 1H, ArH), 3.64 (s, 2H, CH2). ' 3 C NMR (63 MHz, 
CDC13): 8  173.6 (NCO), 143.9 (ArC), 134.5 (ArC), 130.0 (ArC), 127.7 (ArC), 
127.3 (ArC), 126.2 (2 x  ArC), 124.2 (ArC), 123.6 (ArC), 122.5 (ArC), 108.7 
(2 x  ArC), 35.4 (CH 2). HRMS (E1) found m/z 243.0442 (M4), C 14H 1 0C1N0 requires 
243.0451. 
5.3.18.3 1-(3,5-Bis-trifluoromethyl-phenyl)-1 ,3-dihydro-indol-2-one 227p 
F3C-C F3 
Product was obtained as a colourless to light brown solid (72 %) by silica gel 
chromatography using general procedure G (Hexane/EtOAc = 8:2; R = 0.3), 
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mp = 99-101 °C. IR (KBr): 1724 cm - 1 . 'H NMR (250 MHz, CDC13): 8 7.85 
(d, J= 12.0 Hz, 3H, ArH), 7.17-7.26 (m, 3H, ArH), 6.75 (d, J= 8.0 Hz, 1H, ArH), 
3.69 (s, 2H, CH 2). 13 C NMR (63 MHz, CDC1 3 ): 8  173.9 (NC=O), 143.3 (ArC), 136.1 
(ArC), 133.3 (ArC), 132.8 (ArC), 128.1 (2 x  ArC), 126.5 (ArC), 125.1 (ArC), 124.0 
(ArC), 123.7 (ArC), 121.4 (ArC), 108.8 (ArC), 35.8 (CH2). HRMS (El) found m/z 
345.0588 (M), C 16H9F6N0 requires 345.0588. 




Product was obtained as a colourless to pale yellow solid (80 %) by silica gel 
chromatography using general procedure G (Hexane/EtOAc = 8:2; R = 0.35), 
mp = 103-105 °C. IR (neat): 1716 cm - 1 . 'H NMR (250 MHz, CDC13): 5 7.09-7.20 
(m, 6H, ArH), 6.36 (d, J= 7.5 Hz, 1H, ArH), 3.65 (s, 2H, CH 2), 2.27 (s, 3H, CH 3), 
1.98 (s, 3H, CH3). ' 3 C NIMR (63 MHz, CDC13): 6  174.4 (NCO), 145.6 (ArC), 138.7 
(ArC), 134.8 (ArC), 133.1 (ArC), 130.4 (ArC), 128.7 (ArC), 127.7 (ArC), 126.5 
(ArC), 125.5 (ArC), 124.4 (ArC), 122.4 (ArC), 109.3 (ArC), 35.8 (CH 2), 20.3 










Product was obtained as a colourless to light brown solid (45 %) by silica gel 
chromatography using general procedure G (Hexane/EtOAc = 8:2; R = 0.4), 
mp = 148-149.5 °C. JR (KBr): 1716 cm. 'H NMR (250 MHz, CDC13): 6 7.20-7.30 
(m, 4H, ArH), 7.09 (t, J = 8.0 Hz, 1H, ArH), 7.01 (d, J = 8.0 Hz, 1H, ArH), 6.63 
(d, J= 8.0 Hz, 111, Am), 3.63 (s, 2H, CH 2). ' 3 C NMR (63 MHz, CDC13): 6 173.0 
(NC=O), 145.4 (ArC), 135.2 (ArC), 135.1 (ArC), 130.7 (ArC), 130.6 (ArC), 129.1 
(ArC), 128.4 (ArC), 126.7 (ArC), 124.6 (ArC), 123.1 (ArC), 122.7 (ArC), 107.5 
(ArC), 35.3 (CH). HRMS (EI[F)  found m/z 277.0060 (M), C 14H902N0 requires 
277.0061. 
5.3.18.6 1-(2,3-Dimethyl-phenyl)-4-fluoro-1 ,3-dihydro-indol-2-one 227s 
&N)==o  
(~(CH, 
Product was obtained as a colourless to light brown solid (82 %) by silica gel 
chromatography using general procedure G (Hexane/EtOAc = 8:2; Rj = 0.35), 
mp = 119-120 °C. JR (KBr): 1722 cm - '. 1 H NMR (250 MHz, CDC13): 6 7.03-7.20 
(m, 4H, ArH), 6.69 (t, J = 8.5 Hz, 1H, ArH), 6.17 (d, J = 8.0 Hz, 1H, ArH), 3.67 
(s, 2H, Cl2), 2.27 (s, 3H, Cl3), 1.97 (s, 3H, CH3). 13 C NMR (63 MHz, CDC13): 6 
173.6 (NC=O), 160.4 (ArC), 156.5 (ArC), 147.5 (ArC), 138.8 (ArC), 132.8 (ArC), 
130.6 (ArC), 129.5 (ArC), 126.6 (ArC), 125.5 (ArC), 110.4 (ArC), 109.6 (ArC), 
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105.5 (ArC), 32.6 (CH2), 20.3 (CH3), 14.2 (CH3). HRMS (Ef4 ) found m/z 255.1058 
(M), C 16H14FN0 requires 255.1059. 





4-choro-1 -(4-chloro-benzyl)-1 ,3-dihydro-indol-2-one (0.09 	g, 0.31 	mmol), 
3-fluoroaniline (0.62 mmol), Pd(OAc) 2 (2.0 mol %), X-Phos (4.0 mol %), and 
Cs2CO3 (1.5 mmol) were weighed in a microwave tube, equipped with a magnetic 
stirrer bar, and sealed with a silicon septum. Toluene (1 mL) was injected into the 
tube via a syringe and the reaction mixture was subjected to microwave irradiation 
for 10 min at 120 °C. The reaction vessel was allowed to cool to room temperature 
and was diluted with EtOAc (5 mL). The mixture was filtered through a plug of 
Celite and concentrated on a rotary evaporator. The crude material thus obtained was 
purified by silica gel chromatography to give the title product as a colourless to 
brown oil (65 %) by silica gel chromatography (Hexane/EtOAc = 6:4; R= 0.3). IR 
(KBr): 3428, 3352, 1699 cm - '. 1 H NIMR (250 MHz, CDC1 3): 8 7.13-7.25 (m, 7H, 
ArH), 6.96 (d, J= 8.30 Hz, 2H, Aril), 6.67 (m, 4H, Aril), 6.42 (d, J= 7.27 Hz, 2H, 
ArH), 5.48 (bs, 2H, 2 x  NH), 4.78 (s, 2H, benzyl CH2), 3.36 (s, 2H, CH2). 
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5.3.19.1 1-(2-Amino-ethyl)-3-benzyl-thiourea 254a 
S 
NAN NH2 
To a solution of ethylenediamine (0.15 g, 2.5 mmol) in dichioromethane (5 mL) was 
added benzylisothiocyanate (0.38 g, 2.5 mmol) drop wise at room temperature and 
stirring was continued at this temperature for a further 20 h. Then the precipitate was 
filtered, and dried to afford the title product as a white colour solid (0.2 g, 37 % 
yield). R= 0.5 (CHC1 3/MeOH = 9.5:0.5); 'H NMR (250 MHz, DMSO-d6): 6 7.82 
(bs, 1H, NIH), 7.45 (bs, 1H, Nil), 7.02-7.17 (m, 5H, ArH), 4.47 (s, 2H, benzyl-CH 2), 
3.62 (s, 2H, CH2), 3.24 (s, 2H, CH2). MS ES (+ve) found m/z 210 (MH, 15 %), 192 
(100), 91(30). 





To a solution of ethylenediamine (0.08 g, 1.36 mmol) in dichloromethane (3 mL) 
was added 2-chlorobenzylisothiocyanate (0.25 g, 1.36 mmol) drop wise at room 
temperature and stirring was continued at this temperature for a further 20 h. Then 
the precipitate was filtered, dried to afford the title product as a white colour solid. 
Rf= 0.5 (CHC1 3/MeOH = 9.5:0.5); 'H NIMR (250 MHz, DMSO-d6): 6 8.14 (bs, 1H, 
NH), 7.95 (bs, 1H, NH), 7.55-7.62 (m, 1H, ArH), 7.41-7.53 (m, 3H, ArH), 4.88 
(s, 2H, benzyl-CH 2), 3.74 (s, 2H, CH2). MS ES (+ve) found m/z 243 (MH, 100 %). 
197 
Chapter 5 	 Experimental 






H 3C  
To a solution of ethylenediamine (0.09 g, 1.53 mmol) in dichioromethane (3 mL) 
was added 2-chlorobenzylisothiocyanate (0.25 g, 1.53 mmol) drop wise at room 
temperature and stirring was continued at this temperature for a further 20 h. Then 
the precipitate was filtered, dried to afford the title product as a white colour solid. 
Rj = 0.5 (CHC13/MeOH = 9.5:0.5); 'H NMR (250 MHz, DMSO-d6): 6 8.19 (bs, 1H, 
NIH), 7.84 (bs, 1H, NH), 7.34-7.43 (m, 4H, ArH), 4.82 (s, 2H, benzyl-CH 2), 3.76 
(s, 2H, CH2), 2.51 (s, 3H, CH3). MS ES (+ve) found m/z 223 (MH, 80 %), 206 
(100). 
5.3.20 General procedure H for the synthesis of amides 
1.0 equivalent of amine were mixed with 1.0 equivalent of carboxylic acid in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum. The mixture was then homogenized and subjected to microwave irradiation 
(300W power) for 30 min at 150 °C with stirring. At the end of irradiation, the 
reaction mixture was cooled to room temperature and suspended in CHC1 3 . The 
extracts were washed with a saturated solution of NaHCO 3 . The organic layer was 
dried over MgSO4 and concentrated in vacuo. The crude product was purified by 
simple washing with pentane and used for next step without further purification. 
IN 
Chapter 5 	 Experimental 
5.3.20.1 N-(2-Amino-ethyl)-2-phenyl-acetamide 261a 
NH2 
N-(2-Amino-ethyl)-2-phenyl-acetamide was prepared using the general procedure H. 
Phenylacetic acid (0.5 g, 3.7 mmol) and ethylenediamine (0.22 g, 3.7 mmol) yielded 
0.3 g (45 % yield) of the title product as a white solid. R = 0.5 (CHC13/MeOH = 
9:1); 'H NMR (250 MHz, DMSO-d6): 5 7.96 (bs, 1H, NH), 7.19-7.27 (m, 5H, ArH), 
3.34 (s, 2H, Cl2), 2.96 (t, J = 6.5 Hz, 2H, CH2), 2.49 (t, J = 6.5 Hz, 2H, CH2). 
MS ES (+ve) found m/z 179 (MH, 100 %), 161 (90). 
5.3.20.2 N-(2-Amino-ethyl)-4-phenyl-butyramide 261b 
H 
Cr~o N ...-.... NH2 
N-(2-Amino-ethyl)-4-phenyl-butyramide was prepared using the general procedure 
H. 4-phenylbutanoic acid (0.75 g, 4.6 mmol) and ethylenediamine (0.27 g, 4.6 mmol) 
yielded 0.75 g (79 % yield) of the title product as a white colour solid. R = 0.5 
(CHC1 3/MeOH = 9:1); 'H NIMR (250 MHz, DMSO-d6): 5 8.05 (bs, 1H, NH), 
7.35-7.50 (m, 5H, ArH), 3.30-3.35 (m, 2H, CH 2), 2.89-2.96 (m, 4H, 2 x  CH2), 
2.18-2.20 (m, 2H, CH 2), 1.95-2.00 (m, 2H, CH2). MS ES (+ve) found m/z 207 
(MH, 100 %), 188 (100). 
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	 ...-.,.rTh{ 	NH2 
HO'- 	
t!:; 
N-(2-Amino-ethyl)-2-(4-hydroxy-phenyl)-acetamide was prepared using the general 
procedure H. 4-hydroxyphenylacetic acid (0.5 g, 3.3 mmol) and ethylenediamine 
(0.2 g, 3.3 mmol) yielded 0.35 g (54 %) of the title product as a white colour solid. 
Rf = 0.5 (CHC13/MeOH = 8.5:1.5); 'H NMR (250 MHz, DMSO-d6): 8 9.44 
(s, 1H, OH), 8.14 (bs, 1H, NH), 7.22 (d, J= 8.0 Hz, 2H, ArH), 6.87 (d, J= 8.0 Hz, 
2H, ArH), 3.58 (s, 2H, Cl2), 3.45 (s, 2H, Cl2), 3.28 (t, J = 2.5 Hz, 2H, Cl2). 
MS ES (+ve) found m/z 195 (MH, 100 %), 177 (95). 
5.3.20.4 N-(2-Amino-ethyl)-2-(2-hydroxy-phenyl)-acetamide 261d 
OH 
H 
6---Y  O N "'~NH  
N-(2-Amino-ethyl)-2-(2-hydroxy-phenyl)-acetamide was prepared using the general 
procedure H. 2 -hydroxyphenyl acetic acid (0.5 g, 3.3 mmol) and ethylenediamine 
(0.2 g, 3.3 mmol) yielded 0.3 g (47 %) of the title product as a white colour solid. 
Rj = 0.5 (CHC1 3/MeOH = 8.5:1.5); 'H NMR (250 MHz, DMSO-d 6): 6 8.07 
(bs, 1H, NH), 7.10-7.22 (m, 2H, ArH), 6.89-6.95 (m, 2H, ArH), 3.75-3.79 
(m, 2H, Cl 2), 3.10-3.25 (m, 2H, CH2), 2.82-2.85 (m, 2H, Cl 2). MS ES (+ve) found 
m/z 194 (MH, 90 %), 177 (100). 
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5.3.20.5 N-(2-Amino-ethyl)-2-(4-chloro-phenyl)-acetamide 261e 
H 
N -NH2 
N-(2-Amino-ethyl)-2-(4-chloro-phenyl)-acetamide was prepared using the general 
procedure H. 4-chiorophenylacetic acid (0.75 g, 4.4 mmol) and ethylenediamine 
(0.26 g, 4.4 mmol) yielded 0.7 g (75 %) of the title product as a white colour solid. 
Rf = 0.5 (CHCI 3/MeOH = 9:1); 1 H NMR (250 MHz, DMSO-d6): 8 8.28 
(bs, 1H, NH), 7.32-7.40 (m, 4H, ArH), 3.60-3.75 (m, 2H, CH2), 3.42-3.50 
(m, 2H, CH2), 2.80-2.89 (m, 2H, CH2). MS ES (+ve) found m/z 213 
(MH, CI-35, 60%) and 215 (MH, CI-37,20 %), 195 (100), 74 (75). 




N-(2-Amino-ethyl)-2-(4-methoxy-phenyl)-acetamide was prepared using the general 
procedure H. 4-methoxyphenylacetic acid (1.0 g, 6.0 mmol) and ethylenediamine 
(0.36 g, 6.0 mmol) yielded 0.42 g (33 %) of the title product as a white colour solid. 
Rf = 0.5 (CHC13/MeOH = 9:1); 1 H NIMR (250 MHz, DMSO-d6): 6 8.24 (bs, 1H, 
NH), 7.08 (d, J = 6.5 Hz, 2H, ArH), 7.38 (d, J = 6.5 Hz, 2H, ArH), 3.95 
(s, 3H, OCH3), 3.55 (t, J = 3.5 Hz, 2H, Cl2), 3.31 (t, J = 4.0 Hz, 2H, CH 2). 
MS ES (+ve) found m/z 208 (MH, 75 %),190 (100). 
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5.3.20.7 N-(2-Amino-ethyl)-2-(4-amino-phenyl)-acetamide 261g 
H 
N 
- N H2 
H2N 
N-(2-Amino-ethyl)-2-(4-aminno-phenyl)-acetamide was prepared using the general 
procedure H. 4-aminophenylacetic acid (0.75 g, 4.9 mmol) and ethylenediamine 
(0.3 g, 4.9 mmol) yielded 0.15 g (15 %) of the title product as a white colour solid. 
R= 0.5 (CHC13/MeOH = 8:2); 'H NMR (250 MHz, DMSO-d6): 8 7.95 (s, 1H, NH), 
7.06 (d, J= 6.5 Hz, 2H, ArH), 6.50 (d, J= 6.5 Hz, 2H, ArH), 5.00 (s, 2H, NTI 2), 3.44 
(s, 2H, CH2), 3.26 (s, 2H, CH2), 3.15 (t, J = 3.0 Hz, 2H, CH2). 
MS ES (+ve) found m/z 193 (MH, 55 %), 175 (30). 
5.3.21 Synthesis of his (aralkyl) thioureas 





To a solution of N-(2-aminoethyl)-2-phenyl-acetamide (0.1 g, 0.56 mmol) in 
dichloromethane (2 mL) was added benzylisothiocyanate (0.08 g, 0.56 mmol) drop 
wise at room temperature and stirring was continued at this temperature for further 
20 h. Then the solvent was evaporated to dryness and crude product was purified by 
column chromatography to afford the title product as a pale brown solid 
(0.05 g, 27 % yield). Rj = 0.5 (CHC1 3/MeOH = 9.5:0.5); 'H NMR 
(250 MHz, CDC1 3): 6 7.60 (bs, 2H, 2 x  NH), 7.12-7.32 (m, 1OH, ArH), 4.46 
(bs, 2H, benzyl-CH 2), 3.41 (t, J= 5.5 Hz, 2H, CH2), 3.30 (q, J= 5.5 Hz, 2H, CH2), 
3.20 (t, J= 3.0 Hz, 2H, Cl 2). MS ES (+ve) found m/z 328 (MH, 60 %), 319 (100), 
297 (95), 179 (70). 
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5.3.21.2 N- [2-(3-Benzyl-thioureido)-ethyl]-2-(4-hydroxy-phenyl)-acetamide 243 
S 
HOO Q 
A mixture of N-(2-aminoethyl)-2-(4-hydroxyphenyl)-acetamide (0.17 g, 0.90 mmol), 
benzylisothiocyanate (0.14 g, 0.90 mmol) and dichioromethane (2 mL) in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a pale brown solid 
(0.07 g, 24 % yield). R = 0.5 (CHC1 3/MeOH = 9.5:0.5); 1 H NIMR (250 MHz, 
DMSO-d6): ö 9.09 (s, 1H, OH), 7.90 (t, J= 5.0 Hz, 1H, NH), 7.83 (bs, 1H, NH), 
7.38 (bs, 1H, NH), 7.06-7.21 (m, 5H, ArH), 6.89 (d, J = 8.0 Hz, 2H, ArH), 6.52 
(d, J = 8.0 Hz, 2H, ArH), 4.48 (bs, 2H, benzyl-CH 2), 3.39 (bs, 2H, Cl 2), 3.24 
(bs, 2H, CH2), 3.05 (q, J = 5.5 Hz, 2H, CH2). MS ES (+ve) found m/z 344 
(MH, 100 %), 236 (35), 195 (20). 
5.3.21.3 N- [2-(3-Benzyl-thioureido)-ethylj -2-(3,4-dihydroxy-phenyl)-acetamide 
256b 
S 
HO N 	 NANI 
HOI 	
H H 
A mixture of N-(2-aminoethyl)-2-(3,4-dihydroxyphenyl)-acetamide (0.175 g, 0.77 
mmol), benzylisothiocyanate (0.115 g, 0.77 mmol) and dichloromethane (2 mL) in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
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with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a white solid 
(0.08 g, 28 % yield). Rf = 0.5 (CHC13IMeOH = 9.5:0.5); 'H NMR (250 MHz, 
DMSO-d6): 6 8.03 (bs, 1H, NT!), 7.80 (bs, 1H, NH), 7.33-7.53 (m, 8H, ArH), 4.82 
(bs, 2H, benzyl-CH 2), 3.71 (bs, 2H, CH2), 3.55-3.65 (m, 4H, 2 x  CH2). MS ES (+ve) 
found m/z 359 (MH, 45 %), 324 (20), 251 (30). 
5.3.21.4 N-[2-(3-Benzyl-thioureido)-ethylj-2-(2-hydroxy-phenyl)-acetamide 
256c 
OH 	 S 
6"-- N( N  0 	H H 
A mixture of N-(2-aminoethyl)-2-(2-hydroxyphenyl)-acetamide (0.25 g, 1.3 mmol), 
benzylisothiocyanate (0.19 g, 1.3 mmol) and dichloromethane (2 mL) in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a colourless solid 
(0.16 g, 36 % yield). Rf = 0.7 (CHC13/MeOH = 9.5:0.5); 'H NIMR (250 MHz, 
DMSO-d6): 6 9.80 (s, 1H, OH), 8.24 (bs, 1H, NH), 7.78 (bs, 1H, NH), 7.70 (bs, 1H, 
NH), 7.38-7.47 (m, 5H, ArH), 7.19 (t, J = 7.0 Hz, 2H, ArH), 6.84-6.94 (m, 2H, 
ArH), 4.48 (bs, 2H, benzyl-CH 2), 3.60 (bs, 2H, CH 2), 3.34 (q, J= 6.0 Hz, 2H, Cl2), 






5.3.21.5 N-[2-(3-Benzyl-thioureido)-ethylj-2-(4-chloro-phenyl)-acetamide 256d 
S 
A mixture of N-(2-aminoethyl)-2-(4-chlorophenyl)-acetamide (0.25 g, 1.2 mmol), 
benzylisothiocyanate (0.175 g, 1.2 mmol) and dichloromethane (2 mL) in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a white colour solid 
(0.25 g, 58 % yield). Rj = 0.4 (CHC13/MeOH = 9.5:0.5); 'H NIMR (250 MHz, 
DMSO-do): 5 8.19 (t, J= 5.5 Hz, 1H, NH), 8.10 (bs, 1H, NH), 7.53 (bs, 1H, NH), 
7.21-7.39 (m, 9H, ArH), 4.64 (bs, 2H, benzyl-CH 2), 3.40 (d, J= 5.5 Hz, 2H, CH2), 
3.21 (q, J= 6.0 Hz, 2H, CH2), 3.10 (t, J= 3.0 Hz, 2H, CH2). MS ES (+ve) found m/z 
361 (MH, CI-35, 80 %) and 363 (MH, CI-37, 20 %), 212 (75), 195 (50). 




A mixture of N-(2-aminoethyl)-4-phenyl-butyramide (0.25 g, 1.2 mmol), 
benzylisothiocyanate (0.18 g, 1.2 mmol) and dichloromethane (3 mL) in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a white colour solid 
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(0.32 g, 74 % yield). Rj = 0.5 (CHC13/1*vleOH = 9.5:0.5); 1 H NMR (250 MHz, 
DMSO-d6): 8 7.92 (bs, 1H, NH), 7.45 (bs, 1H, NH), 7.30 (bs, 1H, NH), 7.10-7.28 
(m, 1OH, ArH), 4.58 (bs, 2H, benzyl-CH 2), 3.13 (q, J = 6.0 Hz, 2H, CH2), 3.02 
(t, J= 3.0 Hz, 2H, Cl2), 2.44-2.52 (m, 2H, CH 2), 2.00-2.05 (m, 2H, CH2), 1.68-1.75 
(m, 2H, CH2). MS ES (+ve) found 356 (MH, 50 %), 354 (100), 207 (45). 





A mixture of N-(2-aminoethyl)-2-(4-methoxyphenyl)-acetamide (0.21 g, 1.0 mmol), 
benzylisothiocyanate (0.15 g, 1.0 mmol) and dichioromethane (2 mL) in a 
microwave tube, equipped with a magnetic stirrer bar, and sealed with a silicon 
septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a colourless solid 
(0.1 g, 27 % yield). R = 0.5 (CHC13/MeOH = 9.5:0.5); 'H NIMR (250 MHz, 
DMSO-d6): 8 8.29 (bs, 1H, NH), 8.319 (bs, 1H, NH), 7.43-7.52 (m, 5H, ArH), 7.37 
(d, J= 6.5 Hz, 2H, ArH), 7.04 (d, J= 6.5 Hz, 2H, ArH), 4.83 (bs, 2H, benzyl-CH2), 
3.91 (s, 3H, OCH3), 3.51 (t, J= 5.0 Hz, 4H, 2 x  CH2), 3.27 (t, J= 3.0 Hz, 2H, CH2). 
MS ES (+ve) found m/z 357 (MH, 40 %), 208 (45), 191 (30). 
206 
Chapter 5 	 Experimental 
5.3.21.8 N- [2-(3-Benzyl-thioureido)-ethylj -2- (3-chloro-4-hydroxy-phenyl)-
acetamide 256g 
S H 
CI 	 NNN 
H 
A 	mixture 	of 	N-(2-aminoethyl)-2-(3-chloro-4-hydroxyphenyl)-acetamide 
(0.25 g, 1.1 mmol), benzylisothiocyanate (0.16 g, 1.1 mmol) and dichioromethane 
(3 mL) in a microwave tube, equipped with a magnetic stirrer bar, and sealed with a 
silicon septum was subjected to microwave irradiation (100W power) for 30 min at 
75 °C with stirring. At the end of irradiation, the reaction mixture was cooled to 
room temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a white colour solid 
(0.05 g, 12 % yield). R = 0.5 (CHC13/MeOH = 9.5:0.5); 1 H NMR (250 MHz, 
DMSO-d6): 8 10.21 (s, 1H, OH), 8.31 (bs, 1H, NH), 8.18 (bs, 1H, NH), 7.75 (bs, 1H, 
NH), 7.42-7.57 (m, 6H, ArH), 7.23 (d, J= 8.0 Hz, 1H, ArH), 7.10 (d, J= 8.0 Hz, 
1H, ArH), 4.84 (bs, 2H, benzyl-CH 2), 3.19-3.90 (m, 6H, 3 x  CH2). MS ES (+ve) 





N A NIZ'I 
H  HDCr~)O 
A mixture of N-(2-aminoethyl)-2-(3 -chloro-4-hydroxyphenyl)-acetamide (0.25 g, 
1.1 mmol), phenylisothiocyanate (0.15 g, 1.1 mmol) and dichloromethane (3 mL) in 





septum was subjected to microwave irradiation (100W power) for 30 min at 75 °C 
with stirring. At the end of irradiation, the reaction mixture was cooled to room 
temperature and the solvent was evaporated to dryness. The crude product was 
purified by column chromatography to afford the title product as a white colour solid 
(0.07 g, 17 % yield). Rf = 0.5 (CHC13/MeOH = 9.5:0.5); 'H NIMR (250 MHz, 
DMSO-d6): ö 9.66 (bs, 1H, NH), 7.90 (bs, 1H, NH), 7.34-7.45 (m, 5H, ArH), 
7.23-7.20 (m, 3H, ArH), 3.75 (bs, 2H, CH2), 3.40-3.55 (m, 4H, 2 x  CH2). 
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OH  
R1—C
+ HN–R 1) MW, 150°C, 30 min 	- ciic 
2) Pd(OAc)2 I Jigarid 
R = alkyl, aryt 	
base, H 20/toluene or toluene 	 R 
X Br, CI 
MW,100°C.30min 
A general method has been developed for the synthesis of N-substituted oxindoles. The two-step process involves initial microwave-assisted 
amide bond formation between 2-halo-arylacetic acids and various alkylamines and anilines, followed by a palladium-catalyzed intramolecular 
amidation under aqueous conditions. In the case of alkylamines, the procedure can be carried out as a one-pot process without isolation of 
the intermediate amide. 
The indole template is generally recognized as a privileged 
structure in medicinal chemistry, and in particular, oxindoles 
are important constituents of natural indole alkaloids as well 
as drugs in development and also in the clinic.' In this 
context, it is important to continue to develop efficient 
methods for the synthesis of this class of compounds, 
especially routes based upon readily available starting 
materials. Although a number of transition-metal-catalyzed 2 
and radical-mediated 3 reactions have been reported for the 
synthesis of oxindoles, there remains a need for new methods. 
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A conceptually different approach to the construction of 
heterocycles, including oxindoles, has arisen from the work 
of Buchwald, Hartwig, and others and is based upon 
palladium-catalyzed intramolecular amination/amidation! 
Heck reaction of appropriately substituted arenes, via C—N-
C—C bond formation. 4 A recent report describes the use of 
nickel rather than palladium. 5 
In parallel with these developments in the metal-mediated 
construction of C—C and C—N bonds, there has been a 
general recognition that microwave heating can accelerate a 
broad range of reactions in organic synthesis, especially in 
the field of metal-catalyzed cross-coupling reactions.' Mi- 
(a) Hennessy, E. J.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125, 
12084. (b) Culkin, D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36,234. (c) 
Zhang, T. Y.; Zhang, H. Tetrahedron Left. 2002, 43, 193. (d) Lee, S.; 
Hartwig, J. F. J. Org. Chem. 2001, 66, 3402. (e) Ashimori. A.; Bachand, 
B.; Overman, L. E.; Poon, D. J. I Am. Chem. Soc. 1998, 120, 6477. (1) 
Ashimori, A.; Bachand, B.; Calter, M. A.; Govek, S. P.; Overman, L. E.; 
Poon, D. J. I. Am. Chem.. Soc. 1998, 120, 6488. (g) Shaughnessy, K. H.; 
Hamann, B. C.; Hartwig, J. F. I. Org. Chem. 1998, 63, 6546. 
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Org. Let!., 2003, 5, 2311. 
crowave heating can dramatically reduce reaction times, 
increase product purity and yields, and allow precise control 
of reaction parameters, all of which are crucial factors to 
consider when developing reaction protocols for both routine 
synthetic transformations and parallel synthesis. Herein, we 
present an efficient approach to substituted oxindoles using 
microwave-assisted amide bond formation followed by 
palladium-catalyzed intramolecular amidation reaction as 
shown in Scheme I. 
Scheme 1. Synthesis of Substituted Oxindoles 
OH 
R1("i1" 	+ 
1) MW, 150°C,3Omin 
R 1 _ 	 0 H2N-R 	2)Pd(OAc)2/Ligand 
2 	Base, H20itoluene 
I or toluene 3 
R = alkyl, aryl MW, 1O0°. 30 mm X = Br, Cl 
Our approach was inspired by previous studies by Buch-
wald et al., who reported the palladium-catalyzed intra-
molecular amination and amidation of aryl bromides for the 
synthesis of five-, six-, and seven-membered rings.' They 
described the synthesis of N-substituted oxindoles, from the 
corresponding 2-bromo- N -substituted phenylacetamides, us-
ing palladium acetate and various phosphine ligands in high 
yields and with reaction times of 24-36 h. We envisaged 
an alternative approach involving initial generation of the 
amide by microwave-assisted coupling of a 2-haloarylacetic 
acid 1 with an amine 2, followed by palladium-catalyzed 
intramolecular amidation to yield 3. Since the initial amide-
forming reaction generates a molar equivalent of water, it 
was essential to identify conditions in the second step that 
were tolerant of water. 
Heating a mixture of 2-bromophenylacetic acid 4 and 
benzylamine Sunder solvent-free MW conditions led to rapid 
(ca. 30 mm) formation of the corresponding amide in good 
to excellent yield.' To identify optimal conditions for the 
palladium-catalyzed intramolecular amidation reaction to give 
6, we screened a range of different phosphine ligands 7-11 
(Figure 1) for activity using various combinations of pal-
ladium source/solvent/base (Table 1). In general, the best 
results were obtained using either ligand 10 or II (6 mol 
%) in the presence sodium hydroxide or cesium carbonate 
(2.0 equiv). 
These optimized conditions were then applied to the 
synthesis of a range of substituted oxindoles as shown in 
Table 2. In the case of the alkylamines, the palladium-
catalyzed intramolecular amidation step was carried out 
without prior isolation of the intermediate amide. The 
reaction mixture was simply purged with nitrogen gas prior 
(a) Kappe, C. 0. Angrrw. Chem., In!. Ed. 2004, 43, 6250 and 
references therein. (b) Mavandadi, F.: Lidstrom, P. Curr. Top. Med Chem. 
2004, 4, 773. (c) Larhed, M.. Moberg, C.; Hallberg, A. Acc. Chem. Res. 
2002, 35. 717. (d) Wathey, B.; Tierney, J.; Lidstrom, P.: Westman, J. Drug 
Discovery Today 2002, 7, 373. 
(a) Yang. B. H.. Buchwald, S. L. Org. Let!. 1999, 1. 35. (b) Wolfe, 
J. P.; Rennels, R. A.. Buchwald, S. L. Tetrahedron 1996, 52, 7525. 
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10 	 11 
i-Pr 
Figure 1. Ligands screened for intramolecular amidation. 
to introduction of the reagents for the second step. For 
anilines it was necessary to work-up the reaction by 
extraction into chloroform, followed by an aqueous wash 
and evaporation of the organic layer to give a crude product 
that was used directly for the next step. 
The intramolecular amidation reactions were generally 
complete within 30 mm, and with only a few exceptions 
(entries 14, 15, 19, and 22) the yields for the two steps were 
excellent, typically greater than 80%. Scheme 2 shows the 
potential further application of the derived oxindoles in which 
the product 12 from entry 22 was subjected to a microwave-
assisted palladium-catalyzed bis-amination reaction with 
3-fluoroaniline to give the new N-substituted oxindole 13 
in 65% yield. 
A number of features of the procedure described above 
deserve comment: (i) the intramolecular amidation reaction 
proceeds well under partially aqueous conditions, in the case 
of alkylamines, and is subject to substantial acceleration in 
rate when conducted with microwave heating; (ii) good yields 
were obtained without the use of phase-transfer reagents, 
which have been used previously for intramolecular amina- 
Table 1. Optimization of Reaction Conditionsa 
OH 142N-. 1) Mw. 150°c, 30 mm 
Br 	 2) Pd/ Ugand, Base. solvent " 	N 
- 	 Bn 
entry conditions yield5 (%) 
1 Pd(PPh3 )4 , NaOt-Bu, toluene nd 
2 Pd(PPh3)4, K2CO3, dioxane 10 
3 POPd,' K2CO3, toluene 15 
4 Pd(OA02 , 7, NaOt-Bu, toluene nd 
5 Pd(OA02, 8, Cs2CO3, toluene 58 
6 Pd(dba)3, 8, K2CO3, tolune 55 
7 Pd(OA02, 9, H20/toluene 60 
8 Pd(OAc)s, 10, Cs2CO3, toluene 78 
9 Pd(dba)s, 10, Cs2CO3, toluene 65 
10 Pd(OAc)2 , 10, NaOH, H201t0luene 82 
11 Pd(OA02, 10, NaOH, H20IDME nd 
12 Pd(OAc)2, 11, Cs2CO3, toluene 92 
13 Pdz(dba)a, 11, Cs2CO3, toluene 89 
14 Pd(OAe)a, 11, NaOH, H20/toluene 95 
Reaction was conducted with 3 mol % catalyst, 6 mol % ligand, 1.0 
equiv of 2-bromophenyl acetic acid, and 2.0 equiv of base for 30 mm at 
100 °C on a 1.0 mmol scale of acid. I Isolated yields, c POPd: PdCl2[(t-
Bu)7P(0H)1. purchased from Combiphos Catalysts, Inc. 
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1) MW, 300W, 150° 	
R'— 
N 
2) Pd(OAch I Ligand R Base, H 20IToIuene or Toluene 
	
RalkyI, aryl 	MW. 75W, 100°C, 30 mm 
X Br, Ci 
I 
entry 	acid 	am 	
yield
ine product 	 entry 	acid 	amine 	product 	
yield 
(9f) 
CI 	 I 	 - 
2.6- 	p-chloro- 	 54 2,6- 	 , 	 80 	22 Bn-NH 12 	dichloro 	 - dichioro 	benzylamine 
Bn 
F 	 I 	 F 
2- 	 I 2-chloro- Bn-NH. 13 	chloro, 	Bn-NH, 	 I 	,=o 	96 I 	23 Strjfluoro 
6-fluoro I an 
Bn 
Reagents and conditions: acid (1.0 mmol), amine/aniline (1.0 mmol). MW 300W, 150 °C, 30 min then, Fd(OAc)2 (3 mol %), lmgand 11 (6 mol %), 
NaOH (2.0 equiv) H 20/toluene (2 mL 1:1), microwave 75 W, 100 °C, 30 min. Isolated yield based on amide. c Isolated amide (1.0 mmol), Cs2CO3 (1.5 
equiv), toluene (2 mL), microwave 200 W, 100 °C, 30 mm. 
tion reactions;' (iii) the intramolecular amidation reaction 
can be carried out using anyl chlorides in addition to aryl 
bromides, thereby greatly extending the range of substrates 
Org. Lett., Vol. 7, No. 5, 2005 
that can be used; (iv) anilines can be used, in addition to 
alkylamines, extending the range of N-substituted oxindoles 
that can be prepared. 
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Scheme 2. Palladium-Catalyzed Intermolecular Amination 
Cl 
I 	 3-fluoroanihne (2.0 equiv) 
Pd(OAC)2 (2moI%), X-Phos (4moI%) 
Cs2CO3 (1.5 equiv), toluene 






In conclusion, we have developed an efficient route to a 
range of N-substituted oxindoles using sequential microwave-
assisted amide synthesis and intramolecular amidation reac-
tions. The approach is particularly efficient when using 
alkylamines since there is no need to isolate the intermediate 
amide. 
(9) Kuwano, R.; Utsunomiya, M.; Hartwig, J. F. J. Org . Chem. 2002, 
67, 6479. 
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Abstract: A general method for the synthesis of [-aryl/ 
alkylarylidene malonates is reported. The key step involves 
the coupling of an arylboronic acid to a /3-chloroalkyl/ 
arylidene malonate, in the presence of K2CO3  and I mol % 
of the air-stable palladium catalyst (POPd) under microwave 
irradiation, to afford fi-aryllalkylarylidene nialonates in good 
yields. The combination of mild reaction conditions, air 
stable catalyst, microwave-enhanced chemistry, and high 
levels of functional group compatibility make this an attrac-
tive synthetic approach to this class of compounds. 
Among the various reactions involving palladium-
mediated coupling of sp 2-carbon atoms with organome-
tallic compounds to form carbon—carbon bonds, the 
Suzuki reaction has attracted much interest due to a 
number of attractive features including high yields, mild 
reaction conditions, and tolerance of a wide variety of 
functional groups.' In view of the proven versatility of 
this reaction, we contemplated its use in the preparation 
of/3-aryl/alkylarylidene malonates 1, precursors for the 
synthesis of a wide range of derivatives including sub-
stituted quinolones, 2 flavones, 3 and other heterocycles' 
possessing biological activity. 
Previous approaches to fi-aryl/alkylarylidene ma!-
onates 1 have relied largely upon Knoevenagel condensa-
tion of diethyl malonate with the corresponding ketone. 
However, this reaction is limited in scope and generally 
only proceeds well for methyl ketones and cyclohexanorie 
derivatives. 5 Our proposed alternative strategy centered 
on the palladium-catalyzed cross-coupling reaction be-
tweenfl-chloroalkylidine/arylidene malonates 2 and aryl-
boronic acids 3 to yield the desired products 1 (Scheme 
1). Vinyl chlorides 2 appeared to be attractive precursors 
University of Edinburgh School of Chemistry. 
Cyclacel Ltd. 
(a) Miyaura, N.; Suzuku, A. Chem. Rev. 1995. 95. 2457-2483. 
(b) Suzuki, A. I. Organoinet. Chem. 1999, 576. 147-168. (c) Hassan. 
J.: Sevignon, M.; Cozzi, C.; Schulz, E.; Lemaire, M. Chem. Rev, 2002. 
102. 1359-1470. 
Hormi. 0. E. 0.; Peltonen. C.; 1-(eikkilä, L. I. Org. Chem. 1990, 
55. 2513-2515. 
Hormi. 0. E. 0.; Moisio, M. R.; Sund, B. C. I. Org. Chem. 1987, 
52, 5272-5274. 
Khalil. Z. I-I.; Yanni, A. S.; Khalaf, A. A.; Abdel.Hafez, A. A.: 
Abdo. R. F. Bull, Chem. Soc. Jpn. 1988, 61. 1345-1349. 
(a) Lehnert. W. Tetrahedron 1973, 29. 635-638. (b) ho, H.: Isobe, 
M.; Kawai, T.; Coto, T. I. Am. Chem. Soc. 1979, 101, 6076-6080.  
O 	 POPd (1 mol%) 
ROEt 	R'— 	H 	K2CO3 (3.0 equrv) 	R 	'OEt 
Cl 	OEt 	"-" 'OH 	THF, 100 °C 	,=< ,i-OEt 
O 	 (1.5equiv) 	 MW, 3Omin 0 	1 
since they are readily prepared in high yield and on a 
large scale from acyl malonates. We reasoned that 2 
should possess high chemical reactivity in the Suzuki 
reaction and hence be amenable to coupling with a wide 
range of arylboronic acids. Finally, an additional aspect 
of our planned approach involved the use of microwave-
enhanced synthesis to facilitate the coupling reactions .6 
The requisite [1-chloro-alkyl!arylidene malonates 2 
were prepared according to the literature procedure 
involving initial treatment of diethyl malonate with an 
acyl chloride to yield the 2-acyl malonate (yields 90-
95%)7 followed by chlorination with POCI 3I1311 3N to yield 
the vinyl chlorides (yields 45-60%) (Scheme 1), 8 
An initial screen of some typical palladium catalysts 
[e.g., Pd(OAc) 2 , Pd(Ph3 P) 4 , tris(dibenzylideneacetone) - 
dipalladiuni (0)] for their ability to mediate the coupling 
of vinyl chloride 2 (R = Me) with phenylboronic acid gave 
low yields of the coupled product (10-15%). We therefore 
turned our attention to the commercially available' and 
air-stable palladium(II) complex I (t-Bu) 2P(OH) I 2PdCl 2 
(abbreviated as POPd). This catalyst contains phosphi-
nous acid ligands on the palladium that are generated 
by tautomerization of RR'P(0)H to less stable phosphi-
nous acids in the presence of transition metals. Since the 
original introduction of these catalysts by Li,'° they have 
become widely used for cross-coupling reactions" and 
appear to be particularly effective for coupling aryl and 
vinyl chlorides. Thus, Li 12 demonstrated the coupling of 
l-chlorocyclopentene to arylboronic acids using POPd. Of 
interest to us was the performance of this catalyst not 
only with vinyl chlorides 2 but also under microwave 
heating conditions. 
Initial optimization studies were carried out using a 
variety of different bases (Na 2CO 3 , K2 CO3 , Cs 2 CO3, and 
K 3 PO4), and all were found to be effective for the cross-
coupling offi-chloroalkyl/arylidene malonates with phen- 
For a recent example of microwave-assisted Suzuki couplings, 
see: Wu. T. Y. I-I.; Schultz, P. C.; Ding, S. Org. Lett. 2003, 5, 3587- 
3590. 
Rathke, M. W.; Cowan, P. J. J. Org. Chem. 1985. 50, 2622-2624, 
(a) Hormi, 0. E. 0. Org. Synth. 1988. 66, 173. (b) 1-lormi. 0. E. 
0. Synth. Common. 1986. 16. 997. 
POPd is commercially available from CombiPhos Catalysts Inc. 
(http://www.cornbiphos.com ). 
(a) Li, C. Y. Angew. Chem.. mt. Ed. 2001, 40. 1513-1516. (b) 
Li. C. Y.: Zheng, C.: Noonan, A. F. I. Org. Chem. 2001, 66. 8677-
8681 
(a) Yang. W.; Wang, Y.: Carte. J. R. Org. Lett. 2003. 5. 3131. 
(b) Wolf, C.: Lerebours, R. J. Org. Chem. 2003, 68. 7077 - 7084. 
Li, C. Y. J. Org. C/tern. 2002, 67, 3643-3650. 
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TABLE 1. Synthesis of fl-Arylialkylarylidene M alonatesa 
POPd (1 mol%) 
- 	 + 	 K2CO3 (3.0 equiv) 
CO2Et 	 THF, 100 0C 
(l,Sequiv) 	MW. 3Omin 
R 	CO2Et 
Rt._<Co2Et 
































H 3C 	B(OH)2 	 1-pr 	CO2Et 
H3CO 
i-Pr 
10 	 CO2Et 	52 
1 
1b 	 B(OH)2 	
Ph 	CO2Et 	
55 
Ph C1__0 Cl__(:~~02E 














Ph 	H2N__C B(OH)2 H21NI__(3_< 	
60 (35)C 
Ph 	CO2Et B(OH) 2 
15 

























a The reactions of fi-chloromalonates with arylboronic acids in the presence of POPd were carried out in 100 'C in TI -IF using Explorer 
PLS. "A trace of bis-aryl product was observed. C  Yields in parentheses are for control experiments involving heating the reaction at 100 
'C for 36 h under non-microwave conditions. 
ylboronic acid. We were rapidly able to identify reaction 
conditions under which clean and rapid coupling of the 
model substrate (2, R = Me) occurs with phenylboronic 
acid 3, using the air-stable palladium catalyst POPd. 
Optimized conditions were vinyl chloride 2 (1 equiv), 
arylboronic acid 3 (1.5 equiv), K2CO3  as base (3.0 equiv), 
and 1 niol % of POPd in THF. Reactions were irradiated 
with microwave heating for 30 min at 100 'C followed 
by workup and silica chromatography to yield the cor-
responding fl-aryl/alkylarylidene malonates in good yields 
(Table 1). The Suzuki arylation reaction was found to 
work with a wide range of arylboronic acids including  
electron-rich (entries 3, 4, 7, and 14), electron-deficient 
(entries 2, 6, and 9) and sterically demanding (entries 5, 
10, and 12) systems. As has been observed before, the 
Suzuki reaction was found to be compatible with —NH 2 
and —OH functionality in the arylboronic acid leading 
to functionalized products 6 and 7 that could be deriva-
tized further (Scheme 2). 
In view of the known ability of POPd to mediate Suzuki 
couplings of aryl chlorides,' ("' the product 8 from entry 
1 was subjected to a further Suzuki reaction with 
o-nitrophenylboronic acid leading to the biphenyl deriva-
tive 9 in 77% yield (Scheme 3). 
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SCHEME 2 
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Finally, as an illustration of the further application of 
the /3-aryl/alkylarylidene nialonates reported in this 
paper, treatment of 10 with polyphosphoric acid resulted 
in cyclization to the 2-carboxyethylindenone 11 in 50% 
yield (Scheme 4). 
In conclusion, we have developed an efficient and 
versatile route for the synthesis of j3-aryl/alkylarylidene  
malonates 1 from readily available precursors, using the 
air-stable palladium catalyst POPd. A wide range of 
arylboronic acids, bearing a variety of functional groups, 
can be tolerated in the reaction. The use of microwave-
assisted heating permits the reaction time to be reduced 
to as little as 30 min enabling a number of different 
analogues to be prepared in a short period of time. 
Experimental Section 
General Procedure for the Reaction of/3-Chloroarylidene/ 
alkylidene Malonates with Arylboronic Acids. POPd (1 mol 
%), fl-chloroalkylidene/arylidene malonate (1.00 mmot). arylbo-
ronic acid (1.50 to 2.00 mmol), and K 2CO3 (3.00 mmol) were 
weighed in a microwave tube, equipped with a magnetic stirrer 
bar, and sealed with a silicon septum. THF (2 to 3 mL) was 
injected into the tube via a syringe, and the reaction mixture 
was subjected to microwave irradiation for 30 min at 100 C.The 
reaction vessel was allowed to cool to room temperature and the 
crude reaction mixture transferred to a separating funnel and 
diluted with hexane (50 mL) and H 3 0 (15 mL). The layers were 
separated; the organic layer was washed with H20 (20 mL) and 
brine (20 mL), dried over MgSO 4 . and filtered: and solvents were 
removed from the filtrate by rotary evaporation. The resulting 
residue was chrornatographed on silica gel using ethyl acetate/ 
hexane as eluents to afford f3-aryl/alkylarylidene malonates. 
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